cx	cy	x	y	score	nptumor	nphit	tumor	name	status
164.36248516009903	-38.7308689104403	201.8892177931495	-14.4407550473111	0.0006	502	52	KIRC	(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE	Experimental
401.900956239249	10.7220829342404	392.0000578982588	0.000344061592841172	0.192	292	42	STAD	QUERCETIN	Clinical trials
182.13523016498783	30.9397878369215	184.16375518516412	-29.3283316851988	0.0006	512	76	UCEC	1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA	Experimental
139.2842595317228	-11.1262837610102	207.8800343203327	-0.424695778888918	0.0004	343	47	HNSC	GW843682X	Experimental
804.3185516816473	35.8687515271741	779.8674380257781	-27.3982716113884	0.596	512	149	UCEC	BGJ398	Clinical trials in cancer
394.2552155010239	3.38841079387308	375.62024289206835	-0.320211627962578	0.181	512	53	UCEC	TRANS-VACCENIC ACID	Clinical trials
233.94344343250398	-47.8957440040184	204.67029315031724	-18.0715192290859	0.0006	502	55	KIRC	5,6-CYCLIC-TETRAHYDROPTERIDINE	Experimental
151.8158351397221	-36.2060859173743	183.80197643504874	0.365135315858879	0.0004	934	215	BRCA	TIPIFARNIB-P2	Experimental
793.435972009417	-97.9829861237028	806.0287603797952	26.2321356210103	0.584	264	112	SKCM	PWT33597	Clinical trials in cancer
782.7193706950198	66.9472592284719	738.9952465556288	35.9592127728757	0.563	57	24	PAAD	GEDATOLISIB	Clinical trials in cancer
138.76165352439307	-0.430538062085304	208.4962251070056	42.4555427686166	0.0004	264	106	SKCM	CD-1530	Experimental
871.6957848770584	39.4489595697796	798.0638520114951	41.8391295085393	0.586	264	111	SKCM	BUPARLISIB	Clinical trials in cancer
790.6509812006802	36.0715529429	786.7752728548794	-10.3728816495392	0.581	512	53	UCEC	AVASTIN+/-TARCEVA	Clinical trials in cancer
1045.4664844993447	19.7153403395947	1042.0616555835786	8.14970205851805	0.841	57	24	PAAD	PEMETREXED	Approved in cancer
780.0338077976462	-14.7976983183418	784.3064443833466	0.689219774221783	0.582	423	89	COAD	BI847325	Clinical trials in cancer
1121.6879838434381	-0.403444664660299	1141.3155863299064	1.69623928301826	0.94	502	63	KIRC	SORAFENIB	Approved in same tumor type
756.0522194400185	-13.1052459559532	789.7327974639875	10.7981619335051	0.587	543	76	LUAD	VOXTALISIB	Clinical trials in cancer
1149.8676553631024	-12.6977309872789	1137.299951466233	4.83855191034718	0.933	502	65	KIRC	PONATINIB	Approved in cancer
195.39594108660464	-27.7317242157285	206.88880966534788	9.06498501543319	0.0006	502	52	KIRC	1,6-DI-O-PHOSPHONO-D-MANNITOL	Experimental
753.0860255798768	-17.2786386943339	788.7525947591776	-4.68116904021167	0.593	292	41	STAD	PWT33597	Clinical trials in cancer
774.8310341854026	14.1071349962913	720.0398538035065	-1.21041206065411	0.515	202	31	LAML	PIMASERTIB	Clinical trials in cancer
830.5605941875235	-12.6595161909579	694.9152052189786	2.52036857470466	0.512	435	183	THCA	1096708-71-2	Clinical trials in cancer
915.1823825869086	-1.31678470952679	915.9999293646439	-0.000163559512202482	0.716	543	66	LUAD	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
191.31722677119606	60.4099130782108	204.02891615822205	14.5114171415078	0.0008	202	33	LAML	PHOSPHOTHREONINE	Experimental
245.6284586547739	-117.68268673141	230.22126318043397	-51.1512990815921	0.0008	264	165	SKCM	PLX4720	Experimental
116.25687449648053	102.423915030954	196.40859872763937	-33.7172951935975	0.0004	435	183	THCA	VX-11E	Experimental
115.42919853482323	-42.7412746008992	193.9777373651632	6.55821403470964	0.0006	169	44	READ	OLOMOUCINE	Experimental
1130.0140327661184	-9.00981888557291	1118.6472859255712	-0.112702993160838	0.921	599	105	OV	ERIBULIN	Approved in cancer
178.5516072384299	-6.82597612486103	199.9967915944269	11.5872191634121	0.0006	502	55	KIRC	1-{(4S)-4-AMINO-5-[(2-AMINOETHYL)AMINO]PENTYL}-3-NITROGUANIDINE	Experimental
270.94646671039686	-86.4177083530057	216.89741701261508	-22.0727773848456	0.0004	169	38	READ	BRD63610	Experimental
768.3778459565752	-5.85604465426334	790.3356033494308	7.85049134129736	0.593	389	47	LUSC	SF1126	Clinical trials in cancer
932.2995246965569	-2.29689120200058	931.9048210887244	-2.4880053232464	0.732	502	59	KIRC	NINTEDANIB ESYLATE	Approved in other pathologies and in clinical trials in cancer
230.17675486422192	-26.7573617102478	234.1505978062483	-3.78744931184701	0.0006	512	75	UCEC	1-ISOPROPYL-3-(6-QUINOLINYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	Experimental
213.4070643048163	1.89233877692214	187.66946191265382	21.6772161481248	0.0006	264	34	SKCM	N-(3-CYANOPHENYL)-2'-METHYL-5'-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-4-BIPHENYLCARBOXAMIDE	Experimental
563.2667443429342	11.576762306034	594.9116634302583	-6.66225226393146	0.391	264	127	SKCM	IBUPROFEN	Approved in other pathologies
69.80013626619714	-35.2043220867237	226.09618955448602	-20.1098872557388	0.0004	222	133	LGG	LY-2183240	Experimental
161.82873364461267	-41.3914944985932	184.55066993321964	12.2667832865791	0.0006	502	52	KIRC	N-{2-[(2R)-4-AMINO-5,8-DIFLUORO-1,2-DIHYDRO-2-QUINAZOLINYL]ETHYL}-3-FURAMIDE	Experimental
235.15729189802437	30.0888448506304	201.6399196480126	34.566384285858	0.0004	512	111	UCEC	PIPERLONGUMINE	Experimental
202.01792308974686	-71.8561250161298	209.7133795203032	-4.23621711469423	0.0008	423	88	COAD	OLOMOUCINE	Experimental
672.0038811539466	74.0269122428038	743.4188515157242	43.2812420306293	0.535	435	212	THCA	PIMASERTIB	Clinical trials in cancer
258.2132842419868	25.1483920842093	195.4423954339028	-33.9958234464439	0.0004	512	106	UCEC	PNU-74654	Experimental
1195.037295042384	5.16778587012237	1190.0237566022147	-0.955665745649128	0.988	512	53	UCEC	BEVACIZUMAB	Approved in cancer
196.1997211204822	22.8719462637417	184.39156812363802	18.5593676526594	0.0008	512	75	UCEC	N-{4-[(3-BROMOPHENYL)AMINO]-6-QUINAZOLINYL}ACRYLAMIDE	Experimental
728.3086829558255	-36.6323632019338	738.9785324453467	2.90820732597604	0.531	153	21	BLCA	DHA-PACLITAXEL	Clinical trials in cancer
881.3186429451738	17.3156754950882	818.7937206701022	-12.5265737551264	0.595	512	144	UCEC	SONOLISIB	Clinical trials in cancer
512.1523130603604	1.51823854916373	511.640766161566	-4.24945820309586	0.311	502	52	KIRC	SUCRALFATE	Approved in other pathologies
1027.8834396843565	-6.27732213234287	1031.0000055870044	-6.44958836346632e-05	0.831	343	44	HNSC	PEMETREXED	Approved in cancer
738.9247463629118	23.7891960650021	781.8657759263169	-0.477742393077733	0.583	222	53	LGG	OBATOCLAX	Clinical trials in cancer
229.4577971024318	-47.1577041475543	206.33036804414394	21.1992358484915	0.0004	512	67	UCEC	COMPOUND 44	Experimental
221.92813843341182	115.678077009356	208.35974364874878	-29.2262946746122	0.0008	57	24	PAAD	[2-OXO-2-({[(2E,6E)-3,7,11-TRIMETHYL-2,6,10-DODECATRIEN-1-YL]OXY}AMINO)ETHYL]PHOSPHONIC ACID	Experimental
254.22558151981409	9.39891856292621	171.1590780274703	1.85110374461061	0.0006	512	53	UCEC	(2R)-N4-HYDROXY-2-ISOBUTYL-N1-[(10S)-9-OXO-1,8-DIAZATRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL]SUCCINAMIDE	Experimental
385.9255833853599	9.76302048637223	380.88663601134846	-2.74769707597738	0.181	543	74	LUAD	ATP	Clinical trials
819.9748252767001	-15.8878460322549	775.2936744146119	8.32461557957504	0.587	543	76	LUAD	ALPELISIB	Clinical trials in cancer
165.64709111394865	2.62975433898995	203.24975085097253	-4.09026983286594	0.0004	543	65	LUAD	NUTLIN-3A	Experimental
800.0776474893648	-27.8253946126653	760.5382697881801	17.585916356271	0.584	264	31	SKCM	SARACATINIB	Clinical trials in cancer
805.8906008180314	9.4906134354012	773.0276516093478	5.47406126023861	0.574	599	72	GBM	ALPELISIB	Clinical trials in cancer
806.7361023528375	5.05874123834013	790.0415460598368	-14.8592959638978	0.582	512	72	UCEC	PF-04605412	Clinical trials in cancer
241.87668671740144	48.8166478980561	212.5010166542182	-8.6285246962143	0.0006	264	34	SKCM	N,4-DIMETHYL-3-[(1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YL)AMINO]BENZAMIDE	Experimental
295.41066387473387	-45.986903936945	209.00680152179746	-20.6719671841918	0.0006	435	211	THCA	N-[(1S)-1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL]-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
175.49839516063741	-28.4933721153709	193.7467504927255	-16.1990585663652	0.0006	502	54	KIRC	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Experimental
737.032110707484	17.3350206901428	750.1575605614977	-2.40976505508775	0.551	389	44	LUSC	DHA-PACLITAXEL	Clinical trials in cancer
178.01885437110082	1.85314822374937	212.27900211135943	2.37797437012341	0.0006	502	55	KIRC	ETHYL 4-[(4-METHYL-2-PYRIDINYL)AMINO]-1-PIPERIDINECARBOXYLATE	Experimental
839.5803622124948	26.2343430806279	816.9478733075243	1.71558081325622	0.596	264	36	SKCM	MASITINIB	Clinical trials in cancer
792.9845258657297	-67.0626003306461	789.1500515666811	-6.92846085424026	0.583	222	55	LGG	GOSSYPOL	Clinical trials in cancer
142.07367752865363	12.0669384658336	221.62200008585611	-10.300811181276	0.0008	423	90	COAD	PHOSPHOTHREONINE	Experimental
1193.3771166299814	10.1295782655	1202.9467767792548	-1.78246922256017	0.997	264	42	SKCM	SUNITINIB	Approved in cancer
1038.460871999799	4.76353435424517	1035.5682179399057	-0.00125350739290297	0.833	264	107	SKCM	PANITUMUMAB	Approved in cancer
987.1589910525627	-8.43604447962542	1000.6263061052074	-2.10083949839571	0.796	512	118	UCEC	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
257.1272637295277	-18.7644016342633	203.67168305308385	-17.1706783103521	0.0004	512	66	UCEC	AS-605240	Experimental
815.612159898571	88.8029069873439	819.5352354791614	5.30812124048765	0.595	512	144	UCEC	ALPELISIB	Clinical trials in cancer
197.14274414018752	-31.2435808024371	204.1922506248269	12.2137497308554	0.0006	502	52	KIRC	VERDOHEME	Experimental
194.1490422033252	-5.52851746834716	204.6663279059229	1.33619237745802	0.0004	543	66	LUAD	NSC632839	Experimental
210.85633115523643	-32.8078844724981	194.60188349254298	18.0261449928971	0.0006	502	52	KIRC	2-AMINOBUTANOIC ACID	Experimental
1011.5018691177061	3.00118706869742	1014.999975397984	-4.52257122560695e-05	0.815	202	23	LAML	CETUXIMAB	Approved in cancer
994.340546481671	-0.292137295176218	988.7527823780478	3.43943899550544	0.791	512	54	UCEC	AFLIBERCEPT	Approved in other pathologies and in clinical trials in cancer
762.9737557425246	-8.39386716729035	807.8241099771444	-3.12861940617131	0.596	153	27	BLCA	VOXTALISIB	Clinical trials in cancer
752.6210096149462	-0.124239558932032	780.9414158446002	-7.38420893951411	0.584	543	76	LUAD	PICTILISIB	Clinical trials in cancer
732.9371449281749	-14.2043110551482	720.1522423753163	3.75095209919141	0.523	343	52	HNSC	TASELISIB	Clinical trials in cancer
165.21539914756895	41.550742991049	190.60275933495453	-3.89133035013992	0.0006	264	34	SKCM	3-FLUORO-N-(1H-INDOL-5-YL)-5-(4-MORPHOLINYL)BENZAMIDE	Experimental
399.25785241258967	0.850140942368085	392.0000791348193	-0.000367771181572607	0.192	153	27	BLCA	QUERCETIN	Clinical trials
227.82034993159922	51.9000913280638	162.29755757286165	21.4683417380909	0.0006	435	183	THCA	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Experimental
309.69705279423516	-12.7995504988667	316.0098537583784	-4.27503035606833	0.111	502	52	KIRC	PLASMIN	Clinical trials
159.83367533247213	40.2885114939637	173.91421693024316	-8.74153648053397	0.0006	512	76	UCEC	INOSITOL 1,3,4,5-TETRAKISPHOSPHATE	Experimental
235.32556765514911	-0.332805793028513	201.4298774780008	-16.2451300230108	0.0006	264	33	SKCM	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
676.820176935321	-23.0931162032805	709.9606622191425	2.14110853370562	0.514	202	31	LAML	AZD8330	Clinical trials in cancer
785.4005927522117	-1.79765367904253	782.6204636616989	-0.0199710595564966	0.583	389	52	LUSC	NAVITOCLAX	Clinical trials in cancer
1198.444052545327	7.85186737280367	1200.305284379563	12.5674796120734	0.998	264	31	SKCM	IMATINIB	Approved in cancer
587.2998262776063	-7.80143431792692	583.9909261269449	-1.57941385277661	0.381	264	32	SKCM	IRBESARTAN	Approved in other pathologies
812.2091382894208	-0.297835391445176	772.6795715921323	-3.38767358244672	0.583	222	54	LGG	NAVITOCLAX	Clinical trials in cancer
1120.2573812305031	7.80467656587376	1128.540745445144	0.852799665899511	0.928	502	56	KIRC	BEVACIZUMAB	Approved in same tumor type
204.71666345989271	-65.1299168795469	192.8591895724054	-2.87307508944377	0.0004	153	20	BLCA	PARBENDAZOLE	Experimental
185.8720707632512	26.5320752813744	211.0907395992687	-30.3070081080342	0.0006	512	75	UCEC	1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	Experimental
183.48422732909393	21.4056278001473	195.77470111353514	3.47626973196498	0.0008	543	74	LUAD	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)-1,2-ETHANEDIAMINE	Experimental
1103.4858985676865	7.51505020040196	1105.7496378085825	-3.47580662807559	0.911	202	31	LAML	DABRAFENIB	Approved in cancer
179.92923141963252	25.7138116849608	194.4331039844291	-1.83256062384203	0.0006	543	75	LUAD	OLOMOUCINE	Experimental
834.7382693678794	23.7909599538598	781.5280412037118	12.5410440035537	0.594	264	38	SKCM	LUCITANIB	Clinical trials in cancer
218.41587584361622	27.8810200693759	185.77581134273387	-11.2724925235678	0.0004	512	87	UCEC	FQI-1	Experimental
190.18921870322677	-60.280719070673	197.0066327462708	-5.83819138760282	0.0004	153	19	BLCA	FQI-1	Experimental
747.869358384141	13.1944798010707	777.3519378410534	3.37284451643268	0.578	599	72	GBM	DACTOLISIB	Clinical trials in cancer
190.33260106792054	66.7698661990434	208.8176876921768	15.9532777486491	0.0008	512	80	UCEC	(+)-STAUROSPORINE	Experimental
194.14951617038258	30.0946225337448	222.9038861409243	14.9986933216846	0.0006	264	34	SKCM	1-{4-CHLORO-3-[(3-PYRIDINYLOXY)METHYL]PHENYL}-3-[3-(2-METHYL-2-PROPANYL)-1H-PYRAZOL-5-YL]UREA	Experimental
256.93581244384427	46.7606843338698	209.40782486554932	5.36653681408006	0.0004	343	53	HNSC	PARBENDAZOLE	Experimental
783.3451893372263	24.8518214398941	794.5197019366506	30.3067322668833	0.581	264	49	SKCM	LERAFAON	Clinical trials in cancer
778.5411970033125	-29.9771603535519	702.3214629104197	-5.2037045036806	0.513	57	7	PAAD	OBATOCLAX	Clinical trials in cancer
222.00718337561278	-14.3101506091479	217.80915111091505	-4.26603244211856	0.0006	502	52	KIRC	OXAMATE	Experimental
139.27496190142818	49.0072822742547	183.93211468924966	3.3118234829098	0.0006	264	34	SKCM	4-[1-(CYCLOPROPYLMETHYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]PYRIDINE	Experimental
335.46748172106214	-21.1465513400256	304.74354098686905	-1.42469031354727	0.111	57	24	PAAD	LAX-101	Clinical trials
745.2520824521881	-5.13118439453373	735.2468839826822	3.71744353845224	0.532	502	56	KIRC	X-82	Clinical trials in cancer
203.77324676440253	-4.36812778810543	223.96485895830318	-6.63004331714166	0.0006	512	75	UCEC	N-(4-((3-BROMOPHENYL)AMINO)--6-QUINAZOLINYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE	Experimental
176.1669065807762	51.9070618362467	173.6608898847314	-18.5763741865811	0.0006	264	34	SKCM	3-FLUORO-5-(4-MORPHOLINYL)-N-{3-[2-(4-PYRIDINYL)ETHYL]-1H-INDOL-5-YL}BENZAMIDE	Experimental
196.78344047753592	8.25919420373009	177.80399269116583	-5.64207041134927	0.0006	512	53	UCEC	KD3010	Experimental
313.7429981528319	95.7182106369417	166.19949864904015	64.5693569643755	0.0008	264	182	SKCM	OLOMOUCINE	Experimental
237.19666248912264	-39.1096536220317	198.47879301422492	-25.9959234069215	0.0006	512	75	UCEC	RU84687	Experimental
185.7954256153324	3.88646382807815	222.00172762850653	-3.60958835334122	0.0006	502	55	KIRC	(4R)-4-{[N5-(N-NITROCARBAMIMIDOYL)-L-ORNITHYL]AMINO}-L-PROLINAMIDE	Experimental
772.7779502207002	-10.3351277084235	805.9910315016916	3.10269881191698	0.594	423	89	COAD	ENCORAFENIB	Clinical trials in cancer
1138.7656019507176	-5.44373269406088	1132.892049004759	2.70259916533951	0.936	502	58	KIRC	PAZOPANIB	Approved in same tumor type
203.62424580800695	-13.2650037426214	201.54495878684486	-14.5497660568185	0.0008	543	74	LUAD	(5S,6Z)-4,5-DIFLUORO-6-[(2-FLUORO-4-IODOPHENYL)IMINO]-N-(2-HYDROXYETHOXY)-1,3-CYCLOHEXADIENE-1-CARBOXAMIDE	Experimental
605.2714753461918	-3.50621290911189	611.9999517828089	-8.53484311846842e-05	0.412	343	44	HNSC	DS-7423	Clinical trials in cancer
259.9754500287437	-79.8501358086841	224.95781948153538	-26.474776427523	0.0006	57	24	PAAD	1,9-PYRAZOLOANTHRONE	Experimental
224.41570161826266	-38.2364992508719	170.57120571388162	11.8462499844065	0.0006	512	75	UCEC	RU78300	Experimental
161.19367922786319	9.39976149417691	195.20334020087924	-11.7296341561218	0.0006	502	52	KIRC	1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE	Experimental
614.7931253680339	-18.9679748827799	617.9800763197634	-7.85294191892581	0.421	435	183	THCA	INDISULAM	Clinical trials in cancer
783.7515457901416	-31.1553361502879	796.7549155089331	8.40309797694749	0.595	343	62	HNSC	BUPARLISIB	Clinical trials in cancer
836.9887195889336	-40.3396511097761	767.1345460433893	-11.8177232010312	0.594	512	143	UCEC	PILARALISIB	Clinical trials in cancer
778.9786587463384	-8.3946446565318	799.8756969368861	-4.53775460714326	0.595	389	42	LUSC	BUPARLISIB	Clinical trials in cancer
846.7656942062567	16.5100786856756	774.8449834045547	11.9603134607589	0.581	512	54	UCEC	MARIMASTAT	Clinical trials in cancer
506.88695216990334	3.80790024106733	514.8067656600073	-1.57065141587373	0.311	502	52	KIRC	AMPICILLIN	Approved in other pathologies
779.3230883457788	45.4366165306555	797.1249875892998	-13.2636232362727	0.593	343	62	HNSC	PWT33597	Clinical trials in cancer
221.87499301629094	17.6999186328619	217.75237108306763	14.9996756484771	0.0006	264	34	SKCM	N-[3-(TERT-BUTYL)-1-METHYL-1H-PYRAZOL-5-YL]-N'-(4-CHLOROPHENYL)UREA	Experimental
761.4679103715321	61.1475097406058	784.1690412137814	8.25554279105768	0.592	343	63	HNSC	BGJ398	Clinical trials in cancer
233.02479977432444	-4.02259611519798	207.44268755121578	-20.1671973588432	0.0004	512	56	UCEC	REPOSAMAL	Experimental
1126.358490129883	-0.301268071161644	1122.7981654207438	0.528670810284893	0.921	202	22	LAML	SUNITINIB MALATE	Approved in cancer
717.7554340317025	21.6687664772726	714.5652060763498	15.2653597477445	0.516	202	31	LAML	BINIMETINIB	Clinical trials in cancer
516.2205213160391	3.50598573891963	513.480550061655	2.45367764247837	0.311	57	7	PAAD	RASAGILINE	Approved in other pathologies
1168.0513694365936	-2.74845254243348	1157.4207101925624	20.519474620416	0.981	264	32	SKCM	VINBLASTINE	Approved in cancer
603.6477518997507	-10.4821389485076	606.2925706898197	-2.11456874830264	0.412	934	214	BRCA	DS-7423	Clinical trials in cancer
220.7316306155042	-56.7193763898494	219.14506046396974	-12.0890164753282	0.0006	502	55	KIRC	6-NITROINDAZOLE	Experimental
241.81132830109212	-58.1163408941453	201.35923670847495	15.7010284346384	0.0006	502	55	KIRC	3-BROMO-7NI	Experimental
120.31712863930852	9.73878807412882	220.67470554442872	-6.93543506987203	0.0004	435	183	THCA	AM-580	Experimental
221.5876942795819	-47.12763667778	192.31484227562314	0.566254929539355	0.0004	343	44	HNSC	TERT-BUTANOL	Experimental
1078.369015855818	0.513359971914468	1086.8783356437075	-0.513728963477377	0.891	512	102	UCEC	PEMETREXED	Approved in cancer
1137.3818804379694	-0.959618067930194	1132.1989752411462	-1.90529390020311	0.935	502	59	KIRC	LENVATINIB	Approved in cancer
614.8056567722431	0.133038969998069	619.2405934186614	-1.16217452232104	0.421	343	44	HNSC	ABT-751	Clinical trials in cancer
779.5952512881316	-88.2195398587879	835.0859218627254	-17.0868404682287	0.587	264	112	SKCM	VOXTALISIB	Clinical trials in cancer
165.8915537267416	47.4828831973028	197.16616001769148	8.06981696684778	0.0006	264	34	SKCM	2-[(2R)-2-BUTANYLAMINO]-N-[2-METHYL-5-(METHYLCARBAMOYL)PHENYL]-1,3-THIAZOLE-5-CARBOXAMIDE	Experimental
749.0243873738058	-25.0661650031512	746.0081225342467	-1.59064705679839	0.544	502	56	KIRC	XL647	Clinical trials in cancer
161.10849510950624	57.3434135493353	226.10394423320784	18.0222114553223	0.0004	57	24	PAAD	FARNESYL	Experimental
252.52624103785286	-19.7436083959549	193.41053644460834	4.58021964189237	0.0006	264	34	SKCM	TRIAZOLOPYRIDINE	Experimental
216.72736750923843	-100.518387494859	219.60099136124035	-18.8389775125767	0.0004	512	108	UCEC	PARBENDAZOLE	Experimental
259.0272638603434	-5.82756129991321	217.32872061161396	5.38032314265934	0.0006	512	76	UCEC	10,11-DIMETHOXY-4-METHYLDIBENZO[C,F][2,7]NAPHTHYRIDINE-3,6-DIAMINE	Experimental
863.0486512975116	-62.0496349058152	787.8263011989916	-16.7919645000465	0.587	264	115	SKCM	ALVOCIDIB	Clinical trials in cancer
792.0634068220537	17.8140967668325	791.7853344290119	-0.0337620175856728	0.581	512	53	UCEC	ABT-510	Clinical trials in cancer
143.74155512656458	27.0033678337514	223.60041567489537	-2.07545112232447	0.0008	423	89	COAD	SB220025	Experimental
236.53798713078308	-33.7109417493896	209.60050273639612	-9.92369022726922	0.0006	512	67	UCEC	N-(4-AMINO-5-CYANO-6-ETHOXY-2-PYRIDINYL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
815.279540876578	73.0565767035944	754.0536540102426	-5.68515205991002	0.534	202	67	LAML	DACTOLISIB	Clinical trials in cancer
150.92704592221094	-29.5028043345932	186.01997777464345	5.02674819958565	0.0006	502	56	KIRC	CAND 5	Experimental
706.5720599313772	-25.4582795672633	742.6704078501964	18.0430156591628	0.542	934	223	BRCA	BGJ398	Clinical trials in cancer
1229.995059280683	-29.0669312067656	1179.475367563011	4.77170968055782	0.993	264	147	SKCM	SORAFENIB TOSYLATE	Approved in cancer
185.18204493601428	-22.5701082671424	205.29741191154272	4.89690463093893	0.0006	502	52	KIRC	1-(ADAMANTAN-1-YL)-2-(1H-IMIDAZOL-1-YL)ETHANONE	Experimental
495.4402346929444	-6.14878457451522	512.9596739903462	9.17548291426829	0.311	435	183	THCA	RASAGILINE	Approved in other pathologies
319.98837335303	1.09547214390039	330.99990599777124	9.58514556259615e-05	0.131	934	101	BRCA	EDARAVONE	Clinical trials
820.468811720521	31.3682200641588	789.9821402146285	18.0000840967888	0.593	512	79	UCEC	AZD5363	Clinical trials in cancer
680.2378700997491	-82.2168884703339	758.5632351166091	-2.0376061286845	0.524	435	184	THCA	RAF265	Clinical trials in cancer
343.78986218388087	4.07448542285016	351.0001644220177	0.000218034944396095	0.151	389	44	LUSC	EDARAVONE	Clinical trials
232.97444179919773	21.4740457882464	203.67702496181434	5.22481751009229	0.0006	169	39	READ	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
717.3847729950223	-21.7405557709005	734.1969543993298	-0.4699310521803	0.532	543	62	LUAD	REOLYSIN	Clinical trials in cancer
814.7712255889685	20.864488011645	777.4394271780968	9.6292391004863	0.583	169	27	READ	GOSSYPOL	Clinical trials in cancer
744.707021761358	120.391136643902	844.1576581834132	-50.0390578900064	0.593	264	192	SKCM	XL281	Clinical trials in cancer
1000.2412851915502	-9.11954454687398	1017.7219499389324	-8.92302431147937	0.823	435	185	THCA	PANITUMUMAB	Approved in cancer
767.172663995882	16.7603756915716	736.5370650577718	-19.5431054740284	0.523	202	53	LAML	BGJ398	Clinical trials in cancer
861.1656927144895	-32.9523559081001	796.2604487977852	-1.8577852811481	0.584	264	112	SKCM	SF1126	Clinical trials in cancer
603.6374727109508	15.892449558829	620.9463071667124	3.99093208740669	0.421	934	214	BRCA	CYT-997	Clinical trials in cancer
976.4766859945012	10.7342473858493	980.4665201569326	-0.123170667964359	0.781	264	117	SKCM	NADROPARIN	Approved in other pathologies and in clinical trials in cancer
1157.2879781772408	-17.774395035307	1152.2930269821363	0.000720296211511595	0.952	934	298	BRCA	DOCETAXEL	Approved in same tumor type
85.89650610178832	20.8079746527751	233.0186808047088	17.4280329453447	0.0006	264	105	SKCM	TAMATINIB	Experimental
213.70341555966525	-9.49326034834399	218.11274191047968	-5.92583165492681	0.0006	512	76	UCEC	[4-({5-CARBAMOYL-4-[(3-METHYLPHENYL)AMINO]-2-PYRIMIDINYL}AMINO)PHENYL]ACETIC ACID	Experimental
818.6143583658715	-34.598322355713	793.2549365895195	10.3757123813521	0.584	512	72	UCEC	VOLOCIXIMAB	Clinical trials in cancer
774.4319439404098	-110.271067085171	812.4029342044386	-17.5730846273516	0.582	264	187	SKCM	GDC-0623	Clinical trials in cancer
731.4286873514445	-4.17811393076443	802.5728628883444	8.05558628466179	0.595	153	27	BLCA	SONOLISIB	Clinical trials in cancer
787.7004289891992	42.4643317910167	809.2328744368965	-18.3810881614547	0.595	512	143	UCEC	BUPARLISIB	Clinical trials in cancer
839.6855123257405	-51.0772512192254	781.5992375070607	15.6366699350723	0.593	512	144	UCEC	APITOLISIB	Clinical trials in cancer
921.5946196348199	2.05695539115027	920.769083595056	0.00216315064835726	0.721	502	56	KIRC	DALTEPARIN	Approved in other pathologies and in clinical trials in cancer
183.62633388552106	47.4359490986841	199.37281737166748	-1.89788337796978	0.0006	264	34	SKCM	1-(2,6-DICHLOROPHENYL)-5-(2,4-DIFLUOROPHENYL)-7-(1-PIPERAZINYL)-3,4-DIHYDRO-2(1H)-QUINAZOLINONE	Experimental
165.1714534388414	-48.8895218906653	200.12178549966333	1.95772393355128	0.0004	153	17	BLCA	(−)-NUTLIN-3	Experimental
730.4042412015609	-32.4041338259486	730.5014919721876	5.46159718273884	0.533	153	16	BLCA	TASELISIB	Clinical trials in cancer
706.5952521956281	20.0345561468853	807.7962057916369	15.9121731530008	0.594	423	79	COAD	PWT33597	Clinical trials in cancer
1142.6798524162457	59.9526931769906	1189.0011816097976	-16.9578363070302	0.97	264	166	SKCM	VEMURAFENIB	Approved in same tumor type
740.1115660607479	-15.1113322675987	750.4908326292962	-5.60715155041953	0.543	934	221	BRCA	PICTILISIB	Clinical trials in cancer
999.0173076587093	2.79909476404526	994.3182954132951	2.95795347667536	0.795	512	89	UCEC	NINTEDANIB	Approved in other pathologies and in clinical trials in cancer
1199.092580895875	-32.62061140945	1193.3522876117856	-7.68553431883379	0.996	169	46	READ	REGORAFENIB	Approved in same tumor type
160.72478895788683	-76.4931704269894	209.19935670367747	-67.4112219173296	0.0008	264	186	SKCM	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
117.71040504901049	22.9942121132449	188.44893426877113	-2.1894779579311	0.0006	169	44	READ	(1AR,8S,10Z,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8-METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H-OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE	Experimental
112.7689451256706	-105.733647283078	133.73233009034004	19.8766325086609	0.0008	264	186	SKCM	(5S,6Z)-4,5-DIFLUORO-6-[(2-FLUORO-4-IODOPHENYL)IMINO]-N-(2-HYDROXYETHOXY)-1,3-CYCLOHEXADIENE-1-CARBOXAMIDE	Experimental
186.7432948053818	70.9819652743651	189.62512115072698	1.09177210566992	0.0006	264	34	SKCM	6-[4-(2-FLUOROPHENYL)-1,3-OXAZOL-5-YL]-N-ISOPROPYL-1,3-BENZOTHIAZOL-2-AMINE	Experimental
813.1247393449382	-89.5682032143336	734.995463098541	-10.3691904914919	0.584	264	141	SKCM	NAVITOCLAX	Clinical trials in cancer
901.9702534881427	-4.97628882826584	870.9999393051841	0.000193286788146452	0.671	57	24	PAAD	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
1017.3388746405835	6.88879918022695	1012.9998085171864	0.000430282428624196	0.813	169	40	READ	PANITUMUMAB	Approved in same tumor type
267.7411752549921	-119.984236836249	210.378652430151	26.2371124043425	0.0006	435	211	THCA	OLOMOUCINE	Experimental
232.99265129796862	-36.7928628619781	204.18083616015585	13.6100150995525	0.0006	512	53	UCEC	L-165041	Experimental
1091.319017591938	0.55513060838075	1092.063273658588	2.90865394551361	0.891	512	57	UCEC	IDARUBICIN	Approved in cancer
193.70496911662332	-54.151340160529	185.52405998057424	16.202271343298	0.0004	934	214	BRCA	LY-294,002	Experimental
333.59676285762924	-8.92857471880535	324.6832090834707	0.266238024578797	0.123	502	55	KIRC	TETRAHYDROBIOPTERIN	Clinical trials
780.3403027832088	-71.461895143056	749.074197238277	-45.8046966202348	0.583	264	112	SKCM	APITOLISIB	Clinical trials in cancer
1179.6832014280617	-17.0053914754852	1189.4053753775868	0.1642666875955	0.99	423	67	COAD	EVEROLIMUS	Approved in cancer
199.9150968693881	-8.38204703721064	191.860894629375	11.5495218761023	0.0004	343	50	HNSC	PIPERLONGUMINE	Experimental
651.5038290288303	-39.9596020785116	683.2965764465242	-33.8300140807844	0.523	435	212	THCA	TAK-733	Clinical trials in cancer
339.2306064004844	27.1007854497466	205.76399305982156	-55.0138010209293	0.0006	435	212	THCA	SB 203580	Experimental
989.7812144822892	8.29036731457472	996.7457186761669	-0.445465120834626	0.795	264	47	SKCM	NINTEDANIB	Approved in other pathologies and in clinical trials in cancer
160.9037646725165	45.8628934678164	182.7626672026138	-5.58092762428879	0.0006	512	75	UCEC	RU78299	Experimental
1204.9127405552495	56.2771449426063	1206.1597041012192	35.6168233874556	0.985	264	189	SKCM	ARSENIC TRIOXIDE	Approved in cancer
721.0928859398779	-19.5152915429304	735.5387979416837	-0.491930722547295	0.533	153	16	BLCA	RIGOSERTIB	Clinical trials in cancer
187.2035908568617	123.985218248869	171.53877666857258	38.5588504481561	0.0006	57	24	PAAD	(5S,6Z)-4,5-DIFLUORO-6-[(2-FLUORO-4-IODOPHENYL)IMINO]-N-(2-HYDROXYETHOXY)-1,3-CYCLOHEXADIENE-1-CARBOXAMIDE	Experimental
182.34314318838912	-14.2561946077713	204.72372144815958	4.65873583212328	0.0004	292	30	STAD	GW843682X	Experimental
245.33938479653122	-69.3498434125501	148.72543602175583	9.51475650011662	0.0006	435	211	THCA	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Experimental
228.5558196631982	-35.113101491185	207.1878657603389	-12.0242464413914	0.0006	543	75	LUAD	N-[(1S)-1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL]-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
154.94862783717934	-3.66590021432839	196.3055855043709	-21.0315193370707	0.0008	423	88	COAD	N-[(1S)-1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL]-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
1187.6632135447167	-2.0309312833981	1194.204440613785	2.36982397828001	0.994	292	37	STAD	ARSENIC TRIOXIDE	Approved in cancer
314.19125347298046	-4.18491537444436	314.41214063046556	2.76164892973202	0.111	502	53	KIRC	FG-2216	Clinical trials
611.9650439676976	4.43423629741363	614.5623999999062	1.51538217072147	0.412	512	66	UCEC	DS-7423	Clinical trials in cancer
1221.4122694881416	3.23142747868553	1190.0691912666114	4.90659320759863	0.998	512	97	UCEC	VANDETANIB	Approved in cancer
191.02382174671507	-47.8156721553686	205.49580196225338	13.534545158067	0.0008	423	58	COAD	[2-OXO-2-({[(2E,6E)-3,7,11-TRIMETHYL-2,6,10-DODECATRIEN-1-YL]OXY}AMINO)ETHYL]PHOSPHONIC ACID	Experimental
283.1359603928558	40.4165197006787	247.45429895223646	-8.01474329595689	0.0006	57	24	PAAD	N-[(1S)-1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL]-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
1123.3406408640747	37.2758667508591	1158.6965958764877	0.0274857165902631	0.953	57	24	PAAD	REGORAFENIB	Approved in cancer
768.7461442061546	-44.5697002628957	808.0415043310957	3.79759170511807	0.595	153	26	BLCA	BUPARLISIB	Clinical trials in cancer
195.781227436599	-48.0698229154971	209.2280103665748	-5.94113051930299	0.0006	502	55	KIRC	N-{(3R,4S)-4-[(6-AMINO-4-METHYL-2-PYRIDINYL)METHYL]-3-PYRROLIDINYL}-N'-(3-CHLOROBENZYL)-1,2-ETHANEDIAMINE	Experimental
152.0077279663633	-21.5949848697826	209.48126637245787	5.71427190879194	0.0006	502	55	KIRC	1400W	Experimental
195.13091013010762	70.5105862536599	185.23059214858463	-2.09001044002054	0.0006	264	40	SKCM	{4-[(10R,11E,14S,18S)-18-(2-AMINO-2-OXOETHYL)-14-(1-NAPHTHYLMETHYL)-8,17,20-TRIOXO-7,16,19-TRIAZASPIRO[5.14]ICOS-11-EN-10-YL]BENZYL}PHOSPHONIC ACID	Experimental
168.81337995793675	0.0449562315754974	195.54701394689175	-0.779514869074774	0.0006	502	52	KIRC	1,6-DI-O-PHOSPHONO-D-TAGATOSE	Experimental
926.0469291702553	1.88785785549297	925.2312334133952	-0.00158724145876477	0.725	502	56	KIRC	RANIBIZUMAB	Approved in other pathologies and in clinical trials in cancer
516.7159421834776	-1.0005028239429	514.2401710546842	2.53613240364848	0.311	502	52	KIRC	TENECTEPLASE	Approved in other pathologies
867.7281288418798	20.8717135245625	747.1428109650072	-28.9680131683867	0.594	264	112	SKCM	DACTOLISIB	Clinical trials in cancer
146.39754212266968	-12.8041523079584	194.66790516469865	15.2311977291993	0.0004	934	215	BRCA	PARBENDAZOLE	Experimental
221.44752740109647	43.4111858333646	214.20878018215163	14.2523738821498	0.0006	512	67	UCEC	2-({2-[(3-HYDROXYPHENYL)AMINO]-4-PYRIMIDINYL}AMINO)BENZAMIDE	Experimental
670.6642455371324	-68.3198666777042	711.3995496599023	5.95669089189505	0.514	435	183	THCA	ALVOCIDIB	Clinical trials in cancer
241.26121441861306	24.3521515901054	168.81052926077726	-13.6836778852233	0.0004	512	106	UCEC	(−)-NUTLIN-3	Experimental
755.6723092912692	24.9176464339666	790.5457013757866	4.69556236801986	0.594	343	62	HNSC	PILARALISIB	Clinical trials in cancer
798.855221075294	16.7784401576996	779.8586108550741	-9.81580740709433	0.581	222	53	LGG	S-8184	Clinical trials in cancer
197.4936765853551	17.1673121072506	187.31632219393464	-1.95755499481538	0.0004	343	52	HNSC	LY-2183240	Experimental
1102.071307798911	-13.1592951197447	1112.0358853311743	0.166473941724234	0.91	543	66	LUAD	EVEROLIMUS	Approved in same tumor type
861.9046750406468	5.28390915961793	749.3690734557272	34.5340011967878	0.583	264	111	SKCM	GSK2636771	Clinical trials in cancer
1194.5926438604793	-25.4207700213701	1208.9463852821848	-1.5488164235307	1	512	78	UCEC	SORAFENIB	Approved in cancer
755.8277303156148	-42.5030671571454	777.1803860747938	11.8343852409016	0.581	423	65	COAD	DHA-PACLITAXEL	Clinical trials in cancer
853.4567198042464	-48.0047502473123	828.3853683856244	-1.53099818963801	0.585	264	112	SKCM	PF-04691502	Clinical trials in cancer
249.49951991965162	25.4199339389415	221.39380953293718	1.10507788837515	0.0004	169	38	READ	FARNESYL	Experimental
220.8599153609095	-35.2579499723893	192.6232664504986	-8.54617898668766	0.0006	502	52	KIRC	(2S)-2-METHYL-2,3-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5-AMINE	Experimental
663.0572498371414	19.1394447221805	734.1954789091446	-8.2969812294962	0.523	57	24	PAAD	TAK-733	Clinical trials in cancer
609.0024545028133	0.242317836845075	612.0312909330449	-2.97786461324711	0.412	512	66	UCEC	DUVELISIB	Clinical trials in cancer
189.0670967200132	81.6216853194312	166.35143973852956	5.03742682015422	0.0006	435	186	THCA	GUANOSINE-5'-DIPHOSPHATE	Experimental
199.41784674524757	-65.7331771119966	208.785496326434	-16.8329175185509	0.0004	423	57	COAD	MERCK60	Experimental
1175.153272403531	18.0185822321515	1190.0649151270327	-7.67300242741379	0.992	512	119	UCEC	ARSENIC TRIOXIDE	Approved in cancer
240.73284494609376	-29.3350446103354	226.80910691919263	3.40937727648918	0.0006	512	53	UCEC	2-{[3-(3,4-DIHYDRO-2(1H)-ISOQUINOLINYLSULFONYL)BENZOYL]AMINO}BENZOIC ACID	Experimental
156.81232138914217	10.0560540405976	192.31484928453168	0.311068750980894	0.0008	292	37	STAD	GUANOSINE-5'-DIPHOSPHATE	Experimental
218.96328968088616	-39.3663767989842	212.99402144431957	0.994853398176019	0.0004	343	44	HNSC	BISTRAMIDE A	Experimental
777.0862893959519	4.73582386321314	712.014123261619	8.93207408345279	0.523	202	38	LAML	XL281	Clinical trials in cancer
196.4414617214203	33.5738512463305	210.89123349669666	20.5998409320073	0.0006	512	53	UCEC	(2S)-2-[3-({[2-FLUORO-4-(TRIFLUOROMETHYL)BENZOYL]AMINO}METHYL)-4-METHOXYBENZYL]BUTANOIC ACID	Experimental
1202.954892165862	-1.90565516553934	1145.7900288638498	10.8477000233208	0.937	57	24	PAAD	COBIMETINIB	Approved in cancer
804.538385023058	46.7494802225606	811.6819299227562	5.43183510642064	0.596	169	43	READ	BINIMETINIB	Clinical trials in cancer
765.5684648311469	-2.98971653212269	800.0846821406717	-7.79431671401852	0.581	512	54	UCEC	BMS 275291	Clinical trials in cancer
525.8270736623459	-4.39595254260226	526.7501371776889	0.144352444494416	0.324	502	57	KIRC	CARVEDILOL	Approved in other pathologies
723.1527855863792	-15.6871749592194	712.7421407328118	3.73529427687345	0.521	502	56	KIRC	SEMAXANIB	Clinical trials in cancer
798.924709115547	-46.4658520891053	797.1602087246794	4.24276769944413	0.586	543	76	LUAD	BUPARLISIB	Clinical trials in cancer
841.4566676708527	-25.6235447253141	702.6663295488	16.7689587051418	0.512	202	31	LAML	GDC-0623	Clinical trials in cancer
734.3093674065912	34.353855126058	721.7115054682107	4.66550352855495	0.522	169	41	READ	REOLYSIN	Clinical trials in cancer
390.22975810485434	2.08870336657361	392.0000887112071	0.000100227158782218	0.192	389	42	LUSC	QUERCETIN	Clinical trials
183.80293722154485	-18.2227104945107	211.33802355626793	6.95385482884717	0.0008	543	60	LUAD	FARNESYL DIPHOSPHATE	Experimental
1142.362993424421	14.5457808614896	1132.697762589383	-0.0195789316255741	0.932	599	106	OV	DOCETAXEL	Approved in cancer
225.6668241600825	-49.3594155040128	195.42323636487546	-3.16107840461405	0.0004	292	31	STAD	EVODIAMINE	Experimental
201.6346834765568	-50.3591264852973	186.1169684275584	19.1926767525047	0.0008	423	88	COAD	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
630.324796615635	24.3842014281815	683.7552557195451	15.0848027600528	0.511	435	183	THCA	AG-024322	Clinical trials in cancer
712.8352434614716	-46.8052872464308	776.8343694149307	4.55644191396641	0.596	423	89	COAD	REFAMETINIB	Clinical trials in cancer
879.4399472805624	79.0126896615142	827.2309229820394	63.7983002448823	0.584	264	188	SKCM	AZD8330	Clinical trials in cancer
246.12000962748027	71.7644939059392	174.23412523014352	28.8088004455477	0.0004	264	106	SKCM	(+)-NEOPELTOLIDE	Experimental
773.9514450743009	42.1906033295893	764.4355968433521	-3.31687687702782	0.582	512	72	UCEC	VITAXIN	Clinical trials in cancer
388.8167910487638	-2.36294933855518	379.42097053026106	2.39851063726337	0.182	264	33	SKCM	AM-111	Clinical trials
215.7405478681648	-50.5101543670148	213.33694368117273	-11.705909579639	0.0008	423	88	COAD	ERK INHIBITOR II	Experimental
693.3013259252515	-16.0955019410802	713.236070480472	-0.538016100669211	0.512	502	52	KIRC	ICRUCUMAB	Clinical trials in cancer
578.0712466674119	-5.52683247886887	575.3089020354683	0.0894816203273194	0.381	169	27	READ	RASAGILINE	Approved in other pathologies
165.05624984292874	21.8509318805242	199.16050083221273	27.6390185491086	0.0006	512	77	UCEC	PF-562271	Experimental
201.36324633205894	-32.5950303386028	197.1606956032109	14.7698732359804	0.0006	502	52	KIRC	N-(4-{2-[(3-CHLOROBENZYL)AMINO]ETHYL}PHENYL)THIOPHENE-2-CARBOXIMIDAMIDE	Experimental
1196.5728857702645	-19.7834718103627	1194.8750434093465	0.218510685549859	0.997	512	75	UCEC	COBIMETINIB	Approved in cancer
654.7734429818055	-7.6161247043382	650.9993893002769	0.000561302408243591	0.451	512	67	UCEC	CYT-997	Clinical trials in cancer
244.91961653893793	-25.8184669985261	173.17920155317287	-19.2539097177212	0.0006	512	75	UCEC	DPI59	Experimental
856.7568622679544	-84.0433482236528	828.2881435600226	20.9379767330329	0.596	264	187	SKCM	PD-0325901	Clinical trials in cancer
192.90413731621408	13.5328874552322	197.82972084837192	-0.794192225438564	0.0006	202	31	LAML	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUOROBENZAMIDE	Experimental
199.96083608317284	-28.6336726400674	202.30013408737415	-3.30725624629849	0.0006	502	55	KIRC	7-NITROINDAZOLE	Experimental
260.75414412887636	-26.1247346875751	177.61088943232082	-21.7018205891566	0.0006	264	33	SKCM	N-(4-AMINO-5-CYANO-6-ETHOXY-2-PYRIDINYL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
246.4883069044465	36.8231081213492	206.8889604506374	4.71658454682222	0.0006	264	34	SKCM	3-(2-CHLOROPHENYL)-1-(2-{[(2S)-3-HYDROXY-3-METHYL-2-BUTANYL]AMINO}-4-PYRIMIDINYL)-1-(4-METHOXYPHENYL)UREA	Experimental
324.3800451546925	0.958202078824058	309.03211984692257	-2.3202084696718	0.111	502	56	KIRC	EDARAVONE	Clinical trials
734.4013905580692	-24.7823672792056	774.7407053014073	-2.59610853922732	0.583	423	69	COAD	NAVITOCLAX	Clinical trials in cancer
148.61276591618244	-2.35350207872511	194.42942408402246	6.53108486032625	0.0006	502	55	KIRC	N,N-DIMETHYLARGININE	Experimental
208.945223094858	-29.1501255404147	188.72255456476077	13.1337536584169	0.0006	502	55	KIRC	2-ETHYL-ISOTHIOUREA	Experimental
278.0044555451745	-54.7688215102802	229.15202218005345	-46.5895716655082	0.0004	435	213	THCA	LY-2183240	Experimental
213.77078314411833	37.7300108484855	181.29008892003006	-16.1615137540884	0.0006	512	82	UCEC	1-[1-(3-AMINOPHENYL)-3-(2-METHYL-2-PROPANYL)-1H-PYRAZOL-5-YL]-3-(1-NAPHTHYL)UREA	Experimental
506.11078551936777	-6.52316980440696	506.7656911525325	1.98784363249251	0.311	502	57	KIRC	IBUPROFEN	Approved in other pathologies
591.0020602205077	22.0401601910144	576.4579286299235	-11.5560975168961	0.381	264	125	SKCM	RASAGILINE	Approved in other pathologies
793.5328832022916	22.8833778551208	758.6140403930818	2.10229996432361	0.594	264	42	SKCM	XL999	Clinical trials in cancer
191.29793609048144	-42.7623385073292	193.93005767967801	-14.5513963723311	0.0004	423	58	COAD	NUTLIN-3A	Experimental
179.78540916974822	-17.6202123311051	209.69511258156953	16.8991010056252	0.0006	502	53	KIRC	.BETA.-D-GLUCOPYRANOSE	Experimental
258.01133448904227	-42.3368084133661	202.9661074142018	1.54853917001219	0.0006	264	32	SKCM	LGD-1550	Experimental
849.345243795446	44.6315858077054	801.9662124265426	1.83855477004931	0.594	169	45	READ	GEDATOLISIB	Clinical trials in cancer
875.0818983943502	-5.72688381512233	722.3429973527412	16.5631290236914	0.583	264	116	SKCM	BAY1000394	Clinical trials in cancer
145.10981701614224	19.021846186023	193.75118755559453	-22.6099443761017	0.0006	512	76	UCEC	3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE	Experimental
304.8284338221901	15.6368927705319	203.01567056547321	-2.22013619761128	0.0006	435	212	THCA	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUOROBENZAMIDE	Experimental
1089.3239785384626	29.1366057726025	1127.0484918457175	-11.5006752726593	0.936	57	24	PAAD	SORAFENIB	Approved in cancer
90.02091222724775	-27.9443720262572	191.98022651260337	32.1180754233787	0.0008	435	211	THCA	ERK INHIBITOR II	Experimental
96.46633984801953	60.6341265497401	187.5190806971163	-8.04154640699016	0.0004	934	214	BRCA	COMPOUND 44	Experimental
787.7546934632437	15.4896426598404	763.3605350372926	3.0997377506456	0.582	512	75	UCEC	BI847325	Clinical trials in cancer
177.27405983862866	-51.9388968581453	209.47744307103113	-18.9035738975417	0.0004	934	216	BRCA	KINETIN RIBOSIDE	Experimental
1129.7347789045768	-3.25095408440379	1145.6420457969725	-0.430039659529029	0.942	502	58	KIRC	THALIDOMIDE	Approved in cancer
846.8255321952091	23.5630081027317	765.2230287563216	-3.24324511965324	0.582	169	43	READ	GDC-0623	Clinical trials in cancer
788.3195972912054	21.0833227393968	760.6997459089198	-29.6132813235706	0.596	264	36	SKCM	MIDOSTAURIN	Clinical trials in cancer
831.0326244732973	19.4480758762969	797.411104539002	9.51241085868116	0.585	264	40	SKCM	CEDIRANIB	Clinical trials in cancer
160.2337095893167	13.0419960998094	199.61178300684682	-0.0626329770248049	0.0006	502	52	KIRC	(E,4R)-N6-(1-AMINOETHYLIDENE)-4-FLUORO-L-LYSINE	Experimental
219.07456429428728	13.1538418533035	215.5607608673804	19.4577493539294	0.0004	512	71	UCEC	TIPIFARNIB-P2	Experimental
187.12977383252968	-49.79460627021	198.98125537586847	1.21080902972267	0.0006	599	69	GBM	GUANOSINE-5'-DIPHOSPHATE	Experimental
402.26597666509565	-16.2957987418058	373.64956702231467	-4.36648387952596	0.181	169	44	READ	ATP	Clinical trials
732.7465808944872	26.7549984595672	728.2644983622214	10.6244288735604	0.522	202	21	LAML	PLX108-01	Clinical trials in cancer
715.5442222389504	123.51140077143	854.6478209660023	31.4224041616692	0.596	264	187	SKCM	BINIMETINIB	Clinical trials in cancer
943.999999999761	-1.083435563487e-10	944.0000317471321	-0.000241430720507196	0.744	423	58	COAD	SIMVASTATIN	Approved in other pathologies and in clinical trials in cancer
682.440698838554	-32.9990414213648	694.5130810736459	14.4918862412956	0.522	57	24	PAAD	GDC-0623	Clinical trials in cancer
322.0566361412693	-2.67162480229297	304.76495134991814	-2.8776082537488	0.111	502	52	KIRC	SIRNA-027	Clinical trials
748.0859776203769	-8.28856918538207	705.9373039610631	-5.36233381551938	0.511	502	56	KIRC	S-8184	Clinical trials in cancer
753.9935335288076	83.2024161075089	782.1247082620283	24.919156113061	0.563	57	24	PAAD	ALPELISIB	Clinical trials in cancer
823.5046299120867	23.4542588366828	790.4811096919725	-23.233961147557	0.592	512	143	UCEC	GSK2636771	Clinical trials in cancer
803.922711535579	-0.75798732207312	784.4808869479323	-6.25652383528791	0.595	343	62	HNSC	ALPELISIB	Clinical trials in cancer
720.3634229986066	13.5111910556667	731.5855998722049	7.81654150477175	0.533	202	23	LAML	CEDIRANIB	Clinical trials in cancer
181.92526281904537	12.0670676646865	210.75194849292686	-1.83215778447538	0.0006	502	55	KIRC	N6-AMIDINO-LYSINE	Experimental
989.9849408047637	0.954867437260646	989.7741263632826	-0.975205160745929	0.791	512	62	UCEC	NADROPARIN	Approved in other pathologies and in clinical trials in cancer
222.42700981541793	132.406072865567	176.3108504304178	9.78510596418437	0.0006	57	24	PAAD	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
1090.5020370311115	-20.1143339195832	1155.0199967912276	9.89327749644372	0.93	435	210	THCA	VEMURAFENIB	Approved in cancer
171.63427574776935	55.9601994840285	194.05987915455026	-4.53039185385592	0.0008	202	23	LAML	ISOCITRIC ACID	Experimental
737.079814905402	5.24107786776165	728.7796183499554	-6.22261532067705	0.534	502	56	KIRC	MGCD265	Clinical trials in cancer
668.0312126262152	9.20817302927207	694.260209301771	0.65900949160357	0.491	512	73	UCEC	ABT-751	Clinical trials in cancer
228.8542323340904	-20.7288481975384	173.31952234994992	22.8580271181283	0.0006	512	83	UCEC	PURVALANOL B	Experimental
1088.958703228605	-3.81736038118731	1090.914956958593	2.95375750669973	0.891	423	58	COAD	ETOPOSIDE	Approved in cancer
249.609118160954	-23.6808264201125	181.013877290266	9.32889280598363	0.0006	512	53	UCEC	TRIS(HYDROXYMETHYL)AMINOMETHANE	Experimental
159.08200615161792	-37.713446036475	202.86467895417414	-4.59002133467766	0.0004	423	57	COAD	FARNESYL	Experimental
108.45875207635267	-12.3740680915205	184.1248283790107	9.37260896653061	0.0006	169	43	READ	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUOROBENZAMIDE	Experimental
822.7405396139684	-67.5785067355465	776.7809362479256	-11.1047580237926	0.583	543	76	LUAD	BGJ398	Clinical trials in cancer
745.7474268286481	21.792091167951	735.7547040140108	9.58373482613774	0.535	202	23	LAML	LINIFANIB	Clinical trials in cancer
763.9802629699376	-18.6494263895239	780.3871549883243	-5.43331814224803	0.583	423	65	COAD	OBATOCLAX	Clinical trials in cancer
810.5270862506056	-69.5654869562997	800.5228827986867	-39.1170646868462	0.583	264	127	SKCM	GOSSYPOL	Clinical trials in cancer
1132.1544670331134	-14.2801327532044	1140.000071098334	-0.000369176715594222	0.94	599	66	GBM	DASATINIB	Approved in cancer
761.2241142722944	-13.7964816867611	734.2292816553116	-0.746271314076694	0.534	502	59	KIRC	LUCITANIB	Clinical trials in cancer
727.5176866897203	-12.7267730246472	732.9994720231364	0.000795174520362707	0.533	343	53	HNSC	OMIPALISIB	Clinical trials in cancer
168.8953134508376	-36.9865741109848	206.67163114613658	7.2667974664887	0.0004	153	21	BLCA	LY-2183240	Experimental
1104.4823192717731	-6.99935301667091	1110.999801583923	-0.000265665112237912	0.911	423	89	COAD	CETUXIMAB	Approved in same tumor type
749.9773567070808	-4.4038902748473	733.1214253657148	-5.18549685988864	0.535	502	56	KIRC	CEDIRANIB	Clinical trials in cancer
138.084508073002	-61.1852582989835	254.5510840430979	-34.3197782617903	0.0008	264	181	SKCM	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Experimental
167.90509013852395	-43.4689363980768	189.25927020317505	-9.91501707841689	0.0006	423	81	COAD	GUANOSINE-5'-DIPHOSPHATE	Experimental
709.937750940707	36.0345482805285	746.9852000733808	4.76815438445237	0.551	343	84	HNSC	S-8184	Clinical trials in cancer
226.5902630155233	18.7632195397948	201.20969105642968	-52.8000419013333	0.0006	264	34	SKCM	1-(4-CHLOROPHENYL)-3-[(3E)-5-(2-METHYL-2-PROPANYL)-2-PHENYL-1,2-DIHYDRO-3H-PYRAZOL-3-YLIDENE]UREA	Experimental
269.12041293090726	-7.52370992960834	208.0713247420005	9.96284458063406	0.0006	512	75	UCEC	RU82197	Experimental
721.6499070578834	-24.5418662307711	721.928664372686	-2.05001123890315	0.522	343	52	HNSC	SAR260301	Clinical trials in cancer
206.43924920914597	17.9941012302871	230.82543695055824	4.56647739178044	0.0006	512	54	UCEC	BB-3644	Experimental
1016.9155056989362	-6.24911068992498	1009.7371908057587	-0.13635692266584	0.812	57	24	PAAD	PANITUMUMAB	Approved in cancer
138.00817410392466	-24.8259129052129	203.4684665363355	-18.7811536746076	0.0006	423	63	COAD	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
253.36636122090687	-41.7447966938093	199.90748438876676	13.4373523353349	0.0006	543	63	LUAD	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXY-2-PYRIDINECARBOXAMIDE	Experimental
190.7873145895741	3.15325983828873	196.88237126880756	9.08387258531889	0.0006	543	81	LUAD	PURVALANOL B	Experimental
752.8552659613601	41.0971497668906	678.489929201694	-0.897812614501845	0.523	435	183	THCA	ISIS 2503	Clinical trials in cancer
725.1223778191229	-76.2327723777027	775.9997657515519	-0.000196399523247237	0.576	934	223	BRCA	DACTOLISIB	Clinical trials in cancer
805.7715590129229	17.6651051424969	792.5522259110573	8.03192000555543	0.587	264	27	SKCM	ENZASTAURIN	Clinical trials in cancer
761.1355085613449	-90.0183527621771	816.5144668190624	41.9942422112047	0.583	264	133	SKCM	ISIS 2503	Clinical trials in cancer
780.846971378261	17.3359830832148	767.509011810405	-5.82685220160374	0.582	423	89	COAD	GDC-0623	Clinical trials in cancer
1165.3402819494647	16.5296203065351	1140.3892198606823	-4.07667591403106	0.94	202	53	LAML	SORAFENIB	Approved in cancer
198.47239240407467	-25.2407118911431	188.5497850178464	-9.37589735132451	0.0006	502	52	KIRC	ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE	Experimental
367.792832061322	-4.21347010059989	386.08438621764543	-2.97038263003469	0.182	423	63	COAD	AM-111	Clinical trials
811.2688686354448	13.8016251784374	781.7029362262824	25.4916027040613	0.581	169	39	READ	CC-401	Clinical trials in cancer
260.09374552900897	-31.4988762371443	235.23168796444946	-9.50866661409754	0.0006	512	75	UCEC	RU81843	Experimental
796.8409039220603	-17.7593508131263	800.4659122758399	-2.60418083248123	0.595	423	79	COAD	BUPARLISIB	Clinical trials in cancer
355.0006277910911	0.460907830184709	352.00019533450893	-0.000582661614771496	0.152	934	222	BRCA	QUERCETIN	Clinical trials
168.48679600830582	8.54134317080008	215.06008028243014	10.2616392084819	0.0006	502	52	KIRC	ADENOSINE-5-DIPHOSPHORIBOSE	Experimental
1136.717216013615	-10.8921184720197	1131.1813192088964	-3.55076429454061	0.932	202	36	LAML	CABOZANTINIB	Approved in cancer
269.88830957158785	91.7991749847391	220.17929133452364	2.28356108171585	0.0004	57	24	PAAD	PP-30	Experimental
1204.8644080723177	-16.5200503810354	1196.6653595288599	4.99531623457511	0.996	264	80	SKCM	CABOZANTINIB	Approved in cancer
755.486292889822	9.73323790332586	727.625426429921	5.55298339157298	0.532	502	56	KIRC	OSI-930	Clinical trials in cancer
730.3373905151957	-28.0832102354367	710.235371821433	-7.34947611490088	0.513	502	56	KIRC	OBATOCLAX	Clinical trials in cancer
272.5894625146771	55.3374093859526	194.28500575049546	-33.0556449871677	0.0004	264	104	SKCM	(5Z)-7-OXOZEAENOL	Experimental
1146.6693549530446	-9.11264093965499	1132.295418820078	-6.48595203261993	0.936	502	56	KIRC	SUNITINIB	Approved in same tumor type
194.2621703945237	-10.4287527398257	199.27302711119296	-12.8416402700677	0.0006	202	31	LAML	(5S,6Z)-4,5-DIFLUORO-6-[(2-FLUORO-4-IODOPHENYL)IMINO]-N-(2-HYDROXYETHOXY)-1,3-CYCLOHEXADIENE-1-CARBOXAMIDE	Experimental
393.5871961607873	-1.08982104267614	378.848145074009	-1.05651803657156	0.181	292	36	STAD	EDARAVONE	Clinical trials
178.02732988810703	8.72972591236498	193.37733097146537	10.9769169309866	0.0008	202	32	LAML	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
179.0042639581571	109.43173163831	236.79526643149998	5.02525422770748	0.0004	57	24	PAAD	BRD63610	Experimental
199.54922908881738	4.9397839302386	219.24238948321937	11.0989723979123	0.0006	502	55	KIRC	CACODYLIC ACID	Experimental
257.1266674575437	-36.7972512039073	193.72598552315833	-15.6765918711528	0.0008	202	32	LAML	(1AR,8S,10Z,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8-METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H-OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE	Experimental
779.4112433307632	38.6752027504374	780.107273960125	-7.42440856442727	0.595	264	46	SKCM	DOVITINIB	Clinical trials in cancer
261.4710891757416	50.2234707642758	175.1191557257298	15.5189389302791	0.0008	512	67	UCEC	WORTMANNIN	Experimental
202.42149941312005	20.7707502814891	195.53850614760347	5.01163165601793	0.0008	202	32	LAML	[4-({5-CARBAMOYL-4-[(3-METHYLPHENYL)AMINO]-2-PYRIMIDINYL}AMINO)PHENYL]ACETIC ACID	Experimental
178.7167303671654	20.5729737344826	216.7744632759302	-4.03806429443443	0.0006	543	76	LUAD	SB 203580	Experimental
729.2822251974984	12.4183570587068	707.4060878319996	-2.77862349588258	0.514	202	25	LAML	MK-2206	Clinical trials in cancer
382.3992586878949	5.87791872673603	384.4879114453597	2.19346639590714	0.181	264	34	SKCM	DORAMAPIMOD	Clinical trials
746.884629573396	-37.3252872337231	726.5866694136207	1.21671973699722	0.521	502	56	KIRC	AVASTIN+/-TARCEVA	Clinical trials in cancer
153.4069144476187	-13.9249981887097	191.76124023709644	6.94059663703729	0.0004	543	70	LUAD	KINETIN RIBOSIDE	Experimental
191.64475368727176	25.538014854627	201.83160311116475	7.9655148176787	0.011	343	45	HNSC	TRIPTOLIDE	Clinical trials
809.3063598821908	-114.089485163654	794.9667803910903	-75.5205359245966	0.6	264	187	SKCM	SELUMETINIB	Clinical trials in cancer
216.5097447237465	42.5702942048605	196.80530275698834	-18.0721856196348	0.0004	264	34	SKCM	FQI-1	Experimental
783.0653371264779	-6.55105586347506	790.0107965867925	-4.24841185492346	0.6	543	74	LUAD	SELUMETINIB	Clinical trials in cancer
710.6946662683475	-77.8513824111658	740.6480446188915	-5.33352827314798	0.542	435	212	THCA	CI-1040	Clinical trials in cancer
1164.5749140830387	60.2132781851162	1163.555197876079	-16.5305580046993	0.97	264	114	SKCM	TEMSIROLIMUS	Approved in cancer
713.0014060790446	18.4898611194128	773.7221839014466	-1.43893425861711	0.587	543	76	LUAD	COPANLISIB	Clinical trials in cancer
585.9560330116119	10.4291205979785	588.1655444732446	-0.575274076054939	0.384	169	27	READ	IBUPROFEN	Approved in other pathologies
160.65896369663102	-54.0666607595397	206.14456278159827	-13.9109996563075	0.0006	502	56	KIRC	VEGF-AS	Experimental
210.18707457855746	-24.9934107572273	206.49649435090691	-2.5657102062969	0.0006	502	52	KIRC	ALUMINUM(III) ION	Experimental
229.58053913712791	27.3583152792671	204.25427364679635	-3.6727281049765	0.0006	264	34	SKCM	2-AMINO-3-BENZYLOXYPYRIDINE	Experimental
274.00199536439806	8.91096567880498	223.59742722306373	-31.3588940450639	0.0008	264	112	SKCM	PI-103	Experimental
245.2598130904282	-18.6676523433074	215.33803594281596	-11.098970521251	0.0004	934	215	BRCA	ML214	Experimental
1124.8910738488457	-25.7405466326541	1115.886120252959	-18.7017099689806	0.914	435	183	THCA	PACLITAXEL	Approved in cancer
744.6078800185288	-28.9848599016542	793.761980599336	12.3257465723518	0.593	153	27	BLCA	SF1126	Clinical trials in cancer
151.01860425873278	-17.7544393091173	184.48300936055398	1.0588881947956	0.0006	502	52	KIRC	(3R)-3-[(1,2,3,4-TETRAHYDRO-7-ISOQUINOLINYLOXY)METHYL]-2,3-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5-AMINE	Experimental
1209.218652516484	7.79197349356463	1180.8299236288792	-2.8906465413254	0.983	543	86	LUAD	ARSENIC TRIOXIDE	Approved in cancer
742.9587483678483	-82.170599232996	717.8976524488627	-23.9421559343268	0.522	435	212	THCA	BI847325	Clinical trials in cancer
789.6018992875169	-53.8754789345774	795.6482414547874	4.98614096027359	0.596	153	31	BLCA	BGJ398	Clinical trials in cancer
717.0571698650314	58.4260888651978	708.1819640551648	-19.7527789273715	0.522	202	53	LAML	PILARALISIB	Clinical trials in cancer
751.0151936594029	-40.0572027581321	731.2601823005324	-2.58596318559603	0.531	934	101	BRCA	DHA-PACLITAXEL	Clinical trials in cancer
159.06590804581586	3.565668241552	205.03561371199183	-11.0826599785973	0.0008	423	88	COAD	[4-({5-CARBAMOYL-4-[(3-METHYLPHENYL)AMINO]-2-PYRIMIDINYL}AMINO)PHENYL]ACETIC ACID	Experimental
854.7170984862976	17.1009162070379	795.3685400728875	28.3043699139254	0.595	169	43	READ	PIMASERTIB	Clinical trials in cancer
230.96413077848786	-0.531184902603542	203.31257908768396	17.6786567903185	0.0006	512	53	UCEC	KD-3020	Experimental
179.34415945560954	-102.00944495674	168.0210402970986	2.94408298046392	0.0004	222	130	LGG	CYTOCHALASIN B	Experimental
831.7463816424178	34.1519904790833	713.9371716151991	31.5201468425967	0.563	264	111	SKCM	PLX3603	Clinical trials in cancer
754.4380733650673	18.6505663081127	773.4061761642446	-17.6313091042683	0.584	512	76	UCEC	AZD8330	Clinical trials in cancer
1146.0956697661409	-0.475648738496631	1140.7860532630218	3.43762420588291	0.939	202	23	LAML	SUNITINIB	Approved in cancer
1163.3712416040482	-27.4989473848878	1178.8812441345162	4.64771413241237	0.982	222	57	LGG	DOCETAXEL	Approved in cancer
308.77499530215664	-57.6887777741251	219.67241026700304	26.0576474152001	0.031	264	106	SKCM	URSOLIC ACID	Clinical trials
1232.1693108170118	-4.84342362521488	1145.3467481745856	-17.7978038344969	0.982	264	127	SKCM	DOCETAXEL	Approved in cancer
383.5605018589521	-25.4741987879848	382.2747794274482	-13.5305100398561	0.181	264	85	SKCM	ATP	Clinical trials
541.8632463377257	4.14760811602451	540.8333755481755	-0.0886290929438474	0.341	343	56	HNSC	CAFFEINE	Approved in other pathologies
224.27512154336867	-33.1210357176481	194.0626639883684	-4.65487158575479	0.0006	502	52	KIRC	THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE	Experimental
144.2271595405733	-29.0568289434539	198.3889666680186	6.78831905496372	0.0004	934	214	BRCA	AS-605240	Experimental
198.61679750167815	-35.3063340208506	199.2651165820172	-11.1358744394011	0.0006	502	52	KIRC	FENOXAPROP-ETHYL	Experimental
237.8364386207149	-102.083062147379	203.70764922673004	-10.4108411570066	0.0008	169	44	READ	ERK INHIBITOR II	Experimental
809.996464635289	59.0054333519498	765.0387060305571	28.5213385384458	0.587	264	111	SKCM	COPANLISIB	Clinical trials in cancer
212.01115141989217	-16.0200123226157	206.38046845580615	6.57023074926929	0.0006	543	75	LUAD	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
178.55503796345306	47.2955764780625	197.4076424016492	-23.0798460008129	0.0006	264	34	SKCM	4-{4-(3-IODOPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-5-YL}PYRIDINE	Experimental
773.4397202671421	36.5491176950947	802.7668573494748	-3.41682006435673	0.6	512	79	UCEC	SELUMETINIB	Clinical trials in cancer
375.28259649261594	-1.69177321295641	377.0133327815118	0.600507194260445	0.181	543	65	LUAD	LAX-101	Clinical trials
1109.0876494992563	9.86538848054983	1127.785626942584	2.1482456406045	0.928	202	31	LAML	TRAMETINIB	Approved in cancer
879.1033196731928	28.1653281896147	803.921020844932	11.9810053736288	0.6	169	43	READ	SELUMETINIB	Clinical trials in cancer
993.4846829579943	3.85038928703295	991.2858139514339	-2.02311225215743	0.792	264	28	SKCM	SULFASALAZINE	Approved in other pathologies and in clinical trials in cancer
217.51215322945959	47.4112268503463	199.4891461637102	3.80832911281425	0.0006	512	75	UCEC	PHENYLMALONIC ACID	Experimental
210.60073085195165	19.5111319981901	207.88389393103594	30.9353363876308	0.0006	512	75	UCEC	RU78783	Experimental
103.36352463106618	18.5241397334555	172.9375242827911	36.0844883953584	0.0006	435	212	THCA	SB220025	Experimental
769.5819694787781	90.0366524958807	801.3074821976204	-2.76513644009287	0.584	57	24	PAAD	DACTOLISIB	Clinical trials in cancer
824.3898862912582	-3.04986480370141	778.6269077391405	2.04702635007243	0.593	512	76	UCEC	XL281	Clinical trials in cancer
132.69809757381609	98.804769462805	159.68831702302728	7.03548459933455	0.0006	57	24	PAAD	[4-({5-CARBAMOYL-4-[(3-METHYLPHENYL)AMINO]-2-PYRIMIDINYL}AMINO)PHENYL]ACETIC ACID	Experimental
787.2351008277398	-24.783903524302	781.8630102210363	16.7698344479786	0.595	423	79	COAD	ALPELISIB	Clinical trials in cancer
204.7704402891369	34.672642254304	212.10972825126746	-7.13558689600472	0.0008	543	76	LUAD	PI-103	Experimental
807.5815513177441	-8.62853267138286	819.8130968269537	-1.07118857676801	0.595	169	45	READ	SONOLISIB	Clinical trials in cancer
158.43942324577716	-100.264342037209	204.90920843415626	61.9596158473944	0.0006	435	211	THCA	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
321.6760363451833	-6.87708343068837	320.71852285315083	2.1336714085619	0.121	502	55	KIRC	L-CITRULLINE	Clinical trials
818.1035965924985	-7.78060785517863	775.8537616780255	17.7659284963132	0.582	169	43	READ	RO4987655	Clinical trials in cancer
313.5443816404496	-8.31939013990274	310.3443525675489	1.77684146140246	0.111	502	52	KIRC	TELBERMIN	Clinical trials
733.8756651442941	-66.3575506260157	731.8113650062957	20.7332021313381	0.522	57	24	PAAD	ENCORAFENIB	Clinical trials in cancer
1047.9213065677718	-18.2874622956467	1030.9999812691	-5.96875606788672e-05	0.831	222	129	LGG	PEMETREXED	Approved in cancer
837.0475946629641	60.9530798361052	807.3435873913603	-1.53924427546485	0.585	264	35	SKCM	LINIFANIB	Clinical trials in cancer
809.2023463958042	20.4572351008461	786.3253573874672	-0.0744945990461474	0.586	599	73	GBM	BGJ398	Clinical trials in cancer
774.2285621656935	-24.8518871031712	804.3867974745916	1.52371844623644	0.595	292	41	STAD	BUPARLISIB	Clinical trials in cancer
176.43103047508413	-1.49103265150646	198.8029210126364	-5.72873404755956	0.0008	292	31	STAD	PURVALANOL B	Experimental
215.42263658543393	9.68977525855553	197.07282610344558	0.901901955317271	0.0008	292	33	STAD	O-PHOSPHOSERINE	Experimental
208.25018997394235	-86.5666432614894	206.25148853491157	81.8623545476038	0.0008	264	158	SKCM	GUANOSINE-5'-DIPHOSPHATE	Experimental
770.6195397962642	-65.7257100123242	799.1717893417342	-0.564642661922335	0.595	292	41	STAD	COPANLISIB	Clinical trials in cancer
1085.7285771203276	1.44987909432817	1094.0579317635184	-2.39458729733019	0.891	512	88	UCEC	ETOPOSIDE	Approved in cancer
249.79347154250559	-28.5964863492144	226.86725795155178	-23.9476616608883	0.0006	512	75	UCEC	PHENYLPHOSPHATE	Experimental
1096.2459927865536	0.599268890205224	1119.999999845496	-0.000348674761653456	0.92	343	47	HNSC	CETUXIMAB	Approved in cancer
859.4005475110272	45.7973231187798	774.8491563283096	6.00207974266368	0.583	222	53	LGG	OBLIMERSEN	Clinical trials in cancer
219.36536272729847	-63.4515472154711	192.98850865058537	-0.666647194738744	0.0004	934	217	BRCA	PNU-74654	Experimental
754.1697345530557	5.10835949300571	782.715679981464	2.09833730054197	0.583	543	76	LUAD	APITOLISIB	Clinical trials in cancer
693.5971209918572	-39.2567628461765	722.2888100175966	-4.66576769309063	0.522	169	38	READ	RAS PEPTIDE CANCER VACCINE	Clinical trials in cancer
623.0744819004144	-37.9720419775655	632.9794050126252	-11.5430354020534	0.431	222	132	LGG	CYT-997	Clinical trials in cancer
638.3502215430058	-30.7281063580238	661.000030717506	-0.000365046681963577	0.461	934	215	BRCA	PX-12	Clinical trials in cancer
82.88373387393125	79.1563619871029	172.87097165256503	-37.4553077499048	0.0008	264	185	SKCM	SB220025	Experimental
172.13001588776518	-6.24291049778938	191.24428482128897	-16.434144394681	0.0004	934	215	BRCA	NAKITERPIOSIN	Experimental
811.3407737243465	-20.7243619964417	757.5567107846334	2.28378252722109	0.562	599	70	GBM	GSK2636771	Clinical trials in cancer
148.5918591699369	100.435585419438	191.72685505485308	-48.5293619166413	0.0004	264	104	SKCM	DC-45-A2	Experimental
847.0800280127316	-35.5308699806247	786.4071599137848	5.45277768555144	0.594	512	144	UCEC	PWT33597	Clinical trials in cancer
708.713428764335	84.7259402494313	726.9941349893323	-23.5134644540677	0.522	57	24	PAAD	RO4987655	Clinical trials in cancer
708.9349155663083	-12.8807625981255	716.0189701706198	-0.685576609880854	0.522	343	52	HNSC	INK-1117	Clinical trials in cancer
754.6990616324252	30.9088040213566	757.9189173381217	0.48004020638416	0.553	512	67	UCEC	TASELISIB	Clinical trials in cancer
776.2876489857722	-52.8602405243837	777.1709606126865	3.02634440166639	0.585	543	77	LUAD	XL281	Clinical trials in cancer
792.5319786758256	6.70617662893358	777.2226574097259	3.27934842702598	0.583	264	43	SKCM	AZD5363	Clinical trials in cancer
165.07432763654552	12.1311758795779	186.3131516587474	6.02275698957942	0.0008	543	80	LUAD	GUANOSINE-5'-DIPHOSPHATE	Experimental
722.5937806264425	71.1000762605947	770.2554183231158	12.5426136536834	0.551	264	112	SKCM	P1446A-05	Clinical trials in cancer
1217.4877444172791	36.0876274815056	1169.1403772860574	22.5480695835244	0.981	264	125	SKCM	ERIBULIN	Approved in cancer
803.3159066699744	-36.7121356538763	791.1881741307494	3.09847543318028	0.595	389	47	LUSC	SONOLISIB	Clinical trials in cancer
1185.6279339528871	20.0340758165641	1184.778541805686	-8.74659002410817	0.981	169	27	READ	ERIBULIN	Approved in cancer
233.9130105663303	-17.8245023756422	199.6221175932356	9.85170577459098	0.0008	202	32	LAML	PURVALANOL B	Experimental
1136.7180059789746	-19.7216165461221	1150.9999047940078	0.000400240093767934	0.951	343	84	HNSC	ERIBULIN	Approved in cancer
699.5515474508956	41.8867802151357	762.044408303136	3.5916687461995	0.563	599	70	GBM	COPANLISIB	Clinical trials in cancer
631.6583659730504	41.1520206843446	705.1227065876784	35.8197897341179	0.511	435	183	THCA	P1446A-05	Clinical trials in cancer
217.41192262373502	-27.7440624464092	192.20565121402655	-12.1845966669973	0.0006	543	63	LUAD	N-(4-AMINO-5-CYANO-6-ETHOXY-2-PYRIDINYL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
706.0084470772701	-58.8442821516908	747.2120100816929	13.0224040785902	0.522	435	212	THCA	GDC-0623	Clinical trials in cancer
497.5292306313883	11.8484425285219	496.0982878839731	2.55394220298331	0.311	435	211	THCA	ISOPRENALINE	Approved in other pathologies
711.8387129938908	26.6832904675745	755.7110217466424	-13.5020592581045	0.545	934	221	BRCA	BUPARLISIB	Clinical trials in cancer
805.2341575662545	-48.7334850068928	811.9552615616203	9.08491734798508	0.6	423	90	COAD	SELUMETINIB	Clinical trials in cancer
820.0386053933626	-51.3994798041978	795.5009512692684	15.6667155925298	0.595	512	75	UCEC	PD-0325901	Clinical trials in cancer
185.11673155519006	-55.8811108091724	197.16876203335784	-8.38145594790922	0.0008	423	89	COAD	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUOROBENZAMIDE	Experimental
744.3839664435955	3.32521307495526	739.5891084012011	7.18978084979881	0.535	202	23	LAML	DOVITINIB	Clinical trials in cancer
723.445411734572	-53.4621544967528	709.9787201714199	-40.2856411847858	0.513	435	183	THCA	OBATOCLAX	Clinical trials in cancer
124.0373926590371	30.3131413018742	208.07483627276088	23.490256161657	0.0006	169	44	READ	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
704.0830743464007	-11.9057235967618	717.4154916542758	-6.64436573480953	0.521	502	56	KIRC	ERLOTINIB+BEVACIZUMAB	Clinical trials in cancer
777.855904077992	-20.8901528578558	793.1508243308668	-8.18178362808499	0.593	292	41	STAD	SF1126	Clinical trials in cancer
756.7185975149838	100.832063027765	688.9804009010983	31.0531376785252	0.511	435	183	THCA	RO 31-7453	Clinical trials in cancer
245.82133265383433	17.4939563240176	211.98275731062884	15.8865664465261	0.0008	423	88	COAD	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
703.5658169681825	-7.56067980344056	705.3915639040631	3.06190277516862	0.511	502	52	KIRC	DICHLOROACETIC ACID	Clinical trials in cancer
372.6290718601393	26.9312518356438	369.55859829785743	9.17180945718718	0.181	264	125	SKCM	EDARAVONE	Clinical trials
155.60284552270346	-25.3822531536767	191.84091616462197	-3.58010890973401	0.0006	423	63	COAD	1,9-PYRAZOLOANTHRONE	Experimental
209.75918594471304	8.97000858809707	226.81608155428142	-17.9987726885654	0.0006	512	78	UCEC	BIM-1	Experimental
566.9370421229487	-0.752344348759237	580.4310976390638	3.72778968944203	0.381	423	65	COAD	IBUPROFEN	Approved in other pathologies
802.413315757507	94.9127162388804	730.2391348124542	-29.0026873279805	0.554	264	113	SKCM	RIBOCICLIB	Clinical trials in cancer
1188.7005698465402	13.1119970350246	1189.814484993982	0.231253455348451	0.99	153	18	BLCA	SORAFENIB	Approved in cancer
182.70199203361366	-25.9041498731529	201.08559201069755	4.16266982911429	0.0008	502	56	KIRC	CEP-7055	Experimental
781.7995866430083	-42.1617816573333	803.0735810669553	-11.1022402905169	0.583	423	89	COAD	TAK-733	Clinical trials in cancer
212.81419396615408	13.8217344816755	197.4754180548707	15.813635602733	0.0008	202	32	LAML	OLOMOUCINE	Experimental
765.4843590639618	36.2563380150167	792.1862506873887	-1.83297720934286	0.583	169	43	READ	TAK-733	Clinical trials in cancer
813.6104142289194	-38.43942601317	721.0763260453504	-2.15161237180268	0.523	599	105	OV	OBLIMERSEN	Clinical trials in cancer
646.1274270768182	32.5638483826554	717.403560413258	-9.68034210345141	0.512	57	24	PAAD	RAS PEPTIDE CANCER VACCINE	Clinical trials in cancer
759.3968300991835	-70.6099492868006	766.1956320164651	-40.4389910837959	0.583	264	125	SKCM	OBATOCLAX	Clinical trials in cancer
1108.4961091869993	-21.893835086709	1100.4175688856385	13.860855383022	0.912	435	183	THCA	SORAFENIB TOSYLATE	Approved in cancer
280.34856265759436	-8.24013151916751	216.82833509160847	9.41102503538787	0.0004	435	183	THCA	NVP-BHG712	Experimental
794.5369983914323	-25.8952469259047	803.1996551123796	-2.32511425469511	0.594	343	62	HNSC	PF-04691502	Clinical trials in cancer
205.81316023457754	111.554371777342	188.14887770855512	41.3039695676464	0.0006	57	24	PAAD	OLOMOUCINE	Experimental
651.3467588033818	48.4147109602116	707.8357224568301	4.16738256133866	0.522	57	24	PAAD	BI847325	Clinical trials in cancer
843.3342448957899	-17.5063721624598	800.0988384468333	-8.6473558023871	0.595	169	45	READ	BUPARLISIB	Clinical trials in cancer
230.13841498768824	14.3318167186382	199.39202378521543	-6.70900738847104	0.0006	202	31	LAML	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
222.2184852777936	-4.71210624915784	189.24972697774982	28.3721743541817	0.0004	512	71	UCEC	NAKITERPIOSIN	Experimental
244.55106614356865	-47.8689812137799	236.82055646346058	-11.8332831078253	0.0008	435	184	THCA	N-(2,4-DIFLUORO-3-{[5-(3-PYRIDINYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL}PHENYL)ETHANESULFONAMIDE	Experimental
1126.3049948574742	14.707824623798	1111.7733801418956	-2.28940115122987	0.913	202	31	LAML	BOSUTINIB	Approved in same tumor type
783.3651018103176	11.8177095871671	756.6045254523392	1.79002346103903	0.553	389	45	LUSC	GOSSYPOL	Clinical trials in cancer
188.82047298026873	-132.772867230944	179.36417465948944	-17.7535544760981	0.0004	222	132	LGG	PNU-74654	Experimental
793.0082010617699	80.1018163573545	769.566318809052	-22.3514712283495	0.561	264	114	SKCM	AG-024322	Clinical trials in cancer
1071.4684923324828	18.430638398734	1071.9988607389294	0.00111674941848605	0.872	264	164	SKCM	CETUXIMAB	Approved in cancer
287.32139856300154	-94.8550311433666	248.32969555021896	64.1871361160427	0.0008	264	184	SKCM	PHOSPHOTHREONINE	Experimental
239.22486964120202	17.9604947644947	202.0234253164358	6.43237277176212	0.0006	264	34	SKCM	2-FLUORO-4-[4-(4-FLUOROPHENYL)-1H-PYRAZOL-3-YL]PYRIDINE	Experimental
782.7504979555559	7.40251345414913	785.8718697517415	-5.65441955798065	0.585	264	34	SKCM	MOTESANIB	Clinical trials in cancer
1183.2313084603486	-11.2087269849726	1174.7387824826403	-9.22094080465388	0.982	264	48	SKCM	BORTEZOMIB	Approved in cancer
214.60802446991457	51.4678533504708	190.0921602009537	14.2029811970871	0.0006	264	34	SKCM	N-CYCLOPROPYL-4-METHYL-3-(2-{[2-(4-MORPHOLINYL)ETHYL]AMINO}-6-QUINAZOLINYL)BENZAMIDE	Experimental
1174.9394068520662	-23.030156812098	1184.8958707774198	7.11014823565529	0.983	423	96	COAD	ARSENIC TRIOXIDE	Approved in cancer
819.7915383591032	-0.405326794634504	775.0282262442312	20.6766017348359	0.573	512	68	UCEC	OMIPALISIB	Clinical trials in cancer
149.76989404249377	33.7049334183771	202.4753863772812	-9.18455961877567	0.0008	543	74	LUAD	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUOROBENZAMIDE	Experimental
802.0128131199267	6.57041456125182	804.8253867504668	-9.45038376163734	0.596	512	75	UCEC	BINIMETINIB	Clinical trials in cancer
250.05949597556	11.9617153625531	193.86171593809496	25.0643245608969	0.0006	512	75	UCEC	(1AR,8S,10Z,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8-METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H-OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE	Experimental
756.1921303463416	54.4142809755021	774.1340585951077	1.91420247315614	0.593	169	44	READ	XL281	Clinical trials in cancer
364.2386051184999	-8.13322393678368	362.9999472974354	-0.000133947920630817	0.163	599	70	GBM	QUERCETIN	Clinical trials
147.04320618040938	-6.22135023544786	196.62907409730897	-7.8886012407429	0.0006	502	52	KIRC	N-[2-(6-AMINO-4-METHYL-2-PYRIDINYL)ETHYL]-4-CYANOBENZAMIDE	Experimental
211.54387663036047	-39.3296787941884	212.86289676410047	13.3256276900293	0.0004	934	214	BRCA	BISTRAMIDE A	Experimental
1182.4670899714192	13.9367048983733	1182.2735648534251	6.42815713757545	0.982	512	100	UCEC	DOCETAXEL	Approved in cancer
170.25100166400122	-49.7110747547528	182.47415032179157	-10.1357747123529	0.0006	423	63	COAD	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
771.2614832074281	-18.6105772463432	770.1994747538012	9.78683830255477	0.582	423	89	COAD	RO4987655	Clinical trials in cancer
619.9220281861419	1.19247088277041	624.7774066975073	0.00264898881277986	0.424	202	22	LAML	CRENOLANIB	Clinical trials in cancer
745.1975894717108	62.2634638362425	743.7764223893523	-22.1423410493612	0.562	57	24	PAAD	BUPARLISIB	Clinical trials in cancer
780.3389937295085	-25.5536730962672	778.0606505446043	-3.87823281723581	0.583	292	47	STAD	NAVITOCLAX	Clinical trials in cancer
1192.3166990352127	-4.12633361981651	1196.6581527667838	-1.98734701593003	0.996	292	36	STAD	REGORAFENIB	Approved in cancer
232.7113027056055	36.3097662449966	206.6457699528821	-5.36054978455957	0.0006	512	75	UCEC	PURVALANOL A	Experimental
788.5652734160807	-45.335796570699	782.2866499095885	-0.880808626850182	0.594	264	45	SKCM	ENMD-2076	Clinical trials in cancer
709.72198471113	-18.518326770202	699.5725911523573	1.10470043602231	0.513	202	29	LAML	ISIS 2503	Clinical trials in cancer
1192.109411337732	38.4898330960837	1208.3824305498329	-11.1690755149556	0.994	264	101	SKCM	PONATINIB	Approved in cancer
157.64158166629358	-33.1180378375016	207.6677728261977	-9.88304338844546	0.0006	502	52	KIRC	4-(IMIDAZOL-1-YL)PHENOL	Experimental
734.8442081713117	-19.1332079815019	736.6197408358744	8.08859834589566	0.533	502	59	KIRC	ENMD-2076	Clinical trials in cancer
798.4939311482905	-52.8909013979737	769.375027042778	1.89310895603603	0.592	423	79	COAD	GSK2636771	Clinical trials in cancer
828.946691767369	-42.718666442132	795.4182154802924	8.50842832701278	0.593	292	41	STAD	PICTILISIB	Clinical trials in cancer
899.457434467493	25.2225109218432	744.7921345348449	12.4366903810168	0.596	264	187	SKCM	REFAMETINIB	Clinical trials in cancer
770.947130340758	-37.7777452174765	795.6432048759006	-8.30791431712305	0.596	423	79	COAD	BGJ398	Clinical trials in cancer
794.3991104145896	68.193743071959	795.3608730578576	4.58199998112383	0.593	512	86	UCEC	XL228	Clinical trials in cancer
826.424201931518	62.8914679536339	794.1153756863589	-17.9943883464066	0.563	57	24	PAAD	COPANLISIB	Clinical trials in cancer
224.09938735136492	-19.9421010570398	187.80411228285595	-6.2156653614195	0.0008	512	56	UCEC	GSK-677954	Experimental
170.66565966257332	50.6916694347842	203.8561685292687	-2.35962424264471	0.0008	202	32	LAML	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
740.4992659358509	51.6461578255783	777.9093193995329	7.9082253030146	0.581	512	76	UCEC	UCN-01	Clinical trials in cancer
804.9211554542724	-27.3224278219276	791.8762513566303	-9.37698920724165	0.582	543	74	LUAD	RO4987655	Clinical trials in cancer
195.81664941530204	64.6719139689806	199.32777876420147	14.6599795012363	0.0006	512	75	UCEC	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Experimental
246.95843029954708	31.7851306180561	191.98292399388612	9.44312324063463	0.0006	264	34	SKCM	N8-(2-CHLOROPHENYL)-N2-(2,6-DIFLUOROPHENYL)-9-ETHYL-9H-PURINE-2,8-DIAMINE	Experimental
169.30065891256035	-91.3532798392572	210.3264791961967	31.6764623962713	0.0004	264	38	SKCM	(−)-NUTLIN-3	Experimental
794.9617579003324	-59.0890083323532	788.6742679647856	7.61830443806366	0.592	153	26	BLCA	GSK2636771	Clinical trials in cancer
174.97482090440636	24.2609429492276	167.4386471151624	-1.46235917953072	0.0006	512	75	UCEC	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUOROBENZAMIDE	Experimental
99.29154644202613	-46.4145753058362	181.253195643981	21.9359136256196	0.0004	222	127	LGG	BRD9876	Experimental
985.8831889201966	-1.15036990307604	985.4670492283587	0.667978749432677	0.783	512	56	UCEC	SULINDAC	Approved in other pathologies and in clinical trials in cancer
213.56538449306652	23.7261450811881	190.1341881406805	17.318878418696	0.0006	512	76	UCEC	3-(1H-INDOL-3-YL)-4-(1-{2-[(2R)-1-METHYL-2-PYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE	Experimental
827.2340792657828	12.39181819993	793.8080289288575	8.21131374940433	0.584	169	43	READ	AZD8330	Clinical trials in cancer
217.16546602092296	99.6842232761023	232.01842585985767	33.7949508469803	0.0006	57	24	PAAD	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
776.9318688977993	22.6840762139221	775.2631924837971	-11.7067947899739	0.581	512	60	UCEC	AVI4126	Clinical trials in cancer
179.61319253119902	62.4330912831879	249.06183571021273	-0.219569441379463	0.0004	435	183	THCA	UNC0638	Experimental
693.6337282992288	-71.9845718438294	700.0077673025904	-26.7198032035435	0.511	435	183	THCA	RIVICICLIB	Clinical trials in cancer
1182.3134915515475	-0.239899991529342	1178.2598383940679	3.37683548163932	0.984	423	65	COAD	PACLITAXEL	Approved in cancer
1030.4822015351042	-2.06710237517237	1040.682126991403	-2.35420243586418	0.841	543	65	LUAD	ETOPOSIDE	Approved in cancer
763.5492978840872	1.47923883955266	790.3109848541734	5.81321734202902	0.581	423	63	COAD	CC-401	Clinical trials in cancer
727.896162331852	-20.446152974221	759.9302209880849	4.87473023147231	0.544	934	223	BRCA	GEDATOLISIB	Clinical trials in cancer
718.7908545175143	26.8966143183749	755.7047720994126	-0.83853324159918	0.543	934	109	BRCA	NAVITOCLAX	Clinical trials in cancer
223.01402742064624	33.1157869769374	185.96315059557182	-0.326715283214298	0.0008	202	32	LAML	SB 203580	Experimental
726.2579476550628	-32.0621848667972	735.5661521909481	-2.93405832403232	0.533	934	101	BRCA	OBATOCLAX	Clinical trials in cancer
692.774638402875	38.3756277396018	726.9027839446711	-23.6959451508712	0.522	202	53	LAML	VOXTALISIB	Clinical trials in cancer
791.4516732044073	-12.4387157719466	793.3022958017564	19.513627540126	0.595	423	79	COAD	GEDATOLISIB	Clinical trials in cancer
739.4780787889865	-1.45623909038241	742.2127008940759	-0.945396539809735	0.545	934	223	BRCA	SONOLISIB	Clinical trials in cancer
265.0732841338976	79.8332306163521	217.11320116809313	19.957787873806	0.0004	169	38	READ	PP-30	Experimental
368.1210794951316	13.606743412715	386.79092968454694	-6.28674059995615	0.182	169	39	READ	AM-111	Clinical trials
250.50130698726784	40.2236367053778	200.32097939124398	-6.935799703854	0.0006	264	34	SKCM	N3-CYCLOPROPYL-N4'-(CYCLOPROPYLMETHYL)-6-METHYL-3,4'-BIPHENYLDICARBOXAMIDE	Experimental
157.09592902949032	23.5434018386122	210.1464798930451	13.3960377993427	0.0006	169	43	READ	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
676.0817324539253	-3.40284129440019	734.3540372677141	-9.27336261311461	0.523	202	53	LAML	GEDATOLISIB	Clinical trials in cancer
1119.026082082949	-10.9331204731126	1130.9998827651875	7.89845462350058e-05	0.931	934	101	BRCA	ERIBULIN	Approved in same tumor type
672.0976640605331	-41.6945825989363	735.0801920636284	1.16533008938336	0.523	202	53	LAML	SONOLISIB	Clinical trials in cancer
1172.4026633299288	-13.9288662594383	1162.081587427359	0.00105016577163042	0.964	343	84	HNSC	PACLITAXEL	Approved in cancer
789.2201566474677	26.2018437725797	721.9790647716344	16.0624770029642	0.533	57	7	PAAD	NAVITOCLAX	Clinical trials in cancer
378.1846275056867	-14.5550820513681	376.15422616753733	5.13352231756346	0.181	169	39	READ	LAX-101	Clinical trials
666.0248843957373	-12.6427489275677	763.2198730625613	-35.2079980632259	0.523	435	184	THCA	PLX3603	Clinical trials in cancer
808.2067202061113	-35.071321161193	798.368567378051	-6.11428625724875	0.592	292	41	STAD	APITOLISIB	Clinical trials in cancer
1145.2724450682313	-4.88376043780264	1140.492424220099	-2.973027400511	0.937	502	56	KIRC	AXITINIB	Approved in same tumor type
227.00121932844098	-93.7402122880498	212.92634222688932	-38.3577904186507	0.0006	435	183	THCA	GUANOSINE TRIPHOSPHATE	Experimental
1104.0787105766415	14.0347076912715	1125.6546800653252	0.132592636860295	0.924	599	105	OV	PACLITAXEL	Approved in same tumor type
122.73939359914934	38.2783366859574	205.94763452522957	-13.8500684926607	0.0006	264	34	SKCM	N-ETHYL-4-(2-METHYL-5-(METHOXYCARBAMOYL)PHENYLAMINO)-5-METHYLPYRROLO(2,1-F)(1,2,4)TRIAZINE-6-CARBOXAMIDE	Experimental
169.7137760778858	-61.5534023428745	193.58650873573632	-27.8240494839942	0.0004	512	59	UCEC	CYTOCHALASIN B	Experimental
766.3436812370501	-54.6353357596934	771.3339907756272	-0.00658485511985418	0.573	153	18	BLCA	XL228	Clinical trials in cancer
319.23044164093176	-17.2065889004277	215.40354961882278	31.0266258648991	0.0006	57	24	PAAD	SB220025	Experimental
729.9230024000785	19.6793477101083	703.9206829077006	-10.1413357238848	0.522	202	53	LAML	PF-04691502	Clinical trials in cancer
98.77803124498182	-66.2631682276276	179.39290662607976	19.090811970073	0.0004	435	183	THCA	AZ628	Experimental
695.7959579155649	95.309570038259	753.7664814293686	-13.4479260364557	0.563	264	111	SKCM	ARQ736	Clinical trials in cancer
819.4941617326348	53.1938020251482	795.3829751749045	-5.21784084776436	0.584	543	74	LUAD	AZD8330	Clinical trials in cancer
1176.8705317031831	11.5131946872508	1174.3164138208986	-15.1119741700015	0.986	264	30	SKCM	THALIDOMIDE	Approved in cancer
697.7578880698505	-17.8368161242686	724.3204579664637	-7.32604173044911	0.521	502	56	KIRC	BEVACIZUMAB+RITUXIMAB	Clinical trials in cancer
209.84751268449176	-60.6327012616464	215.93132197674362	1.35070313737742	0.0008	423	89	COAD	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)-1,2-ETHANEDIAMINE	Experimental
228.78224503974977	32.4690537771309	189.58389631260667	-30.694249692556	0.0006	512	67	UCEC	LY-294,002	Experimental
798.3355284735952	-9.90614677456185	813.8971995873669	0.280020713988051	0.596	423	89	COAD	BINIMETINIB	Clinical trials in cancer
368.83845541030695	-23.6019068896496	362.000341035052	0.000320412110539792	0.162	57	24	PAAD	QUERCETIN	Clinical trials
776.6932323578021	-5.17973774217674	778.0261159462065	-6.21653812721365	0.575	599	72	GBM	GEDATOLISIB	Clinical trials in cancer
179.64224697259635	-29.0766708611665	187.25703569148675	-2.11804215365146	0.0006	502	55	KIRC	L-(+)-(S)-CANAVANINE	Experimental
1180.4303779098586	24.2750355304418	1196.9990270484616	-11.9940100268714	0.997	512	90	UCEC	REGORAFENIB	Approved in cancer
746.886887005016	-0.499427056851886	780.2134733522289	6.39507906562312	0.583	292	39	STAD	GOSSYPOL	Clinical trials in cancer
1109.1546494193776	-1.80151993707375	1110.9999175918842	0.000193163353998216	0.911	57	7	PAAD	ERIBULIN	Approved in cancer
142.57932781241317	59.914477245019	217.68136865508797	0.393421756298608	0.0004	264	104	SKCM	VX-11E	Experimental
603.7702641160389	-31.6697983294086	624.0198013856054	7.8534064370599	0.421	435	183	THCA	ABT-751	Clinical trials in cancer
1229.6138136987524	22.9552954342543	1175.5371091884588	-0.0033959161480368	0.972	57	24	PAAD	ARSENIC TRIOXIDE	Approved in cancer
205.49942470613047	61.1217400620979	188.67571715952627	25.9529984793919	0.0006	169	44	READ	PHOSPHOTHREONINE	Experimental
679.8270079365559	90.4245162751994	765.354356438845	23.5076604056779	0.536	57	24	PAAD	BINIMETINIB	Clinical trials in cancer
815.5338001162313	-25.8255680975227	786.309650570865	6.37180239352824	0.584	543	76	LUAD	PWT33597	Clinical trials in cancer
183.0672355155738	43.1678264066146	205.9599863474469	-28.1064521762192	0.0004	512	55	UCEC	ZEBULARINE	Experimental
747.7045116085545	-33.4598299248624	731.8463540773588	-9.46185279513247	0.533	502	56	KIRC	GOSSYPOL	Clinical trials in cancer
192.17872940113446	111.407657257827	180.84113024373187	19.0908596283765	0.0006	169	44	READ	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Experimental
215.81991473702115	-19.4287169267832	221.9987639448279	0.000639838368670098	0.022	343	44	HNSC	TG-100-115	Clinical trials
760.9924038460574	48.4327685194413	784.5732459672239	-1.46579740848165	0.581	292	36	STAD	DHA-PACLITAXEL	Clinical trials in cancer
179.9360546209812	-2.71621034938991	201.04433008518882	5.06174564720345	0.0006	543	76	LUAD	SB220025	Experimental
217.42796925640855	33.165075551057	165.41774779687066	-7.74472943031941	0.0006	264	33	SKCM	1,9-PYRAZOLOANTHRONE	Experimental
1174.4504848277534	-7.19243657171003	1180.1693978284945	0.709767760307273	0.983	512	56	UCEC	LENALIDOMIDE	Approved in cancer
153.10511684161685	2.42906601104673	195.69938914148597	10.7164971855318	0.0006	502	55	KIRC	N-(CHLOROPHENYL)-N'-HYDROXYGUANIDINE	Experimental
637.9364852015668	-52.6916049847619	691.0001548168883	0.00130074254639112	0.491	264	119	SKCM	INDISULAM	Clinical trials in cancer
704.6934181883375	-41.725078951041	734.1731847251119	3.46230766342023	0.532	153	16	BLCA	INK-1117	Clinical trials in cancer
111.17414473208622	34.9135268945468	206.74883723317222	43.9783014654756	0.0006	435	183	THCA	N-METHYL-N-{2-[METHYL(7-NITRO-2,1,3-BENZOXADIAZOL-4-YL)AMINO]ETHYL}ACETAMIDE	Experimental
261.8150777219643	67.381627248569	187.00067246568503	-3.22225507004958	0.0008	57	24	PAAD	FARNESYL DIPHOSPHATE	Experimental
726.3024011979207	-42.1382142446619	732.0000009300574	-0.000297305682124716	0.532	423	68	COAD	REOLYSIN	Clinical trials in cancer
514.2824386596693	18.7586811320055	524.0967471363301	0.0851998931100013	0.321	57	24	PAAD	ISOPRENALINE	Approved in other pathologies
245.23414141732718	-2.37667147147877	183.97599163351165	28.1511244725734	0.0004	512	66	UCEC	PI 3-KG INHIBITOR II	Experimental
188.80874300714424	30.5267266345382	219.20294405049967	27.9663410182993	0.0006	512	75	UCEC	RU83876	Experimental
189.06852020868268	-9.89977057163927	216.7073194057621	-8.40971688318905	0.0006	502	56	KIRC	AT001/R84	Experimental
750.1298555523598	-45.790673520071	795.6199161162715	-2.58952379326502	0.594	153	27	BLCA	GEDATOLISIB	Clinical trials in cancer
586.8181127592542	-3.17649640887089	590.7254460262643	-0.380527310893797	0.391	512	57	UCEC	UREA	Approved in other pathologies
707.9376566262129	-7.6185038913255	716.552989744565	-20.4803604837831	0.511	57	7	PAAD	DHA-PACLITAXEL	Clinical trials in cancer
174.7593009869402	4.71065613022265	189.60922001208198	-4.25028856701897	0.0004	202	22	LAML	GTP-14564	Experimental
163.81362869657525	36.3813879913491	186.11774716738077	12.9746722261165	0.0006	512	75	UCEC	RU82209	Experimental
211.0255199195746	-20.2264119247316	215.52407690918199	-24.6941271092246	0.0006	512	75	UCEC	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
791.7469910680898	-20.6921809051462	769.3835347272988	-2.01603422070957	0.574	599	72	GBM	PWT33597	Clinical trials in cancer
743.1205967868751	16.9886506075592	714.8539325390901	1.07146909654773	0.521	599	105	OV	S-8184	Clinical trials in cancer
385.43763643744677	0.894049165587177	389.85602668304796	0.134832460019481	0.191	512	56	UCEC	INDEGLITAZAR	Clinical trials
138.4522923872802	-116.341436683847	128.0011475394521	-7.32145401099575	0.0008	264	181	SKCM	(1AR,8S,10Z,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8-METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H-OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE	Experimental
769.1655375058523	42.6867048881379	731.9990658063549	0.000745725868569025	0.532	512	56	UCEC	REOLYSIN	Clinical trials in cancer
705.0852588998048	-3.72335448357202	716.9838191548204	-5.56758748163134	0.523	202	23	LAML	AS703569	Clinical trials in cancer
821.271077913824	-28.5374252704984	790.6809740255438	-2.53146385878381	0.595	343	62	HNSC	SONOLISIB	Clinical trials in cancer
797.4060035813173	2.04302357015081	801.8660884715205	0.657070734688659	0.596	153	27	BLCA	DACTOLISIB	Clinical trials in cancer
239.72668396051796	37.2867249157178	190.759013737327	-21.2812475905441	0.0004	264	57	SKCM	NG-25	Experimental
829.4713493416295	-25.792522254803	805.9437452999744	-25.7787371917232	0.596	169	43	READ	REFAMETINIB	Clinical trials in cancer
725.9271285975808	29.1873666569741	744.3179503300186	-12.5001026704299	0.522	202	53	LAML	SF1126	Clinical trials in cancer
384.1489136829543	16.743812485746	392.00013535568417	0.000305767940517399	0.192	343	62	HNSC	QUERCETIN	Clinical trials
1200.4600329629177	-24.3435352234773	1189.6103004224708	3.46377695625802	0.986	543	81	LUAD	BOSUTINIB	Approved in cancer
377.37178016742916	7.54818426923208	385.71660263265056	-0.220800594719094	0.181	543	74	LUAD	K-252A	Clinical trials
724.9304875826648	14.5401941888672	769.0447791878452	2.78078821400072	0.573	599	72	GBM	APITOLISIB	Clinical trials in cancer
700.7277789217522	-38.8380970230151	722.0003401449992	-0.000309508744066989	0.522	423	58	COAD	RAS PEPTIDE CANCER VACCINE	Clinical trials in cancer
758.3205347155624	-18.0294336488289	778.894735256323	12.5203389787409	0.582	543	74	LUAD	GDC-0623	Clinical trials in cancer
820.9139177907296	-43.4414244893757	775.835690596172	-20.6247462397124	0.596	169	45	READ	VOXTALISIB	Clinical trials in cancer
376.31410169431626	-7.83795518160312	381.3840225841191	2.3680028985691	0.182	543	63	LUAD	AM-111	Clinical trials
77.9496204328738	-59.4356280516942	153.03235180875225	-18.1691699576364	0.0004	264	180	SKCM	LY-2183240	Experimental
242.64028697705393	123.437726557915	193.23246721265878	59.7250360800321	0.0008	264	181	SKCM	N-[(1S)-1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL]-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
175.83954248973436	92.5972112941575	236.8592447298027	-20.653943675206	0.0008	264	114	SKCM	ZK 304709	Experimental
188.50697973799387	52.4690584560241	236.39707129723664	10.8491784061752	0.0004	512	126	UCEC	KINETIN RIBOSIDE	Experimental
392.63310090837155	-18.9121971227241	380.99997123659955	0.00024453253718093	0.181	222	53	LGG	EDARAVONE	Clinical trials
165.05096995364303	-122.923241829257	220.82680816834946	60.5118654144408	0.0008	264	183	SKCM	[4-({5-CARBAMOYL-4-[(3-METHYLPHENYL)AMINO]-2-PYRIMIDINYL}AMINO)PHENYL]ACETIC ACID	Experimental
249.93931479671173	55.9019139603233	175.15654419513768	-34.7283082054411	0.0006	57	24	PAAD	PHOSPHOTHREONINE	Experimental
885.9078544712963	-64.1116648517672	762.7891984188933	-63.8286019419472	0.592	264	187	SKCM	CI-1040	Clinical trials in cancer
1109.553270228178	-11.0461787797149	1111.0000697460168	-0.000249063513820147	0.911	502	56	KIRC	ERIBULIN	Approved in cancer
151.0059568152676	28.3927772221883	204.7528133682894	-9.87764688701509	0.0008	202	32	LAML	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Experimental
1118.7274096724814	3.60392348297924	1136.4596779923918	-4.88134750793461	0.936	502	56	KIRC	CABOZANTINIB	Approved in cancer
572.3669693925575	-3.31352657517243	578.2192282044799	-3.31247167515755	0.381	512	75	UCEC	CITRIC ACID	Approved in other pathologies
160.84467401195428	-49.7580813409863	183.04914607541198	8.27902761617543	0.0006	502	55	KIRC	6S-5,6,7,8-TETRAHYDROBIOPTERIN	Experimental
407.6642752579613	4.47440772374594	395.59464358429	5.43609950769593	0.192	512	144	UCEC	QUERCETIN	Clinical trials
819.0806841338759	15.3864892939873	796.8762090005296	1.1805643315613	0.593	343	62	HNSC	PICTILISIB	Clinical trials in cancer
222.4608485330224	83.9938066014757	181.08253169453897	-18.9683903795362	0.0006	57	24	PAAD	ERK INHIBITOR II	Experimental
217.95880181460618	5.60244522106447	196.32794746465788	-3.49761315841147	0.0004	343	54	HNSC	(−)-NUTLIN-3	Experimental
1183.4302804940858	-42.1465673672848	1143.7101315545137	-5.86798986539634	0.94	435	212	THCA	TRAMETINIB	Approved in cancer
182.23180206296394	-39.1945316460599	200.06769466070517	13.3801399723002	0.0004	423	57	COAD	REPOSAMAL	Experimental
1100.594951306438	-1.83652305448061	1120.1902881307167	-1.67193250411265	0.922	502	57	KIRC	LENALIDOMIDE	Approved in cancer
231.90989931603687	-11.0131036422472	211.33910833162216	-2.52127822552211	0.0004	934	214	BRCA	TERT-BUTANOL	Experimental
218.98128261881058	-10.358309198688	194.25244173940737	-9.67321989546258	0.0006	202	29	LAML	TRIFLUOROETHANOL	Experimental
874.5728897037765	-19.8313032851253	767.7211325023507	-13.3509778142101	0.592	169	45	READ	GSK2636771	Clinical trials in cancer
251.55479929725504	45.0253670456954	209.79392848168197	13.1513592069853	0.0006	264	34	SKCM	4-{4-[(5-HYDROXY-2-METHYLPHENYL)AMINO]-7-QUINOLINYL}-1,3-THIAZOLE-2-CARBALDEHYDE	Experimental
825.0305339622346	51.0008712511168	776.5951658729304	-13.1065661053535	0.583	264	43	SKCM	TRICIRIBINE	Clinical trials in cancer
224.19658309443017	27.3732490057163	205.32463110242864	-0.166163391327473	0.0008	292	41	STAD	PI-103	Experimental
173.3355495400606	-58.1593210176914	209.22767844061542	9.6180877043962	0.0004	423	57	COAD	PP-30	Experimental
699.6622156771087	-46.0039713978978	729.7510200762063	-13.9149207496521	0.523	934	214	BRCA	RIGOSERTIB	Clinical trials in cancer
210.6964263775727	-54.4215806761222	200.59786286479323	-8.88203213701627	0.0008	153	17	BLCA	NVP-BGT226	Experimental
807.6579089815622	-15.7087548471969	800.302234029102	0.0193817794271354	0.595	389	47	LUSC	ALPELISIB	Clinical trials in cancer
156.95890341453807	33.2365846710802	193.87715876783736	-10.3482416627498	0.0004	169	39	READ	NSC632839	Experimental
206.04977049142425	-21.7141943850172	213.6053808798234	-5.21833909383122	0.0006	502	56	KIRC	BROLUCIZUMAB	Experimental
756.4396236114309	-49.2177896844389	798.1837505083731	4.51098181831048	0.594	423	79	COAD	PF-04691502	Clinical trials in cancer
370.1062232768359	-11.0208517928092	378.91769144614585	-3.50706039120814	0.181	423	89	COAD	K-252A	Clinical trials
116.69037342690086	-56.3036557689153	196.5770180018752	14.6057280040307	0.0006	435	183	THCA	HEXAN-1,6-DIOL	Experimental
718.1463011161137	-1.91680295072342	737.4264501621277	-4.02025024169507	0.535	502	56	KIRC	TIVOZANIB	Clinical trials in cancer
746.8463687370974	-41.1725000085895	775.9995598570426	-6.03975477738891	0.581	543	63	LUAD	CC-401	Clinical trials in cancer
297.19743991517316	79.1653973548869	229.44249765271954	22.4096830558392	0.0006	435	211	THCA	PURVALANOL B	Experimental
205.01594948596883	-129.541499885366	196.73594703448578	-9.07180636834801	0.0008	934	214	BRCA	WORTMANNIN	Experimental
182.57169492629234	0.898614843642576	219.29786489158988	-0.178474371264201	0.0006	502	55	KIRC	(E)-N5-(1-AMINOETHYLIDENE)-L-ORNITHINE	Experimental
357.05932283077334	-8.92036733001535	351.00001422353023	-0.000257865426647186	0.151	343	84	HNSC	EDARAVONE	Clinical trials
714.4052961982115	-39.6908795151058	727.8391648542478	-3.40697133822505	0.523	343	52	HNSC	RIGOSERTIB	Clinical trials in cancer
151.31086554841826	17.9479482174135	209.78900930382105	2.23164944246719	0.0008	543	75	LUAD	ERK INHIBITOR II	Experimental
804.6490929202506	27.8170602724965	791.936843959324	-5.99976666854968	0.594	389	47	LUSC	PF-04691502	Clinical trials in cancer
1164.5258941801462	-9.23790417650358	1192.694914446883	-6.66067760614806	1	423	91	COAD	SORAFENIB	Approved in cancer
187.42270608344288	-3.62329872176122	200.34997585904276	-17.5820043291073	0.0004	934	214	BRCA	MST-312	Experimental
695.2820280741606	-25.7248487656312	706.9911488572161	-6.64956409866699	0.511	57	7	PAAD	S-8184	Clinical trials in cancer
171.50520874970323	-22.6976605788639	209.08837732925866	21.7710647398708	0.0008	934	218	BRCA	NVP-BGT226	Experimental
1146.8972490052377	-28.3416691847001	1091.9434999471493	-0.677294883647619	0.911	435	183	THCA	ERIBULIN	Approved in cancer
1178.4716097718222	-4.46932960948467	1184.086859325422	2.0199789069718	0.986	543	74	LUAD	COBIMETINIB	Approved in cancer
154.85066156917853	-30.2525947397425	180.40684184286778	0.308785735524452	0.0006	502	52	KIRC	D-(-)-3-PHOSPHOGLYCERIC ACID	Experimental
799.8102421437961	-63.0019607867876	807.120814434902	3.33869189588592	0.582	512	75	UCEC	GDC-0623	Clinical trials in cancer
329.1671437327874	-11.1070739437048	331.0000012649536	-0.000282154385331523	0.131	153	21	BLCA	EDARAVONE	Clinical trials
734.0076548409135	14.0456512718684	773.5761168745645	-7.60773511320861	0.581	512	54	UCEC	PRINOMASTAT	Clinical trials in cancer
623.1267773735909	-11.727307885046	624.3352917042508	-1.78731000607104	0.423	343	44	HNSC	CH5132799	Clinical trials in cancer
207.72896984267052	-0.572019855703843	197.97042302936686	3.06378296971479	0.0008	343	62	HNSC	PI-103	Experimental
191.1948936774372	98.4765347865251	175.0846848566224	44.7771696633519	0.0004	264	104	SKCM	P-0850	Experimental
241.9762743031754	30.9768274703797	168.7225485889761	-6.84174908264316	0.0004	512	67	UCEC	P-0850	Experimental
511.42729184938565	7.05053656989429	520.9998562378188	8.14747274944239e-05	0.321	599	105	OV	RASAGILINE	Approved in other pathologies
774.4504349649472	-61.8775914805113	797.2351662149775	-10.3354116173862	0.585	543	74	LUAD	BINIMETINIB	Clinical trials in cancer
387.01156966264915	4.97091601591256	389.7752043109148	-4.23834659990268	0.191	512	56	UCEC	BEZAFIBRATE	Clinical trials
567.2210466821641	-8.18897029445768	584.9001657083289	-1.96265076164673	0.381	423	88	COAD	ISOPRENALINE	Approved in other pathologies
197.79036234506478	12.0721595405282	198.11820844786757	-3.99303950485228	0.0006	502	52	KIRC	2-PHENYLHEME	Experimental
218.5271403525457	22.7128700318752	184.90085776371225	8.14040626946695	0.0006	512	53	UCEC	HEPTYL-BETA-D-GLUCOPYRANOSIDE	Experimental
176.4270276029917	29.1172767101184	205.59607037722898	-8.70072610936228	0.0006	264	34	SKCM	N-CYCLOPROPYL-3-{[1-(2,4-DIFLUOROPHENYL)-7-METHYL-6-OXO-6,7-DIHYDRO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL]AMINO}-4-METHYLBENZAMIDE	Experimental
207.26116869613256	50.850880580711	220.0448693846229	10.7202318020038	0.0006	169	44	READ	SB 203580	Experimental
222.38779768222406	62.1895104054825	224.90060331669028	-12.3351192451804	0.0006	512	75	UCEC	PHENYL(SULFO)ACETIC ACID	Experimental
697.6078483735702	-22.0377142820366	705.7879134664593	-1.06163525678448	0.511	502	52	KIRC	DIHYDROXYACETONE PHOSPHATE	Clinical trials in cancer
648.0726065927937	-22.0716419989398	689.7121958539872	-13.4411162737854	0.514	435	183	THCA	RIBOCICLIB	Clinical trials in cancer
727.9880238266558	104.720662044628	753.3753909123225	-35.9811408287318	0.562	57	24	PAAD	PILARALISIB	Clinical trials in cancer
689.9406608833827	-25.6605541588379	708.7801388015891	5.51320639943378	0.511	502	53	KIRC	2-METHOXYESTRADIOL	Clinical trials in cancer
696.5461777335827	-13.712545376438	729.1648803625334	-4.51730838980984	0.532	153	16	BLCA	TCMDC-137004	Clinical trials in cancer
168.43059429325194	-29.128639890753	197.15623402751984	7.19606662518845	0.0004	153	20	BLCA	PIPERLONGUMINE	Experimental
151.0458348207965	55.3585987704733	184.8704614211851	-20.063068647596	0.0004	512	54	UCEC	CHAETOCIN	Experimental
1190.1813601227568	-65.3494673400617	1234.6041606736906	31.2355680453901	0.991	264	191	SKCM	BOSUTINIB	Approved in cancer
1213.6096495606882	-17.2934371434138	1187.8167249128635	-1.9570882202861	0.988	543	74	LUAD	TRAMETINIB	Approved in cancer
394.9555303092817	-10.7434645165435	381.64423929657727	-3.41444504967205	0.182	264	49	SKCM	ICO-007	Clinical trials
280.4143441043984	-41.4779773162293	195.68900146270016	9.21407140213324	0.0004	512	94	UCEC	NSC632839	Experimental
836.3965619733508	-22.1459269616131	791.7902760159698	-9.22604570477307	0.592	512	79	UCEC	AFURESERTIB HYDROCHLORIDE	Clinical trials in cancer
201.41196967901112	-58.6885285126874	222.04555940092524	12.5502490525623	0.0004	934	216	BRCA	PIPERLONGUMINE	Experimental
583.3366137725895	-5.68515410510221	582.0607062544169	-0.111968901073567	0.383	512	53	UCEC	PEGAPTANIB	Approved in other pathologies
746.6823865415233	7.43574021131377	793.9584211157069	-2.63240555761399	0.592	292	41	STAD	GSK2636771	Clinical trials in cancer
290.6236425708976	-5.30339003826592	201.67667484072538	-11.5548711572571	0.0008	264	30	SKCM	BIM-1	Experimental
512.8771336963766	-2.55842419343415	507.68377391718565	-3.0066763456889	0.311	502	52	KIRC	RETEPLASE	Approved in other pathologies
392.2639071473903	-5.5169507266036	393.6046045905329	-2.12036928236722	0.191	512	56	UCEC	(E)-ELAFIBRANOR	Clinical trials
1105.2779742298549	37.6001746898597	1153.0903355442551	-22.8142236259928	0.94	435	210	THCA	DABRAFENIB	Approved in cancer
95.26872238903015	-10.598632033516	203.56034040295444	-0.469934693615357	0.0006	57	24	PAAD	SB 203580	Experimental
842.8686695764529	38.6284287898594	793.6031046791237	-27.7287300948871	0.582	264	49	SKCM	ISIS 5132	Clinical trials in cancer
1061.468285747828	-6.33279533334505	1068.0280972879673	-0.11136366320784	0.865	169	45	READ	CETUXIMAB	Approved in same tumor type
712.9646102143944	-8.51824282571076	720.7737122145652	0.45570603402075	0.521	502	56	KIRC	TAK-593	Clinical trials in cancer
849.189547138508	94.3555180688018	764.5817964354363	51.114657585436	0.595	264	187	SKCM	PIMASERTIB	Clinical trials in cancer
249.3698719197943	-36.0601288511934	220.46695851204706	-3.47780405205731	0.012	934	214	BRCA	TG-100-115	Clinical trials
146.09349070951103	-44.3139815393093	180.76216632206297	-9.73479901407518	0.0006	169	47	READ	PURVALANOL B	Experimental
236.0762736442036	-28.6269552740236	196.77028624992874	9.11623586466544	0.0004	343	44	HNSC	NAKITERPIOSIN	Experimental
720.9906278673773	-5.40610687906593	714.5330473118477	-1.75822474060578	0.526	202	23	LAML	MIDOSTAURIN	Clinical trials in cancer
778.9682611348352	10.6079549594451	795.8785943581288	1.95548799414019	0.596	389	47	LUSC	DACTOLISIB	Clinical trials in cancer
171.2237672687054	-16.2621789627741	214.7670848658088	-12.3836723888794	0.0006	502	55	KIRC	7-NITRO-2H-INDAZOLE-2-CARBOXIMIDAMIDE	Experimental
829.8713459802046	-1.01934036024059	800.6340628166796	10.7697073458585	0.596	292	42	STAD	BGJ398	Clinical trials in cancer
197.51907062436865	1.19129303038943	191.44994906347574	-1.42940980073581	0.0006	502	52	KIRC	5-[(4'-AMINO-5',8'-DIFLUORO-1H,1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-1-YL)CARBONYL]-2-PYRIDINECARBONITRILE	Experimental
1165.6266656519304	-15.6726594842725	1176.199592327285	-1.39270526394847	0.981	512	59	UCEC	VINBLASTINE	Approved in cancer
726.1729225816114	-27.1239106136304	741.7625260251382	-2.96542236763071	0.535	502	56	KIRC	LINIFANIB	Clinical trials in cancer
202.5851146074456	14.3358703052258	188.2198489266405	-9.41314444217596	0.0008	202	32	LAML	N-[(1S)-1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL]-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
103.52311970146116	49.7035640299899	182.24332280283375	25.5370701100112	0.0006	57	24	PAAD	PI-103	Experimental
658.9637452147834	-21.2615749691815	660.9999448391522	0.000146907828138865	0.461	343	46	HNSC	PX-12	Clinical trials in cancer
194.67194855626934	-15.3129552942823	206.84946257428913	2.2967013994953	0.0004	202	24	LAML	CYTOCHALASIN B	Experimental
186.15526787001022	-44.8887428084677	210.61364237500916	6.08673335293201	0.0006	202	30	LAML	GUANOSINE TRIPHOSPHATE	Experimental
598.9118128769934	0.703563446823495	595.272320240225	-0.836022815043634	0.394	512	60	UCEC	IRBESARTAN	Approved in other pathologies
212.39656205023834	56.6463857862671	224.92781672747876	8.17104336932107	0.0006	264	34	SKCM	1-(2,6-DICHLOROPHENYL)-5-(2,4-DIFLUOROPHENYL)-7-PIPERIDIN-4-YL-3,4-DIHYDROQUINOLIN-2(1H)-ONE	Experimental
1189.3594523023712	-12.8440890724213	1183.8833290294656	1.48034028201891	0.984	292	39	STAD	PACLITAXEL	Approved in cancer
293.2706099260308	-12.4493681198241	178.46390690618222	0.763207761517833	0.0006	169	44	READ	SB220025	Experimental
741.7712906708302	-8.06113691911386	732.0086208989993	7.01502821274244	0.533	502	60	KIRC	NAVITOCLAX	Clinical trials in cancer
370.6728400768231	0.938873606240946	386.87420062111016	4.29366455867671	0.181	512	75	UCEC	K-252A	Clinical trials
581.8536121908177	-1.64225550289189	584.1148176456842	3.66413944616579	0.381	512	57	UCEC	CHOLINE	Approved in other pathologies
158.47640109234726	-8.53719614572503	213.2762379348675	-16.4570879649273	0.0006	502	54	KIRC	GAMMA-IMINO-ATP	Experimental
172.07547990119127	43.5807437609568	198.15105513239777	22.9671213066492	0.0004	169	40	READ	KINETIN RIBOSIDE	Experimental
1211.2235914447933	-21.505470807327	1170.692469915792	-5.1214199947355	0.998	264	28	SKCM	VANDETANIB	Approved in cancer
147.77914899157668	14.7183956483094	210.97693067832085	9.68975559009232	0.0006	502	52	KIRC	12-PHENYLHEME	Experimental
766.6367727504016	-13.3879448545143	801.3083502180858	2.46993048159237	0.592	512	76	UCEC	ENCORAFENIB	Clinical trials in cancer
807.7456012698807	24.7985252273438	786.9368013486686	4.786317239612	0.595	389	42	LUSC	COPANLISIB	Clinical trials in cancer
843.0124375787346	-6.55987433339109	801.2557908321205	-26.1927932989346	0.593	512	143	UCEC	PICTILISIB	Clinical trials in cancer
75.35934095407552	-12.4773188388668	238.36688824648087	-0.172959637900931	0.0008	222	127	LGG	NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE	Experimental
223.45996026344693	-132.459114372652	278.64107791898033	-20.4363772683633	0.0008	264	186	SKCM	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)-1,2-ETHANEDIAMINE	Experimental
139.2766470029308	-17.8477067478105	202.884680556326	7.14669738388238	0.0008	423	88	COAD	(1AR,8S,10Z,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8-METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H-OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE	Experimental
219.68119292282555	38.1621745821577	232.80420432819574	-19.0630989489534	0.0006	512	78	UCEC	SB220025	Experimental
214.68273735069243	-31.42023769327	181.42029074359414	-6.7970049644814	0.0006	502	55	KIRC	S-(DIMETHYLARSINO)-D-CYSTEINE	Experimental
186.71211037608325	-14.7411785367123	201.31571887131184	-7.55635613271056	0.0004	343	46	HNSC	EVODIAMINE	Experimental
816.6829049031342	27.3924941373143	773.7053183745966	-4.11910146378796	0.573	599	72	GBM	PF-04691502	Clinical trials in cancer
738.3131576110097	77.3250830709488	755.778172989671	37.3623787443182	0.562	57	24	PAAD	PICTILISIB	Clinical trials in cancer
1250.2004207895648	11.8708090482381	1172.0080495087116	-38.6263904137541	1	264	198	SKCM	SORAFENIB	Approved in cancer
254.6659239888214	-31.244358823783	186.32015876207615	10.7577313992582	0.0006	264	34	SKCM	N-CYCLOPROPYL-4-METHYL-3-[1-(2-METHYLPHENYL)-6-PHTHALAZINYL]BENZAMIDE	Experimental
1162.9439584547697	4.00645281201844	1177.3896092153946	-6.21836622950684	0.984	169	39	READ	VANDETANIB	Approved in cancer
771.9127730972228	23.8799538247069	757.8427615247846	-24.357461983364	0.584	264	43	SKCM	IPATASERTIB	Clinical trials in cancer
187.0945460384654	12.346524629553	195.89284764488474	-9.84003473959774	0.0008	343	55	HNSC	NVP-BGT226	Experimental
317.4130948077072	-6.86954253643432	307.61533042141684	4.89926901276749	0.111	502	52	KIRC	NADH	Clinical trials
737.2271028279554	-32.2887434892889	737.9091224139016	-9.41932262034652	0.544	934	221	BRCA	PILARALISIB	Clinical trials in cancer
721.3469963498526	46.7734923378958	726.4686063778544	15.0626758292963	0.533	202	23	LAML	XL999	Clinical trials in cancer
701.2989762468285	9.39877469781163	704.5560512282024	-10.9087630640701	0.513	57	7	PAAD	OBLIMERSEN	Clinical trials in cancer
395.8306257506312	31.01629663064	391.7180986935278	17.2101960709797	0.181	264	186	SKCM	K-252A	Clinical trials
708.8975102105727	-42.150657301073	733.3174150817323	-4.03420304802785	0.533	153	16	BLCA	OMIPALISIB	Clinical trials in cancer
263.47845445852437	-8.20234504402083	228.71235734904857	9.14320161700783	0.0006	512	75	UCEC	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)-1,2-ETHANEDIAMINE	Experimental
268.75274599012096	114.385878289584	177.48455044295875	-65.1087568101077	0.0008	264	185	SKCM	SB 203580	Experimental
727.7280434739397	7.3682771472358	741.1554370458966	-4.51826304777728	0.524	202	31	LAML	PD-0325901	Clinical trials in cancer
1207.3312080432006	-26.4963381004316	1202.194333908113	6.42500816084885	1	423	89	COAD	TRAMETINIB	Approved in cancer
743.6352937099181	-34.2361451373902	729.4995583845653	-3.68402741912087	0.524	202	22	LAML	AMUVATINIB	Clinical trials in cancer
1142.3246113566338	-8.16558439442289	1147.999879359385	0.000286549124894009	0.948	599	66	GBM	BOSUTINIB	Approved in cancer
692.555808646281	-21.0787281731315	689.680877492679	-3.24334140397701	0.491	512	81	UCEC	PX-12	Clinical trials in cancer
811.208847107848	7.06498516692398	804.1499265596074	-2.90397633827877	0.596	389	47	LUSC	VOXTALISIB	Clinical trials in cancer
191.559658619493	-29.3924443667137	211.99573206999787	-9.1670413037059	0.0006	502	52	KIRC	THIOCOUMARIN	Experimental
1213.0598990168244	-9.90931853399795	1183.9805061792824	-7.82763862086631	0.986	423	95	COAD	BOSUTINIB	Approved in cancer
106.69522614500669	0.68788573919781	232.93741354250147	4.61207695780627	0.0004	435	183	THCA	COMPOUND 44	Experimental
839.9395286991571	-31.2012319695405	784.2702606809411	11.6152004675967	0.584	543	74	LUAD	PD-0325901	Clinical trials in cancer
750.4182979837632	22.2076010087213	773.368476806844	0.677205984599368	0.574	599	72	GBM	SF1126	Clinical trials in cancer
749.7828330196419	72.1886273561994	782.2875624618247	6.79947465238786	0.583	264	39	SKCM	TALMAPIMOD	Clinical trials in cancer
237.40966246080893	49.005694288081	198.37874963209626	-10.649171617783	0.0006	512	53	UCEC	(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDRO-1-ISOQUINOLINECARBOXAMIDE	Experimental
200.43803451100118	-19.4445153476364	194.58065175199133	8.9616312549233	0.0004	423	92	COAD	LY-2183240	Experimental
183.12579718740048	-48.861197706653	205.5920351805629	16.1127773196445	0.0006	502	52	KIRC	5-[(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1H,1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-1-YL)CARBONYL]-3,4-DIHYDRO-2-PYRIDINECARBONITRILE	Experimental
189.06528741272265	21.8658471583127	188.55655337505868	22.8329016090727	0.0006	512	72	UCEC	VALATEGRAST HYDROCHLORIDE	Experimental
244.70093337409523	-11.1548694456814	199.0967902174375	-20.0909661536684	0.0006	512	75	UCEC	RU90395	Experimental
813.1484805344525	30.5768135320178	796.8736215018032	-22.8467483441013	0.593	264	31	SKCM	AS703569	Clinical trials in cancer
763.3245162517395	-32.3245258421929	784.0555317699664	-7.28473071633033	0.581	512	53	UCEC	BEVACIZUMAB+RITUXIMAB	Clinical trials in cancer
375.62968725984706	12.9396243627517	376.13222524827336	-5.29498788107554	0.181	512	75	UCEC	OXALIC ACID	Clinical trials
241.08681005151135	-33.08378644013	189.14669134277452	-20.2247708016066	0.0008	512	56	UCEC	NETOGLITAZONE	Experimental
167.21806673897373	17.0429167338266	189.57406175668606	8.04503559315361	0.0004	512	67	UCEC	SB 225002	Experimental
181.64110666256101	-21.9982726902925	192.94474840054508	14.1041153511164	0.0006	502	55	KIRC	N5-(N-HYDROXYCARBAMIMIDOYL)-L-ORNITHINE	Experimental
713.0243608156289	-22.4474532590684	712.2259571809994	8.1627916608295	0.511	502	56	KIRC	DHA-PACLITAXEL	Clinical trials in cancer
205.9030594731753	-44.4655227230168	206.67977381981032	-5.94143282995856	0.0004	343	50	HNSC	FQI-1	Experimental
330.10625813719054	-1.03947449583788	329.7164025999698	1.77607096928568	0.131	502	54	KIRC	TRIFLUSAL	Clinical trials
750.4402307947751	-12.4187166484624	790.2256314468736	6.37464471917724	0.595	292	41	STAD	SONOLISIB	Clinical trials in cancer
804.7939162338704	13.8109428942323	768.1615150762757	4.54253839224606	0.581	512	53	UCEC	SEMAXANIB	Clinical trials in cancer
163.93840820554988	67.9183386147693	180.4797905996269	14.2121715881583	0.0006	512	75	UCEC	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-(3-{[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO}PHENYL)BENZAMIDE	Experimental
594.9949478723973	-1.62273319275235	596.8932635504788	4.91176121681997	0.394	264	28	SKCM	MESALAZINE	Approved in other pathologies
720.5443406065361	-43.1086538011461	727.1172788780253	2.26647389700565	0.533	934	104	BRCA	GOSSYPOL	Clinical trials in cancer
317.94333315866686	-2.62178771862065	312.0244962265155	-5.40856765313265	0.112	502	52	KIRC	TREBANINIB	Clinical trials
249.1797842059412	3.83850061175002	178.7982532640232	2.01454503407342	0.0008	512	144	UCEC	PI-103	Experimental
658.8434505726672	2.694333877763	729.4523258225219	8.92870668235378	0.523	435	184	THCA	ARQ736	Clinical trials in cancer
226.74082096207778	39.1632300266817	221.78369446634363	0.0362927319989126	0.0004	512	104	UCEC	GW843682X	Experimental
150.22903822829716	-25.6463688800142	186.86826772122615	-14.0438566598864	0.0006	502	56	KIRC	PIDOLIC ACID	Experimental
554.4841141436071	-13.8165302800696	561.000049961158	0.000267390970975612	0.361	264	114	SKCM	APREMILAST	Approved in other pathologies
174.47651403622618	12.3634578353957	207.6397594006429	-2.35852933937485	0.0006	543	63	LUAD	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
856.3944205622679	33.0228598272973	834.9619783779781	42.4984009503748	0.585	264	111	SKCM	PILARALISIB	Clinical trials in cancer
824.8605388443647	2.39226952222072	772.0025063228798	7.79948723042207	0.592	512	75	UCEC	CI-1040	Clinical trials in cancer
654.2157739356994	66.3651814312694	753.8713727922984	-19.663281262267	0.534	435	212	THCA	ENCORAFENIB	Clinical trials in cancer
590.2464655848684	0.448643472791531	578.6888556391805	-1.1429822391126	0.381	543	75	LUAD	ISOPRENALINE	Approved in other pathologies
234.93080618502836	-23.2161756199224	176.14788673968968	10.0732861192656	0.0006	512	75	UCEC	N-BENZYLADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE)	Experimental
1215.409494887319	-1.73073213191032	1176.1645117918586	2.33316729919068	0.982	169	34	READ	DOCETAXEL	Approved in cancer
779.8585326688619	-2.03714884773106	788.144237449004	1.09103896944816	0.582	543	74	LUAD	BI847325	Clinical trials in cancer
208.71022303400449	-6.56069526864482	206.50521853079957	10.2209109889125	0.0004	343	44	HNSC	AS-605240	Experimental
181.44289283370878	4.58847360751707	202.70767562960538	8.23381379830562	0.0006	502	55	KIRC	1,3-PHENYLENEDI-2,1-ETHANEDIYL DICARBAMIMIDOTHIOATE	Experimental
380.9317351139878	11.4764278084712	387.72030002112336	-1.81320514654038	0.183	264	34	SKCM	PH-797804	Clinical trials
190.42221808872023	-22.2256074515124	191.10538518483722	-12.7774965093786	0.0006	502	55	KIRC	AMINOTHIAZOLINE	Experimental
1203.7285192265697	28.2344696737824	1203.5095221857505	-4.90085035103755	0.997	169	43	READ	COBIMETINIB	Approved in cancer
1076.6627193308086	-15.1510174227716	1080.9696681285593	-0.0153432479709181	0.881	169	39	READ	ETOPOSIDE	Approved in cancer
225.09272365930588	-110.234905725866	252.98548149703277	-16.5696475346754	0.0004	435	183	THCA	(5Z)-7-OXOZEAENOL	Experimental
250.0281763411895	102.149954065241	208.18951221409404	-24.7001204938587	0.0004	264	110	SKCM	AM-580	Experimental
176.4961531176162	-10.7224462802675	189.99122877062274	-5.36762609745438	0.0006	502	52	KIRC	ETHYL 4-[(4-CHLORO-2-PYRIDINYL)AMINO]-1-PIPERIDINECARBOXYLATE	Experimental
188.12628845398416	7.02590330787751	185.76039513533712	-6.1891084130225	0.0006	502	55	KIRC	(3S,5E)-3-PROPYL-3,4-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5(2H)-IMINE	Experimental
176.59999903583568	35.8181539639511	216.73924118305052	-5.81419236641568	0.0004	202	45	LAML	LY-2183240	Experimental
700.8977084739191	23.68835594556	708.4660783255096	14.7422439400273	0.512	202	31	LAML	BI847325	Clinical trials in cancer
195.0544189419708	55.9759744403775	205.39284408521408	8.47498507836576	0.0006	202	28	LAML	{4-[(10R,11E,14S,18S)-18-(2-AMINO-2-OXOETHYL)-14-(1-NAPHTHYLMETHYL)-8,17,20-TRIOXO-7,16,19-TRIAZASPIRO[5.14]ICOS-11-EN-10-YL]BENZYL}PHOSPHONIC ACID	Experimental
779.1201995382119	80.1381291075251	817.9423934637496	-11.5480694324102	0.593	169	45	READ	PWT33597	Clinical trials in cancer
110.86426560983506	-27.6047701921147	251.64290222956888	17.3339516529383	0.0006	264	141	SKCM	GUANOSINE TRIPHOSPHATE	Experimental
553.9556959092647	-0.290078128557809	547.9886501655885	3.84086292429811	0.351	343	84	HNSC	RASAGILINE	Approved in other pathologies
1134.1963694701087	-4.59633350556484	1133.054120777875	7.35912609720708	0.936	502	59	KIRC	VANDETANIB	Approved in cancer
740.1744321641437	30.7479043961158	746.0109589223454	-3.810639039661	0.544	264	28	SKCM	TELATINIB	Clinical trials in cancer
570.953865789465	33.6028250825397	584.3358054198834	14.5568296310458	0.381	264	181	SKCM	ISOPRENALINE	Approved in other pathologies
678.6046289659838	12.1593705149896	700.2137819283664	18.5240192639378	0.515	435	183	THCA	ABEMACICLIB	Clinical trials in cancer
836.3921839655397	-27.3145495672659	791.26282000626	-1.47675115058917	0.593	389	42	LUSC	PICTILISIB	Clinical trials in cancer
128.28612586264964	1.86818521304465	178.6492527335237	19.7582064777966	0.0006	512	75	UCEC	[4-({4-[(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)AMINO]-2-QUINAZOLINYL}AMINO)PHENYL]ACETONITRILE	Experimental
134.06050660849053	39.4943403470204	165.6198075783873	22.7910885713163	0.0006	57	24	PAAD	GUANOSINE-5'-DIPHOSPHATE	Experimental
738.6363748621663	-21.4540666310148	729.7976498311468	-1.87814677204551	0.535	502	56	KIRC	MOTESANIB	Clinical trials in cancer
224.4760551207555	-9.77912516604519	217.27932898764095	-30.6137615226592	0.0008	512	84	UCEC	O-PHOSPHOSERINE	Experimental
239.67113012236177	-6.07718483115357	198.2837813483314	-2.25893219174191	0.0006	169	39	READ	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
796.7992273002004	-33.8968394586898	722.1819490105534	-8.4157815151716	0.542	934	223	BRCA	APITOLISIB	Clinical trials in cancer
214.68928212524438	-23.8808526038903	202.61829858807482	9.82391769446599	0.0008	543	60	LUAD	[2-OXO-2-({[(2E,6E)-3,7,11-TRIMETHYL-2,6,10-DODECATRIEN-1-YL]OXY}AMINO)ETHYL]PHOSPHONIC ACID	Experimental
192.00346530775042	-35.3338929617718	225.90882369866588	3.89818076266101	0.021	934	214	BRCA	TRIPTOLIDE	Clinical trials
254.4782091647581	17.620265154623	211.66377821519245	-4.87702038031125	0.0008	169	38	READ	FARNESYL DIPHOSPHATE	Experimental
1121.6433919384092	-15.0877284215313	1130.9999385435715	-0.000309915966226981	0.931	153	21	BLCA	ERIBULIN	Approved in cancer
618.2921684506924	9.41639657514315	633.6268274199741	1.60707967154212	0.431	343	46	HNSC	CYT-997	Clinical trials in cancer
717.8919759080705	32.8081718614417	790.452214321732	11.9383222388935	0.596	343	62	HNSC	DACTOLISIB	Clinical trials in cancer
139.04176241232818	-90.7780262341226	155.61898607487336	-17.1362618594273	0.0004	222	132	LGG	PARBENDAZOLE	Experimental
235.7637981893812	14.7729873068561	160.04013924619096	-47.9700791769357	0.0006	264	34	SKCM	N-(CYCLOPROPYLMETHYL)-2'-METHYL-5'-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-4-BIPHENYLCARBOXAMIDE	Experimental
163.396579488512	-3.87067402700362	202.1623351030624	-1.62596152337574	0.0004	934	216	BRCA	EVODIAMINE	Experimental
285.06248020677833	-27.3370557420876	215.2149559487023	0.926863920827827	0.0004	222	130	LGG	FQI-1	Experimental
276.7202121896675	-73.8499474875323	184.25446639213138	1.7249173959251	0.0008	435	210	THCA	PLX4720	Experimental
204.46592488780445	129.670719344892	162.21213276056383	-26.9183218312926	0.0006	435	212	THCA	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
191.26986369940278	-13.0724407645093	201.78367062907665	-2.14946608652576	0.0008	389	42	LUSC	GUANOSINE-5'-DIPHOSPHATE	Experimental
202.00880175708457	99.9932229977361	203.23836498536124	-0.695850865851014	0.0008	512	75	UCEC	ERK INHIBITOR II	Experimental
802.8866524686803	-14.9540027725087	770.1603938716784	-3.84922111753298	0.582	512	75	UCEC	RO4987655	Clinical trials in cancer
303.7835602058531	-4.10711592012856	191.12331261304232	50.2059822263889	0.0006	435	183	THCA	ZK 304709	Experimental
692.2908963694694	-29.3823635457117	721.1572607793822	-4.06789690140067	0.521	502	58	KIRC	PTC299	Clinical trials in cancer
618.4338467257779	-3.55820781079458	622.999865217648	0.000663838517539261	0.423	512	67	UCEC	CH5132799	Clinical trials in cancer
594.75339562637	2.83702767109352	588.680555581368	3.70748695452369	0.391	512	60	UCEC	CARVEDILOL	Approved in other pathologies
768.9824782935477	66.6240781826534	802.5926607854866	10.9061171751346	0.595	512	144	UCEC	GEDATOLISIB	Clinical trials in cancer
749.2458673700944	17.6101929835744	765.1343067221287	0.084094083232003	0.562	599	70	GBM	PILARALISIB	Clinical trials in cancer
709.5797872327911	5.13404405323195	709.6623141033526	-2.92519244201685	0.513	502	56	KIRC	OBLIMERSEN	Clinical trials in cancer
699.8046565960695	-25.2726100937527	713.5954971259662	-4.66377306241429	0.511	502	52	KIRC	NICOTINAMIDE	Clinical trials in cancer
737.7839135313053	43.8614344882024	798.0025738392803	-19.0321569418157	0.596	169	45	READ	BGJ398	Clinical trials in cancer
184.24627627192464	-64.4002512448178	189.23972796710748	7.79566418281229	0.0004	934	215	BRCA	SB 225002	Experimental
178.58194876081336	-24.960174025287	223.4227395888919	0.767669393243068	0.0006	502	52	KIRC	7,8-DIHYDROBIOPTERIN	Experimental
727.6656929424962	36.0119113719527	742.9997442296343	0.000184554153520367	0.543	599	60	GBM	XL228	Clinical trials in cancer
834.1636525916365	-32.2090463667496	789.0522677087583	22.9111439595999	0.583	169	27	READ	OBLIMERSEN	Clinical trials in cancer
127.12508103479227	63.9274004272269	204.7543681806531	44.0561598483045	0.0006	57	24	PAAD	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUOROBENZAMIDE	Experimental
803.6687982729333	71.3047812891234	781.5519657248926	-5.56361032026803	0.595	169	45	READ	ALPELISIB	Clinical trials in cancer
343.9423127172532	-6.63025077388127	317.95572727284156	9.02277131807523	0.121	57	24	PAAD	ATP	Clinical trials
716.7089662912342	6.99885436782444	720.9708942043203	9.98855918000891	0.523	202	53	LAML	COPANLISIB	Clinical trials in cancer
149.2035148317521	45.1286214136586	250.75199211263498	-56.371507899759	0.0006	264	115	SKCM	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Experimental
761.1020650230556	-2.83380922126184	760.6440396142178	-1.22517827079878	0.562	599	70	GBM	BUPARLISIB	Clinical trials in cancer
227.11578815510094	-29.9392983139215	186.5140501551262	3.97474217927214	0.0006	512	62	UCEC	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Experimental
224.3807031903392	2.07740827323849	203.7434540784884	14.2195224473226	0.0004	934	214	BRCA	PI 3-KG INHIBITOR II	Experimental
350.1264239736233	12.6967871827242	342.1054714915266	0.00633080556002596	0.142	57	24	PAAD	AM-111	Clinical trials
747.0957163496591	28.9597540152205	745.5100733309	2.57135206048861	0.522	202	53	LAML	PICTILISIB	Clinical trials in cancer
731.993605930695	2.53669363756933	777.1586232504968	-0.723271037674749	0.595	153	27	BLCA	ALPELISIB	Clinical trials in cancer
760.1467335897363	-56.1991256550992	774.772688145769	-10.072692724737	0.592	423	89	COAD	CI-1040	Clinical trials in cancer
159.39055340230144	88.1525367990207	192.9103652103043	12.5175644811197	0.0006	57	24	PAAD	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
174.12716673480122	-45.3270639740047	191.98205299199668	0.172914520483118	0.0006	202	29	LAML	HEXAN-1,6-DIOL	Experimental
395.84588707358324	13.2374508274617	376.68532183299357	4.06682770250291	0.181	423	78	COAD	ATP	Clinical trials
200.01578287826737	36.3455702399194	155.57663304548817	10.5801189160417	0.0006	264	34	SKCM	N-CYCLOPROPYL-2',6-DIMETHYL-4'-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-3-BIPHENYLCARBOXAMIDE	Experimental
1212.0450470952685	3.39234009629797	1197.1654518823	4.74818742435713	1	512	55	UCEC	ERLOTINIB	Approved in cancer
840.9114220938599	71.3296204395756	721.0472778442253	33.6572961982608	0.534	57	24	PAAD	AZD8330	Clinical trials in cancer
184.75946191703432	-10.5122905286943	212.49210272904355	13.6608762624323	0.0006	502	55	KIRC	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYL-2,4-PYRIMIDINEDIAMINE	Experimental
202.42911929245764	0.805115800310034	220.36432279994247	22.3418179245007	0.0004	512	72	UCEC	ML214	Experimental
185.88382576223552	-80.0621321628132	192.0777358964097	1.78567075891988	0.0004	222	127	LGG	MERCK60	Experimental
1192.7676275023882	18.2241667748372	1204.6379816345325	-7.35535530813564	1	512	107	UCEC	EVEROLIMUS	Approved in cancer
596.6678399758378	-7.25770777253959	592.3692838769157	-5.47257369214725	0.391	512	80	UCEC	CAFFEINE	Approved in other pathologies
1183.5125196181111	-5.44333239499539	1191.7956442611896	-1.93359605955379	0.99	292	35	STAD	TEMSIROLIMUS	Approved in cancer
1197.5325711699313	13.7267600852792	1189.277458348536	2.14697995449933	0.99	292	35	STAD	EVEROLIMUS	Approved in cancer
263.4975225520071	0.31452295203988	173.97222169764993	10.0494891095633	0.0006	169	43	READ	(5S,6Z)-4,5-DIFLUORO-6-[(2-FLUORO-4-IODOPHENYL)IMINO]-N-(2-HYDROXYETHOXY)-1,3-CYCLOHEXADIENE-1-CARBOXAMIDE	Experimental
793.9915850173151	105.843465288903	768.2511732679031	10.648609074279	0.595	169	45	READ	COPANLISIB	Clinical trials in cancer
163.16542319350268	-24.4368055703501	200.45624497159747	13.9153829187046	0.0006	169	39	READ	1,9-PYRAZOLOANTHRONE	Experimental
380.18122167884985	0.679634215964086	383.22936498671487	2.36690975024294	0.181	423	65	COAD	EDARAVONE	Clinical trials
1216.7609520309722	-22.7051329515467	1195.2415869147699	10.1156534484521	0.993	512	91	UCEC	PONATINIB	Approved in cancer
158.6211078862403	-12.980885805465	187.76652412659644	-8.19733455703886	0.0008	543	74	LUAD	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
139.63603183853974	120.016955023505	275.23141514377335	11.0937433570909	0.0008	264	181	SKCM	ERK INHIBITOR II	Experimental
238.7611107754593	53.4728024904035	220.35075796554528	10.4769901718781	0.0006	264	34	SKCM	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	Experimental
845.8431548467291	-63.9033660895036	825.7141748781931	-36.1360853658418	0.596	264	114	SKCM	BGJ398	Clinical trials in cancer
147.77317070752136	8.19827681608893	202.57690660200365	18.4680239939366	0.0006	423	63	COAD	2-({2-[(3-HYDROXYPHENYL)AMINO]-4-PYRIMIDINYL}AMINO)BENZAMIDE	Experimental
722.7303854889597	-11.3387801568329	739.6167230506037	4.62477928126964	0.535	502	56	KIRC	VATALANIB	Clinical trials in cancer
131.28082493585694	-21.1459048638567	216.7410981939117	4.94553194439686	0.0004	934	217	BRCA	LY-2183240	Experimental
153.413003205646	72.347800090618	203.50813859738886	22.482449372446	0.0008	264	114	SKCM	R547	Experimental
723.3944774895485	10.1967688960632	738.6781124781377	0.262755305046994	0.531	502	56	KIRC	BEVACIZUMAB+TRASTUZUMAB	Clinical trials in cancer
760.4728712939476	-22.6031565160952	789.3532486960165	0.560605379502704	0.581	292	36	STAD	S-8184	Clinical trials in cancer
170.38742126534325	12.7712693199994	211.80004350797043	-3.99584751988527	0.0004	343	44	HNSC	PI 3-KG INHIBITOR II	Experimental
777.7583203276834	33.3499066501721	757.3542908861307	-3.28232276775208	0.575	264	32	SKCM	VATALANIB	Clinical trials in cancer
1141.4146786335662	2.53391991019274	1143.7063034390603	-0.00124830004915566	0.944	934	103	BRCA	PACLITAXEL	Approved in same tumor type
179.03274081253184	-59.082144904883	199.33868818556599	-14.8994418966786	0.0004	423	57	COAD	BRD63610	Experimental
722.9354975129174	22.1464943378211	728.7171649536722	-6.07542058454192	0.531	934	101	BRCA	S-8184	Clinical trials in cancer
911.1785308220132	0.745654744932153	910.9999663811534	0.000341437053521076	0.711	502	52	KIRC	DEXAMETHASONE	Approved in other pathologies and in clinical trials in cancer
828.5031183509857	-50.9706184088478	798.4550435833004	-15.3283289486773	0.598	512	144	UCEC	DACTOLISIB	Clinical trials in cancer
171.1079889942529	32.0040496104054	184.36752196774623	-10.3519615082364	0.0006	502	56	KIRC	TRIS(HYDROXYMETHYL)AMINOMETHANE	Experimental
744.3837266162185	48.1721488355412	787.7712080350638	8.20251784311637	0.584	264	36	SKCM	XL228	Clinical trials in cancer
211.4134324192299	-45.648638097958	188.8342003395797	1.77927887928672	0.0006	502	52	KIRC	BILIVERDINE IX ALPHA	Experimental
767.0761993399909	-32.5641944019765	794.6628090608525	6.3655860602114	0.594	389	42	LUSC	PILARALISIB	Clinical trials in cancer
171.84410632832453	27.8413852427615	214.48494979220644	-9.70580533718658	0.0006	512	58	UCEC	D-1,4-DITHIOTHREITOL	Experimental
222.10732503206506	-42.6569902437741	216.49675932264364	3.05336776228751	0.0006	502	52	KIRC	ANISTREPLASE	Experimental
1072.7029318308662	-6.41764875388824	1094.5810177985995	-4.17996536221415	0.892	169	42	READ	TEMSIROLIMUS	Approved in cancer
152.14253767402084	12.2332578825113	188.5016237810839	-25.2740990457795	0.0008	512	76	UCEC	PHOSPHOTHREONINE	Experimental
122.74671357052107	-9.39478621961237	245.6392149619298	-33.1151847200106	0.0006	435	211	THCA	[4-({5-CARBAMOYL-4-[(3-METHYLPHENYL)AMINO]-2-PYRIMIDINYL}AMINO)PHENYL]ACETIC ACID	Experimental
80.5374982419874	51.554893866104	237.66862611522373	38.5209402484098	0.0008	264	183	SKCM	PURVALANOL B	Experimental
689.9323213622215	76.9002146087121	692.9635811963946	47.397194022594	0.513	435	183	THCA	BAY1000394	Clinical trials in cancer
156.01760419562214	-43.902778357554	186.23426373413162	10.8280039032456	0.0008	423	89	COAD	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
266.786333582123	-62.6654502337801	213.68783492620335	29.9111767491123	0.0006	512	75	UCEC	1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	Experimental
788.4645201856439	-37.0228138406641	783.9305248523368	9.08136261566779	0.593	423	89	COAD	XL281	Clinical trials in cancer
1123.9267770626195	-10.0268846359198	1121.192521369617	-1.92142760671226	0.921	57	8	PAAD	DOCETAXEL	Approved in cancer
239.66571485581585	-24.945998125784	194.51027407669832	-0.3782703113107	0.0006	264	34	SKCM	(3R,5S)-N-{4-CHLORO-3-[(3-PYRIDINYLOXY)METHYL]PHENYL}-3-FLUORO-5-(4-MORPHOLINYL)-1-CYCLOHEXENE-1-CARBOXAMIDE	Experimental
767.323298963396	-60.4428477817568	789.3791476169956	0.726677747553367	0.592	153	27	BLCA	APITOLISIB	Clinical trials in cancer
817.3448364984793	42.1975329809554	805.5216937556859	56.9978162842697	0.581	264	112	SKCM	AVI4126	Clinical trials in cancer
1143.2932782592975	-14.0991919846932	1152.0000263130637	-0.000237932946674846	0.952	153	29	BLCA	DOCETAXEL	Approved in cancer
150.71031907320747	-8.0826046973373	205.03488717433066	-6.56543041036457	0.0006	502	52	KIRC	3-[(4-CHLOROPHENYL)CARBAMOYL]-2-NAPHTHYL DIHYDROGEN PHOSPHATE	Experimental
176.78276837755388	-32.1610245630081	213.67008004241225	6.40152945530281	0.0006	502	52	KIRC	N5-CARBAMOTHIOYL-L-ORNITHINE	Experimental
186.98226713802867	-39.9263881498776	191.65765617470538	1.81215365635853	0.0004	153	17	BLCA	GW843682X	Experimental
611.5237764837798	11.4666479485972	612.0001197313256	-7.60477149697181e-05	0.412	169	38	READ	GI-4000	Clinical trials in cancer
1005.5626661402081	12.7296404271955	1016.2745841201215	7.93724408373737	0.822	435	183	THCA	DABRAFENIB MESYLATE	Approved in cancer
144.73477801620518	-36.1046733143671	204.80371422921607	2.38325994644902	0.0004	153	19	BLCA	TIPIFARNIB-P2	Experimental
222.56742337874934	9.12372645175219	186.1967351466551	-26.4525985823894	0.0006	264	34	SKCM	4-{1-METHYL-2-(4-PIPERIDINYL)-4-[3-(TRIFLUOROMETHYL)PHENYL]-1H-IMIDAZOL-5-YL}-N-[(1S)-1-PHENYLETHYL]-2-PYRIMIDINAMINE	Experimental
799.4612892793135	42.0349525144152	760.5207508848947	8.07774726604828	0.552	264	28	SKCM	XL820	Clinical trials in cancer
1172.8632708763769	-2.95285319983441	1179.5552513669415	4.24735528154861	0.981	292	36	STAD	ERIBULIN	Approved in cancer
1147.710724843001	7.16876031774888	1185.4600376772519	-0.0157506627219846	0.984	169	47	READ	ARSENIC TRIOXIDE	Approved in cancer
698.5894498937905	-31.8068155687839	713.2619030306336	-5.62577137765948	0.522	934	214	BRCA	SAR260301	Clinical trials in cancer
731.2210870915634	-9.58742798935845	717.0810197110533	-2.27794204109341	0.511	502	54	KIRC	VEGF RECEPTOR TYROSINE KINASE INHIBITOR II	Clinical trials in cancer
870.8656544207635	-46.9736833883432	768.3765718236903	-4.64627132631671	0.595	264	114	SKCM	ALPELISIB	Clinical trials in cancer
352.2238307759927	-21.2857433946694	325.57736060812533	-5.99612394748215	0.121	57	24	PAAD	K-252A	Clinical trials
206.44206669031036	-54.2389165650877	187.25989291786212	9.12244806457056	0.0006	502	52	KIRC	4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE	Experimental
205.13633519678945	-39.633177679173	214.81291833980723	1.5426828086986	0.0006	543	63	LUAD	2-({2-[(3-HYDROXYPHENYL)AMINO]-4-PYRIMIDINYL}AMINO)BENZAMIDE	Experimental
181.28757176787988	51.4392067359196	195.60712484974795	-5.31910191570051	0.0006	264	34	SKCM	3-(1-NAPHTHYLMETHOXY)-2-PYRIDINAMINE	Experimental
1221.3820055783654	-15.1204147312913	1189.4332457567843	10.1220179810423	0.986	169	45	READ	BOSUTINIB	Approved in cancer
1082.443441968364	-7.66276025509029	1089.4492209530224	4.19534551260733	0.892	169	41	READ	EVEROLIMUS	Approved in cancer
236.51049985152216	4.75103551727554	205.81067456192784	4.55713129245811	0.0006	512	75	UCEC	1-TERT-BUTYL-3-(4-CHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	Experimental
131.10788218690246	6.86280358920897	218.67383677165375	10.9296857239257	0.0006	512	75	UCEC	MALONIC ACID	Experimental
257.73531704871556	5.79255154181513	170.00731441134266	17.6784281357961	0.0006	512	75	UCEC	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
571.9478836895656	2.54292570183091	578.960706865447	3.81265250128979	0.381	512	75	UCEC	ISOPRENALINE	Approved in other pathologies
754.9358003384887	-23.0725823381104	782.0158038658584	-11.4658821204966	0.583	423	67	COAD	GOSSYPOL	Clinical trials in cancer
766.2113817759875	76.7720785002231	808.0998247715163	-15.616741291017	0.594	169	45	READ	PILARALISIB	Clinical trials in cancer
782.3418381225151	-50.1786004590107	792.5324362621699	-1.02686927824197	0.584	423	89	COAD	AZD8330	Clinical trials in cancer
1115.3703557253555	20.976602058047	1126.146853531652	29.9624292639201	0.926	435	212	THCA	BOSUTINIB	Approved in cancer
645.4084462489288	14.504565890547	776.7092905809374	-0.764925439082617	0.533	435	212	THCA	XL281	Clinical trials in cancer
585.5803048864906	5.20229566630942	579.6569167305087	-0.494215491827617	0.382	264	27	SKCM	CAFFEINE	Approved in other pathologies
680.0617348610366	-12.7286520575119	779.1967801295721	-2.16093993959362	0.583	543	74	LUAD	TAK-733	Clinical trials in cancer
211.0260878005485	30.4695907394845	212.83616248677453	4.07708043628895	0.0006	169	39	READ	2-({2-[(3-HYDROXYPHENYL)AMINO]-4-PYRIMIDINYL}AMINO)BENZAMIDE	Experimental
547.514553143713	-4.64246551090469	551.0000467751616	-6.7967334871355e-06	0.351	153	22	BLCA	IBUPROFEN	Approved in other pathologies
179.9268168126014	-44.5430033226909	190.55622997854158	2.52857207447869	0.0004	423	69	COAD	KINETIN RIBOSIDE	Experimental
764.2476939760156	26.4919794469335	742.6414347647755	-4.0139087085754	0.551	343	84	HNSC	DHA-PACLITAXEL	Clinical trials in cancer
777.4469170960615	27.9803755689674	812.9035831679731	-35.1246827277402	0.584	264	45	SKCM	MK-2206	Clinical trials in cancer
573.5280307000908	-8.25445468180999	575.0107171289023	0.623644308091684	0.381	512	55	UCEC	MINOCYCLINE	Approved in other pathologies
707.8603791542466	-34.8852810921667	703.0129208610227	8.46269276867247	0.522	202	53	LAML	BUPARLISIB	Clinical trials in cancer
217.26257608190218	55.5168285986238	201.11433073179046	11.4563999820045	0.0006	264	34	SKCM	1-{4-[5-(4-CHLOROPHENYL)-4-(4-PYRIMIDINYL)-1H-PYRAZOL-3-YL]-1-PIPERIDINYL}-2-HYDROXYETHANONE	Experimental
727.4641390818325	42.7241290424764	795.8189882801877	18.136828236006	0.596	169	43	READ	PD-0325901	Clinical trials in cancer
525.0461468745435	-15.0399988004001	525.1505221568509	-2.42302934748591	0.311	435	183	THCA	APREMILAST	Approved in other pathologies
749.2923554550467	3.70508502917897	754.6808398977514	-2.36180796456483	0.553	389	44	LUSC	OBATOCLAX	Clinical trials in cancer
536.5642589748629	-3.86490689903971	534.1039990119536	-1.42512780633024	0.331	934	101	BRCA	RASAGILINE	Approved in other pathologies
850.319396345464	-12.9339710339178	772.5400514006318	1.78288033158799	0.586	512	80	UCEC	SARACATINIB	Clinical trials in cancer
260.130304907182	-53.7174338077997	222.9544963448709	39.3281822852393	0.0004	435	183	THCA	P-0850	Experimental
976.4585296478274	-1.30540240250079	985.0000167830799	-0.000199252754100598	0.785	423	67	COAD	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
515.7885735078034	-7.45751982150645	531.0000901670217	0.000386639603448202	0.331	599	106	OV	IBUPROFEN	Approved in other pathologies
266.3235577632088	40.282006188754	179.73906164354585	-31.6010811962424	0.0004	435	183	THCA	(+)-NEOPELTOLIDE	Experimental
1134.13226265536	8.83954841695942	1137.1866433739308	-0.0176934949950009	0.937	543	68	LUAD	VANDETANIB	Approved in cancer
187.628151519408	-26.5385635288254	204.6870284860896	0.500156433333814	0.0006	423	58	COAD	(+)-CERULENIN	Experimental
240.18415967018365	12.9645096367422	186.75294113559056	-1.29024127704417	0.0006	512	75	UCEC	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
222.96707331637455	22.3291769901446	210.71736494688162	8.09164414965517	0.0006	264	34	SKCM	4-PHENOXY-N-(2-PYRIDINYLMETHYL)BENZAMIDE	Experimental
201.30700634937284	9.30496082160801	219.89693740155172	16.2980257971197	0.0006	512	67	UCEC	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
396.96905240019385	-4.81646483043505	375.7815662903132	-1.13895730540327	0.182	264	34	SKCM	KC706	Clinical trials
117.12216485943235	-78.4365640015944	265.2397731187338	37.5870842792401	0.0008	264	181	SKCM	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
720.1789885838085	-66.2372877626824	741.5001967489178	14.453665726511	0.522	202	53	LAML	APITOLISIB	Clinical trials in cancer
173.81725400967832	-87.8343257698017	209.24273719058164	3.96076606826819	0.0006	423	63	COAD	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXY-2-PYRIDINECARBOXAMIDE	Experimental
832.1895577678266	-61.2620772767251	790.0179018493033	-11.9988724709161	0.594	169	45	READ	DACTOLISIB	Clinical trials in cancer
181.99012610171113	73.1649341069664	172.59034963641906	-3.39226906339002	0.0004	512	66	UCEC	TERT-BUTANOL	Experimental
799.5181453041629	64.002019471932	779.2566985405452	19.9890651460424	0.582	264	43	SKCM	AFURESERTIB HYDROCHLORIDE	Clinical trials in cancer
404.7580872203244	-6.09027358707286	394.347487360896	0.172713152253095	0.192	169	45	READ	QUERCETIN	Clinical trials
572.8788647453658	-15.2386198741517	587.2994725120807	0.444753055007823	0.384	222	54	LGG	IBUPROFEN	Approved in other pathologies
1182.6234114005074	-21.4352672814114	1187.2766477153525	-1.90680682711059	0.986	292	31	STAD	BOSUTINIB	Approved in cancer
581.8947774952208	-12.28281134758	581.5084533093321	-4.66307722932083	0.381	169	39	READ	CHOLINE	Approved in other pathologies
775.6733630373307	-46.2745218631206	790.2957627828162	-20.9091927002437	0.594	423	79	COAD	SF1126	Clinical trials in cancer
134.5992479580695	-9.76618055888579	198.70451974467076	19.1842050948576	0.0006	502	55	KIRC	1,4-PHENYLENEDI-2,1-ETHANEDIYL DICARBAMIMIDOTHIOATE	Experimental
200.4198644471994	67.6364641874923	178.90874068216164	25.7090776269862	0.0008	512	78	UCEC	NVP-BGT226	Experimental
224.5988781392458	13.2799576021663	209.65205333568173	-24.7258327165679	0.0006	512	75	UCEC	5-ISOPROPYL-2-[(3S)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINYL]-1,3-THIAZOLE-4-CARBOXYLIC ACID	Experimental
812.6231028595495	-54.9675193628565	776.2005084615064	-2.77248824437515	0.583	343	92	HNSC	NAVITOCLAX	Clinical trials in cancer
510.4032593820679	-5.88123074901725	510.469691163287	4.25906109190737	0.311	502	52	KIRC	ALTEPLASE	Approved in other pathologies
756.1444055437482	-4.17639964742796	786.4315647124145	-8.4611293266305	0.585	543	76	LUAD	PILARALISIB	Clinical trials in cancer
800.0461201726553	24.7174725274504	772.9783273149822	-6.49002974782343	0.583	169	28	READ	NAVITOCLAX	Clinical trials in cancer
1169.0404164801364	8.54872442944236	1161.9998381883365	0.000671387196234718	0.962	389	58	LUSC	DOCETAXEL	Approved in cancer
1099.1954616858084	-35.9209693349942	1136.5704442294566	10.8290302444168	0.927	435	183	THCA	PALBOCICLIB	Approved in cancer
507.7813515356974	-1.35118943793208	510.9038756806846	-2.96864858834806	0.311	202	32	LAML	ISOPRENALINE	Approved in other pathologies
254.19007010681162	86.073730168779	170.3855258087982	-5.97786956874751	0.0006	57	24	PAAD	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
890.5771521384459	52.5028874394816	776.1349511772138	77.3794405703806	0.594	264	192	SKCM	ENCORAFENIB	Clinical trials in cancer
801.7597496485846	10.9633262374312	744.7325431553809	-18.6087487395579	0.544	264	27	SKCM	AMUVATINIB	Clinical trials in cancer
1156.9734695520153	11.1875861002627	1187.894433187073	0.523433201630041	0.984	222	53	LGG	PACLITAXEL	Approved in cancer
734.2223800600685	-41.1890580841242	750.4451168306149	3.89992236825947	0.546	934	223	BRCA	VOXTALISIB	Clinical trials in cancer
616.9240333436408	4.579871282206	620.2229540870164	-0.00243276700166462	0.421	202	24	LAML	PAC-1	Clinical trials in cancer
197.25752582405494	48.5546410799373	191.29862239031797	16.2424026086753	0.0006	169	41	READ	GUANOSINE-5'-DIPHOSPHATE	Experimental
575.2979809435566	7.5180945143606	577.6688123274477	-1.7654200789384	0.381	423	65	COAD	RASAGILINE	Approved in other pathologies
313.06464097493534	70.7090316153901	233.9102241707781	1.08870170236725	0.0008	264	111	SKCM	N-(2,4-DIFLUORO-3-{[5-(3-PYRIDINYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL}PHENYL)ETHANESULFONAMIDE	Experimental
794.134711931006	54.8827535827828	741.4019272165267	6.91836458596686	0.536	57	24	PAAD	REFAMETINIB	Clinical trials in cancer
219.99924506424054	-23.1332158986943	210.02793334874136	12.1973409393959	0.0008	202	32	LAML	SB220025	Experimental
303.3602840995252	-20.4558279766486	176.07823967880896	12.9956899412664	0.0004	264	104	SKCM	UNC0638	Experimental
1092.5567411581396	11.1199752474025	1142.8745715563034	-5.73945051663136	0.939	57	24	PAAD	TRAMETINIB	Approved in cancer
265.11494752158524	-28.6133471061037	309.54612313323173	2.4751142998507	0.111	202	27	LAML	ATP	Clinical trials
249.2642801685055	-13.0752730989243	194.3532544130525	14.6997032789289	0.0006	512	53	UCEC	BATIMASTAT	Experimental
784.9174933593453	32.458692787384	783.9698257315611	8.83713125160239	0.581	222	53	LGG	DHA-PACLITAXEL	Clinical trials in cancer
198.7433622940106	-41.9644809463844	206.00275191896444	-10.1892712302601	0.0008	934	223	BRCA	PI-103	Experimental
261.62963051506745	30.5918350394383	182.4994649039304	-22.9449755378792	0.0006	264	34	SKCM	4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE	Experimental
804.499026595037	21.6946423764335	799.817646298014	4.93129425980351	0.596	389	49	LUSC	BGJ398	Clinical trials in cancer
133.90326191951397	-14.3504986525116	197.82646025865208	-1.83098106164613	0.0006	512	67	UCEC	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
798.7525383328646	-3.35512161553496	777.6917664036981	-1.42425137597388	0.575	599	72	GBM	SONOLISIB	Clinical trials in cancer
679.0129952240937	38.4516912710664	710.0926746346437	20.8550750065889	0.542	57	24	PAAD	CI-1040	Clinical trials in cancer
206.71312719939385	-25.5667537288266	201.16378297978187	2.47222473329339	0.0004	292	31	STAD	PIPERLONGUMINE	Experimental
329.9481879312966	-37.0434405200428	306.91921870945885	-0.0170455901079549	0.111	435	183	THCA	EDARAVONE	Clinical trials
300.0580785877897	39.7468137426628	197.6298944362063	-16.2083792744283	0.0006	57	24	PAAD	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
1047.0036920023454	-3.16151186184803	1042.999777811235	-0.000392641519283643	0.843	423	75	COAD	PANITUMUMAB	Approved in same tumor type
636.3593946751149	58.6939512419848	773.3130414555415	-19.9487555001456	0.55	435	212	THCA	SELUMETINIB	Clinical trials in cancer
192.5550796930997	19.2793581148624	215.14388158002302	24.5730172975969	0.0006	512	61	UCEC	(+)-CERULENIN	Experimental
770.6740225993439	53.381482374369	705.7299548573573	-21.7379892163962	0.535	57	24	PAAD	PIMASERTIB	Clinical trials in cancer
156.22811235136678	-51.6676597448892	200.31550587378928	13.2963461655036	0.0004	343	50	HNSC	KINETIN RIBOSIDE	Experimental
193.61400776430187	-19.3562539875486	190.2652273152607	5.68803580967779	0.0006	502	52	KIRC	N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYL-4-PYRIMIDINYL]-D-PROLINAMIDE	Experimental
1193.7828684569088	-9.35195695008693	1195.168318365092	-0.0146393648560661	0.994	153	23	BLCA	PONATINIB	Approved in cancer
843.2193430461205	31.4713506444261	815.3788208560869	13.5565277573427	0.594	512	92	UCEC	NAVITOCLAX	Clinical trials in cancer
789.9491160696488	-30.5406329576921	784.6296030751176	-3.15899871538295	0.586	543	76	LUAD	GEDATOLISIB	Clinical trials in cancer
175.35419936317484	-17.2162086038058	197.7764384359238	-14.9790811313101	0.0006	502	52	KIRC	N-(4-METHYL-3-{[3-(4-PYRIMIDINYL)-2-PYRIDINYL]AMINO}PHENYL)-3-(TRIFLUOROMETHYL)BENZAMIDE	Experimental
1198.5110650383067	-11.5122009930307	1200.6619970517088	0.392118512313118	1	292	32	STAD	SORAFENIB	Approved in cancer
418.55891980663273	-4.60267175357183	398.5499893692316	-4.40141924201248	0.191	264	113	SKCM	QUERCETIN	Clinical trials
270.80095976365857	-28.3411373662611	166.83310913775932	4.37291359590876	0.0006	512	75	UCEC	(5S,6Z)-4,5-DIFLUORO-6-[(2-FLUORO-4-IODOPHENYL)IMINO]-N-(2-HYDROXYETHOXY)-1,3-CYCLOHEXADIENE-1-CARBOXAMIDE	Experimental
816.9100245091722	-20.6122223804272	794.6675994726037	2.9380615587761	0.594	292	41	STAD	PILARALISIB	Clinical trials in cancer
228.2979954954551	63.3225668032042	192.89070175997753	-14.3315545926812	0.0006	264	39	SKCM	1-[1-(3-AMINOPHENYL)-3-(2-METHYL-2-PROPANYL)-1H-PYRAZOL-5-YL]-3-(1-NAPHTHYL)UREA	Experimental
217.82886356050375	-0.555316808460105	201.66873550061078	3.97580328799563	0.0006	202	31	LAML	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
375.3768856932892	2.99920445679129	379.7685012744578	-1.58435873845661	0.181	512	58	UCEC	LAX-101	Clinical trials
642.6488401312921	-4.86617729148074	728.5774600661771	-40.2507202716531	0.522	435	212	THCA	RO4987655	Clinical trials in cancer
181.03176299492964	-33.8643565522846	214.46024608081657	8.14851213625298	0.0008	423	58	COAD	FARNESYL DIPHOSPHATE	Experimental
532.8123967252475	-7.02999737741874	530.9998849680264	-0.000359498679699755	0.331	153	21	BLCA	RASAGILINE	Approved in other pathologies
322.22772256491163	-28.2189426507473	312.4546716010862	-2.47640111587725	0.111	202	31	LAML	K-252A	Clinical trials
207.6259122738611	13.9849456000757	198.56644404499974	7.56692921369267	0.0006	502	52	KIRC	4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE	Experimental
1141.9315238304903	-1.98709777812573	1154.7878544130538	0.00231417734971728	0.954	389	45	LUSC	PACLITAXEL	Approved in same tumor type
1120.7037785563684	-5.53314978844443	1132.765473102057	-0.147733453659384	0.93	343	47	HNSC	TEMSIROLIMUS	Approved in cancer
328.2074043851399	2.73410042922862	313.1881900747316	-1.23859292567158	0.112	502	52	KIRC	STANNSOPORFIN	Clinical trials
1110.652055450481	3.71592233891272	1113.5584045586772	3.79263785156309	0.914	202	33	LAML	ARSENIC TRIOXIDE	Approved in same tumor type
826.1822215114057	99.3999130320542	787.5959242277363	56.3458882050351	0.581	264	125	SKCM	DHA-PACLITAXEL	Clinical trials in cancer
1104.7461128165182	1.50147247284431	1119.8078635132329	4.8401057312783	0.917	202	31	LAML	COBIMETINIB	Approved in cancer
879.655205187994	-32.5254418445692	790.8637171250837	18.7923133565263	0.584	264	111	SKCM	PICTILISIB	Clinical trials in cancer
173.09194086301588	0.804790195770693	220.63832361514906	3.97557605460179	0.0006	502	55	KIRC	ETHYL N'-PHENYLCARBAMIMIDOTHIOATE	Experimental
703.4302647880867	39.1666550705252	720.9698597325269	20.8419782902233	0.523	57	7	PAAD	GOSSYPOL	Clinical trials in cancer
193.50501675674167	-94.1338403289665	194.8069997012152	-24.9095050394353	0.0004	934	215	BRCA	GW843682X	Experimental
725.4148506723678	-90.6442655303171	757.3177647732033	29.6669946625418	0.536	435	212	THCA	BINIMETINIB	Clinical trials in cancer
821.91176813166	-59.5495108667979	805.3620202393304	22.3165994489943	0.594	169	45	READ	PF-04691502	Clinical trials in cancer
1026.5760896035667	16.2533004827337	1026.5617141119062	0.621306358497634	0.825	57	24	PAAD	CETUXIMAB	Approved in cancer
770.2201875883886	1.89376166642052	803.3263291992025	-9.53997562010227	0.596	343	62	HNSC	VOXTALISIB	Clinical trials in cancer
207.06711677295942	-16.9493323925264	175.74515863780692	-14.336218541423	0.0006	512	67	UCEC	1,9-PYRAZOLOANTHRONE	Experimental
747.592725278656	-16.7813769352676	802.6253108160981	3.02779429226121	0.596	543	76	LUAD	DACTOLISIB	Clinical trials in cancer
818.7312118181827	7.133186832842	809.8778550172907	-4.98090840161069	0.592	169	43	READ	CI-1040	Clinical trials in cancer
628.4505754715567	-6.95422215085756	632.0503643438734	0.720393132094614	0.431	934	215	BRCA	ABT-751	Clinical trials in cancer
318.45382865869846	32.0055656230326	193.08568043470262	41.6993539521106	0.0004	222	129	LGG	GW843682X	Experimental
162.01166021335945	-10.3319524969752	203.76711163624884	0.744012199556892	0.0006	502	55	KIRC	ISOPROPYL CARBAMIMIDOTHIOATE	Experimental
662.9058642003943	89.8969769758074	718.7585273450783	-0.267556196982184	0.551	264	112	SKCM	RIVICICLIB	Clinical trials in cancer
678.2961778208199	62.5588314288818	726.9844161293383	1.63172825611912	0.521	599	105	OV	DHA-PACLITAXEL	Clinical trials in cancer
389.55772159337835	13.6692305943089	385.53897632525826	-1.97193846681762	0.182	512	67	UCEC	AM-111	Clinical trials
130.64782582537944	-37.2206025081859	204.1268667080951	21.2533617857791	0.0004	222	127	LGG	GSK429286A	Experimental
1186.5680125204792	6.32534967176207	1180.224428241117	-5.17074658596425	0.981	222	53	LGG	ERIBULIN	Approved in cancer
629.1816377949274	7.16813931710499	735.5427571686963	26.9249195172918	0.511	435	183	THCA	S-8184	Clinical trials in cancer
200.73369836540115	55.6823935279653	200.8997800912274	-6.33048373723597	0.0006	512	76	UCEC	3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1-METHYL-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE	Experimental
259.7174336987488	-66.6823184244695	191.63641975445523	-27.4692752364904	0.0006	169	43	READ	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
723.3143182680433	36.47460411586	795.6176173967535	-2.86416076333774	0.593	389	47	LUSC	PWT33597	Clinical trials in cancer
750.0999266679115	-21.1632871129613	766.0910779061591	0.0702880678736619	0.565	153	16	BLCA	XL281	Clinical trials in cancer
363.7638350060373	4.9592992484545	385.8075705456738	6.13303252944092	0.181	169	43	READ	K-252A	Clinical trials
1188.2112920708737	-23.5070503127844	1177.0863624756853	-3.33234484716149	0.982	423	79	COAD	DOCETAXEL	Approved in cancer
156.19289700433538	15.8407571228493	203.7982750921852	-23.556309718354	0.0006	512	75	UCEC	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
192.16520609834996	-25.6105743677074	208.29445881654783	12.9575911114689	0.0006	502	52	KIRC	4-({4-[(4-METHOXY-2-PYRIDINYL)AMINO]-1-PIPERIDINYL}CARBONYL)BENZONITRILE	Experimental
789.1318625391335	-6.25243077011186	793.6918174401403	-26.3813434178787	0.581	169	27	READ	DHA-PACLITAXEL	Clinical trials in cancer
330.0398219210951	-5.93994452822878	315.61921025776974	-1.60674823724187	0.111	57	7	PAAD	EDARAVONE	Clinical trials
698.8323177795749	15.8136099611326	784.1742667296522	4.62953534004953	0.594	169	44	READ	ENCORAFENIB	Clinical trials in cancer
739.794833836382	-25.6706556336679	716.3706138230856	6.25702561462731	0.513	502	55	KIRC	PD-173074	Clinical trials in cancer
1136.457807539569	13.262551553311	1126.8504455358827	-0.732638928163396	0.929	543	68	LUAD	PANITUMUMAB	Approved in cancer
694.695112933933	6.4720804177565	733.9344634712114	3.8199091498409	0.543	934	223	BRCA	SF1126	Clinical trials in cancer
204.78598650670406	-8.56439513706206	196.66475404904952	5.26433573829104	0.0004	292	31	STAD	(−)-NUTLIN-3	Experimental
1203.3195967506103	11.5867806298658	1196.3901054346456	0.583719772418135	0.989	423	81	COAD	TEMSIROLIMUS	Approved in cancer
172.281845409996	-32.6652734362926	208.30701292127003	-6.03576447758678	0.0004	153	20	BLCA	EVODIAMINE	Experimental
207.7594688356194	23.7888892278344	224.91755024247485	18.7467284036982	0.0006	512	76	UCEC	2-(1H-IMIDAZOL-1-YL)-9-METHOXY-8-(2-METHOXYETHOXY)BENZO[C][2,7]NAPHTHYRIDIN-4-AMINE	Experimental
725.7103542773339	-7.06472032198744	715.9622208081194	3.34906521914559	0.532	202	31	LAML	CI-1040	Clinical trials in cancer
906.3885933528004	7.51738391321811	891.9999669121988	0.000372705535028217	0.692	169	41	READ	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
1133.3047096686257	23.7233329664841	1129.962336643038	5.08991135192036	0.941	57	24	PAAD	BOSUTINIB	Approved in cancer
144.01896477057554	-76.8425301582942	202.31544703712933	-1.93237246127296	0.0008	343	52	HNSC	WORTMANNIN	Experimental
264.14321241806533	26.2729263274131	171.9632880061396	6.48219950446855	0.0006	512	67	UCEC	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXY-2-PYRIDINECARBOXAMIDE	Experimental
183.7663785576222	-29.9498802068115	217.74853664036755	7.10633779142381	0.0006	502	52	KIRC	PIMAGEDINE	Experimental
202.6967834340316	-25.4703310393986	210.48831072996418	-13.1468547087534	0.0006	502	55	KIRC	ARGIMESNA	Experimental
175.33981912979948	-65.2111947751891	207.5400750529772	5.87171735969014	0.0004	934	215	BRCA	OLIGOMYCIN A	Experimental
785.9708032028852	-11.095808725053	782.746302985508	-12.6678614975169	0.583	543	76	LUAD	GSK2636771	Clinical trials in cancer
154.6520468963636	-9.97690938108522	206.99226044667157	-6.95402160908225	0.0006	543	63	LUAD	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
227.96674875627195	8.85563132643546	223.10906966582732	6.96908646992108	0.0004	512	79	UCEC	MST-312	Experimental
985.7362559364956	3.6400832750322	984.9999385575255	0.000187273762549012	0.785	292	38	STAD	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
241.80431587806194	7.26256637867772	212.28904314287823	-5.10610305412314	0.0006	512	75	UCEC	PASBN	Experimental
745.4941355088407	-10.8315718313449	716.632060295233	-9.99890971866785	0.523	202	22	LAML	TANDUTINIB	Clinical trials in cancer
1100.617761165408	21.8637753540539	1122.7758256963225	-3.97748851899087	0.92	934	235	BRCA	EVEROLIMUS	Approved in same tumor type
291.94765309270065	58.2463251805167	228.0588623268226	20.7064233754602	0.0004	222	132	LGG	(−)-NUTLIN-3	Experimental
372.73278655666553	-5.31832181557797	382.6122478047594	1.68599146423065	0.182	512	53	UCEC	MBX-8025	Clinical trials
721.0155731293061	-36.3915123042076	716.8720099015287	10.0458097365176	0.522	934	214	BRCA	INK-1117	Clinical trials in cancer
753.0164319809255	-8.02172567531829	791.708596548611	5.20370986933926	0.586	543	74	LUAD	REFAMETINIB	Clinical trials in cancer
290.2243361995004	5.48337143969601	202.45310389259305	-44.9704663265071	0.0006	57	24	PAAD	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Experimental
755.4344226490991	62.0132165234572	753.6789620494612	3.55275515428934	0.552	512	67	UCEC	INK-1117	Clinical trials in cancer
688.9761783271629	-6.36481341363563	736.5905727171853	-37.3583847360695	0.562	57	24	PAAD	BGJ398	Clinical trials in cancer
132.83492206283836	52.1938035177579	212.8518657624274	-13.9076182722124	0.0006	169	39	READ	N-(4-AMINO-5-CYANO-6-ETHOXY-2-PYRIDINYL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
603.8980233356541	1.56758744946353	611.9999326943808	-0.000445996986400132	0.412	423	57	COAD	GI-4000	Clinical trials in cancer
225.4953719663636	-24.6747789343661	214.2803003419497	-14.4643646300177	0.0004	512	66	UCEC	BIX-01294	Experimental
347.9830888655441	-38.9394846349154	325.08010344703564	0.0185085257546689	0.121	435	212	THCA	K-252A	Clinical trials
699.3835407327842	-9.95028970851473	738.1271296822908	-4.57388169181331	0.533	153	21	BLCA	OBATOCLAX	Clinical trials in cancer
861.4255022539386	-16.2794271885544	784.5191544012374	-4.1517492781922	0.562	57	24	PAAD	VOXTALISIB	Clinical trials in cancer
208.34148700526197	-11.9867064280219	209.07520408099833	11.5214069958706	0.0004	543	78	LUAD	LY-2183240	Experimental
213.30030116794325	62.7573063824771	196.81886868034982	-10.590390281957	0.0006	264	34	SKCM	3-(4-FLUOROPHENYL)-2-PYRIDIN-4-YL-1H-PYRROLO[3,2-B]PYRIDIN-1-OL	Experimental
696.3014928579684	-90.6867185888159	672.0997598680535	-17.8780311624284	0.524	435	212	THCA	AZD8330	Clinical trials in cancer
105.41917891697165	87.5102687758678	149.16773472412828	-41.520569739879	0.0006	264	133	SKCM	HEXAN-1,6-DIOL	Experimental
771.3228604451326	8.99659939513094	803.0856816123444	4.90376945952835	0.595	343	62	HNSC	COPANLISIB	Clinical trials in cancer
189.69150978300556	42.6915627502712	221.10433029388872	-8.58328383878484	0.0006	169	44	READ	[4-({5-CARBAMOYL-4-[(3-METHYLPHENYL)AMINO]-2-PYRIMIDINYL}AMINO)PHENYL]ACETIC ACID	Experimental
607.0226993488789	5.81524810678496	609.4064236157778	1.46226354113281	0.412	512	66	UCEC	BUPARLISIB HYDROCHLORIDE	Clinical trials in cancer
593.3816783361149	-18.4198004717798	611.9984081618821	-0.000279393696530406	0.412	57	24	PAAD	GI-4000	Clinical trials in cancer
520.7845820998705	-3.62421209955531	511.09606668263893	2.96883576088749	0.311	202	28	LAML	PEGADEMASE BOVINE	Approved in other pathologies
795.0444994068619	30.4421234693199	752.4161509171546	-3.38835746657128	0.553	343	84	HNSC	OBLIMERSEN	Clinical trials in cancer
531.0508141143744	0.170852999701367	527.896205613688	1.4250668415234	0.331	934	218	BRCA	CAFFEINE	Approved in other pathologies
166.27522336526903	-10.0003576455634	208.18818891885832	-1.0698656227828	0.0008	153	18	BLCA	GUANOSINE-5'-DIPHOSPHATE	Experimental
227.64028259923128	-4.52270969369593	209.21796955637438	-5.53382327002555	0.0006	202	31	LAML	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)-1,2-ETHANEDIAMINE	Experimental
839.0335166291824	16.5343110588024	811.4417298852084	-4.01956985178731	0.594	512	144	UCEC	PF-04691502	Clinical trials in cancer
325.8480977103922	-7.61683161007053	317.2316031313926	-0.31635306894259	0.112	502	52	KIRC	KD7040	Clinical trials
258.76043118896314	11.6476895520051	228.68843505643883	-1.35452694359896	0.0006	512	78	UCEC	{4-[(10R,11E,14S,18S)-18-(2-AMINO-2-OXOETHYL)-14-(1-NAPHTHYLMETHYL)-8,17,20-TRIOXO-7,16,19-TRIAZASPIRO[5.14]ICOS-11-EN-10-YL]BENZYL}PHOSPHONIC ACID	Experimental
706.5204844786031	-45.6219021250463	730.917919180243	2.47723931366727	0.534	502	57	KIRC	ORANTINIB	Clinical trials in cancer
782.6429660493386	-20.6996666023735	764.021180607462	-4.45712365519762	0.562	599	70	GBM	PICTILISIB	Clinical trials in cancer
757.6110844680817	-8.51422826986845	788.9192341114925	12.8625357848344	0.581	512	56	UCEC	PTC299	Clinical trials in cancer
813.0629528982001	-31.4961791005981	790.7988351744992	-9.757890507703	0.593	343	62	HNSC	SF1126	Clinical trials in cancer
173.87725871908236	-13.4484649783411	190.9716595069067	12.419117367129	0.0004	512	52	UCEC	BRD63610	Experimental
704.8397037443859	66.9530696764464	717.8331384256807	22.9078765470072	0.536	435	212	THCA	REFAMETINIB	Clinical trials in cancer
718.6325219787759	50.8461977362364	748.9006863209435	1.41634186399114	0.552	512	67	UCEC	TCMDC-137004	Clinical trials in cancer
797.4282285671126	9.62690724559087	786.4936367676397	3.13842278353087	0.582	264	34	SKCM	RALIMETINIB	Clinical trials in cancer
245.22377228581396	43.4455307878893	192.64071758536124	2.22943047961701	0.0004	512	103	UCEC	EVODIAMINE	Experimental
759.2585355134026	32.0452594798376	748.3618505135911	-3.79074764884825	0.552	512	67	UCEC	SAR260301	Clinical trials in cancer
212.95689522924408	46.0101884805997	191.918315666439	-8.91504340096219	0.0006	264	34	SKCM	3-FLUORO-5-(4-MORPHOLINYL)-N-{1-[2-(4-PYRIDINYL)ETHYL]-1H-INDOL-6-YL}BENZAMIDE	Experimental
195.2245148700221	-23.2274579198154	197.27585164267379	-1.27546861800283	0.0008	153	16	BLCA	PURVALANOL B	Experimental
978.3467157473057	-8.44588489080706	980.1840785261307	4.28962899057427	0.784	512	108	UCEC	CELECOXIB	Approved in other pathologies and in clinical trials in cancer
1190.1863300446576	-30.5560323828041	1182.1412480200831	-4.64950566866878	0.982	292	54	STAD	DOCETAXEL	Approved in cancer
187.3542222282285	-19.0225751253435	213.1726988371965	9.56072625905483	0.0004	512	56	UCEC	MERCK60	Experimental
805.2742734134175	-21.3306284442076	777.8283931208031	-17.3921116771453	0.593	423	79	COAD	APITOLISIB	Clinical trials in cancer
361.8545172426404	-2.68968889007914	360.9999550239272	0.000157923501319601	0.161	423	59	COAD	LAX-101	Clinical trials
668.713148342935	53.4042289349983	724.0239684312753	41.365767432791	0.536	435	212	THCA	PD-0325901	Clinical trials in cancer
226.64392711027506	-15.7071243487088	200.87602179173248	21.9857269338129	0.0006	512	75	UCEC	N-[(1S)-1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL]-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
837.6333716560861	2.18650360665129	756.7612164090908	5.39227077075725	0.553	343	84	HNSC	GOSSYPOL	Clinical trials in cancer
711.3751681153747	-1.58426027226477	762.1937432406111	-2.75902339302411	0.553	343	84	HNSC	OBATOCLAX	Clinical trials in cancer
1127.1739537698104	-14.6047661274903	1127.2339855645255	0.147460258990805	0.93	343	48	HNSC	EVEROLIMUS	Approved in cancer
1195.088453141773	-14.5876755052154	1191.247123640658	11.5304335485496	0.977	264	32	SKCM	AXITINIB	Approved in cancer
254.4426288498389	33.6752871261492	218.75645439406904	4.98775699336534	0.0006	202	53	LAML	PI-103	Experimental
1054.9517206566964	5.78508333646295	1040.6387221545606	-8.63218609960867	0.841	57	24	PAAD	ETOPOSIDE	Approved in cancer
190.77546402285708	-17.3116980717006	181.80148120910826	4.21044724041485	0.0006	502	52	KIRC	ETHENO-NAD	Experimental
716.424110701807	-5.89308269999145	725.5430574811577	-3.08308707863353	0.521	502	55	KIRC	NITROARGININE	Clinical trials in cancer
1189.0139336053662	26.7966617488607	1193.7798954453408	8.43370816156221	0.996	423	94	COAD	REGORAFENIB	Approved in same tumor type
774.2746243632246	19.2304984752823	787.4210688467388	0.495439944143982	0.592	389	42	LUSC	GSK2636771	Clinical trials in cancer
183.70020813005743	8.15480546656426	203.0177278810086	33.462581629217	0.0006	264	33	SKCM	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
1129.7262317683317	10.6266477547717	1130.589279658264	-3.72504058498703	0.93	543	62	LUAD	GEFITINIB	Approved in same tumor type
743.6029915682328	11.2932554751396	729.802666297547	0.469357282409419	0.532	543	60	LUAD	RAS PEPTIDE CANCER VACCINE	Clinical trials in cancer
1228.199265341939	9.38058652341653	1206.3715355039988	4.98922404092957	1	169	44	READ	SORAFENIB	Approved in cancer
804.0070978119531	-57.8946677481886	802.791811756909	10.3656741504556	0.594	423	79	COAD	PILARALISIB	Clinical trials in cancer
161.7120047828025	17.448369472864	191.13650382577887	-6.26929114481459	0.0004	343	47	HNSC	PNU-74654	Experimental
759.1847633751894	14.162432819548	727.3280518836358	-5.40496116350164	0.523	599	106	OV	GOSSYPOL	Clinical trials in cancer
744.4282416280834	-22.2620860093656	801.5662675485412	-6.38855146060678	0.594	153	27	BLCA	PF-04691502	Clinical trials in cancer
311.98007163975325	-35.8040673810708	248.31274331060197	17.9258944304413	0.0006	435	212	THCA	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
1081.8181396921755	6.76881585037933	1091.0850800000082	-2.95395899009782	0.891	423	67	COAD	PEMETREXED	Approved in cancer
806.9206465869694	81.8049942457318	781.7848234011818	-16.1905288675529	0.595	512	143	UCEC	COPANLISIB	Clinical trials in cancer
888.5049122505195	5.1611897413654	808.8690171421003	9.49214997534858	0.587	264	112	SKCM	SONOLISIB	Clinical trials in cancer
209.2009111252912	37.7159592179352	192.81455430111635	18.5763870460439	0.0006	264	34	SKCM	N-ACETYL-L-ARGININE	Experimental
770.2178715924537	-50.9829681368464	789.7133814930224	-6.20397989119874	0.594	153	26	BLCA	PILARALISIB	Clinical trials in cancer
721.7363578452492	17.8952114309195	742.9249324056965	1.6349898877379	0.535	502	56	KIRC	FORETINIB	Clinical trials in cancer
577.4739088519256	15.8515774120187	582.0160500246764	5.15041251532273	0.381	169	44	READ	ISOPRENALINE	Approved in other pathologies
371.66170216397757	6.80881932114676	382.00860703409705	-6.40025815158975	0.181	512	78	UCEC	ATP	Clinical trials
1111.3208431084893	-6.45731880924083	1106.9639115930008	-0.166211500202508	0.909	543	72	LUAD	TEMSIROLIMUS	Approved in cancer
216.93850734044122	-35.2332598212407	215.01081899831166	-1.0488639459727	0.0006	502	55	KIRC	1,2,4-TRIAZOLE-CARBOXAMIDINE	Experimental
826.4458873772197	-35.2541268263847	759.4343516349505	5.12610411583978	0.582	169	43	READ	BI847325	Clinical trials in cancer
762.271369993614	-42.3547586599962	783.9828248984047	-10.0749789996944	0.593	153	27	BLCA	PWT33597	Clinical trials in cancer
255.48340191268835	41.3837978589589	205.9089200401419	9.8148332827426	0.0006	264	34	SKCM	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(4-PIPERIDINYLOXY)PHENYL]METHANONE	Experimental
149.28220363657297	22.8744998336126	203.66480282416407	-5.66803296814714	0.0004	292	40	STAD	LY-2183240	Experimental
163.7517162879612	103.789686539237	182.22440428352178	-12.6040657032107	0.0004	264	104	SKCM	KU 0060648	Experimental
195.2273030279255	4.56953077730486	208.3547876335226	-4.14363069419596	0.0004	292	32	STAD	PARBENDAZOLE	Experimental
542.4919409803481	-1.92312457306193	540.9999461778459	-0.000182986740128399	0.341	423	60	COAD	CHOLINE	Approved in other pathologies
291.03138229977105	26.54483659099	147.16422652201004	2.53208515246018	0.0004	264	104	SKCM	AZ628	Experimental
611.8211929737953	-6.33606523431155	615.38283820538	-3.29448371117087	0.412	934	214	BRCA	DUVELISIB	Clinical trials in cancer
1177.8999035611134	-9.50401727497777	1195.4645163247437	13.0119361050851	0.988	264	27	SKCM	NILOTINIB	Approved in cancer
212.82823234535712	-3.55579244301467	192.11180422410087	12.2631035062143	0.0006	543	75	LUAD	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
217.48138856240413	-43.7858384682533	209.01910382247812	-0.352014272657982	0.0006	512	75	UCEC	RU79073	Experimental
981.670637621602	0.714236552712322	981.8193729836973	-2.14996303576396	0.784	512	62	UCEC	SIMVASTATIN	Approved in other pathologies and in clinical trials in cancer
618.9857802507815	-8.70931288581045	622.3283286369423	2.93600272989192	0.422	343	44	HNSC	DUVELISIB	Clinical trials in cancer
387.6413197947566	-9.2197000689568	392.083730265204	0.0428869816173574	0.192	423	79	COAD	QUERCETIN	Clinical trials
1133.0268089639496	-0.121931539851829	1124.6845820912217	-1.39215925179269	0.924	502	56	KIRC	PACLITAXEL	Approved in cancer
670.8167059741179	3.42360271920043	720.7572158819381	4.85417726618994	0.523	599	105	OV	OBATOCLAX	Clinical trials in cancer
546.8756906062845	0.792759411857531	551.0000760182509	-0.00030354058606008	0.351	389	44	LUSC	RASAGILINE	Approved in other pathologies
701.6324348935996	-20.3330618399153	704.7145164362521	1.13460204737476	0.512	202	23	LAML	REOLYSIN	Clinical trials in cancer
73.21319259443933	8.48102547711483	227.2138885713421	-27.2070924359018	0.0006	435	211	THCA	(1AR,8S,10Z,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8-METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H-OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE	Experimental
1188.2281036173722	-7.44918362454246	1185.22429564149	0.308200936452693	0.986	512	74	UCEC	THALIDOMIDE	Approved in cancer
714.6105042150757	13.825596272348	716.7116762866635	1.97047640042319	0.512	502	53	KIRC	EZN-2968	Clinical trials in cancer
808.88426081282	29.2292994183575	763.1164635621014	4.69889983307399	0.572	264	28	SKCM	X-82	Clinical trials in cancer
741.1542363083519	94.0720860725721	782.8136240115078	-33.2845869229131	0.561	264	114	SKCM	RO 31-7453	Clinical trials in cancer
793.7300461288077	-48.3227700549939	785.1409645648392	3.8456622004062	0.596	292	42	STAD	DACTOLISIB	Clinical trials in cancer
1180.038005139913	8.49302979259221	1178.5450413390201	-0.158939799389827	0.981	292	30	STAD	CETUXIMAB	Approved in cancer
799.7234950139172	-23.2069856010141	787.5021930014277	-4.07738899305491	0.594	389	47	LUSC	GEDATOLISIB	Clinical trials in cancer
722.4637778008602	-29.6430482823253	723.2213313357713	4.31890957370433	0.534	502	59	KIRC	DOVITINIB	Clinical trials in cancer
915.7644841987357	5.78576116677615	914.9998275451844	-0.000373195870452037	0.715	934	219	BRCA	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
217.454783849051	60.2312300775054	207.5405946165244	-0.263114548629176	0.0006	264	33	SKCM	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXY-2-PYRIDINECARBOXAMIDE	Experimental
163.3720787663137	-33.1145922797249	178.48313011968833	7.74680998958365	0.0008	423	88	COAD	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Experimental
759.9812132935691	6.7013671290552	781.9532233273711	-14.7118239136167	0.583	169	27	READ	OBATOCLAX	Clinical trials in cancer
576.6554066896709	-0.0598646309818776	579.9315311552261	0.000892182558800414	0.381	292	36	STAD	RASAGILINE	Approved in other pathologies
812.5423280022295	-46.0475053989637	802.9469029332062	12.1363042608641	0.592	343	62	HNSC	GSK2636771	Clinical trials in cancer
124.07692890440097	-21.7636487660928	200.94846231391546	-12.957691141424	0.0004	343	47	HNSC	SB 225002	Experimental
711.6274187053526	101.020837923849	724.6095946798329	5.51564733571018	0.512	57	24	PAAD	REOLYSIN	Clinical trials in cancer
748.7832933657547	51.5802765574386	794.7437487936313	21.6291002955993	0.595	512	75	UCEC	PIMASERTIB	Clinical trials in cancer
232.19481345242454	-31.1378012668054	204.4995973811607	26.1099695068478	0.012	512	66	UCEC	TG-100-115	Clinical trials
580.5840215368371	8.9145756626188	583.3112997725403	1.14238246578248	0.381	543	65	LUAD	CHOLINE	Approved in other pathologies
813.3234793095063	-15.1976919717655	790.315894909725	-13.4795263442716	0.598	423	79	COAD	DACTOLISIB	Clinical trials in cancer
786.9479735929801	4.52847689949016	781.6740470221823	1.26881790246512	0.576	599	72	GBM	VOXTALISIB	Clinical trials in cancer
676.5279129919317	-17.1175292301297	711.9351293553149	-12.3644195408706	0.513	202	31	LAML	TAK-733	Clinical trials in cancer
215.87833285832883	-57.0036291163416	201.7387007788246	-30.7849709844647	0.0006	512	75	UCEC	RU85493	Experimental
397.587996416882	6.97838908571435	391.9999546557152	4.00654048462457e-05	0.192	543	77	LUAD	QUERCETIN	Clinical trials
120.3619603506723	49.0201237584623	230.86467968640466	-10.7024743693128	0.0006	57	24	PAAD	PURVALANOL B	Experimental
747.6795212134784	-57.4237812805024	746.3301681139851	-36.2123427952479	0.533	435	184	THCA	NAVITOCLAX	Clinical trials in cancer
198.38779510122487	59.9763775031469	200.2165104261212	2.14963605204161	0.0008	389	47	LUSC	PI-103	Experimental
686.4197661067859	4.14510344626981	730.7330024781812	0.0577158049941318	0.533	153	21	BLCA	OBLIMERSEN	Clinical trials in cancer
1170.290869452716	-6.57894923501905	1168.999965835839	0.000617632979356131	0.969	512	52	UCEC	PANITUMUMAB	Approved in cancer
1095.718522191817	-6.81453901118346	1117.2241058903408	3.97691663898968	0.92	934	218	BRCA	TEMSIROLIMUS	Approved in cancer
322.42414859985985	11.4335331857162	144.34628245605882	-23.7092312552982	0.0006	435	183	THCA	R547	Experimental
1170.527349109188	2.38179553743467	1181.1321901218519	7.73296563079248	0.984	169	28	READ	PACLITAXEL	Approved in cancer
717.6031074298281	16.6736459114036	727.4408587328813	6.53473840425545	0.523	202	21	LAML	PEXIDARTINIB	Clinical trials in cancer
766.8186399595885	-25.7373467706873	734.1076147972586	13.5145324055025	0.545	934	221	BRCA	COPANLISIB	Clinical trials in cancer
845.4033719970771	1.23826982459906	775.9187857384405	-3.22756870569185	0.584	512	75	UCEC	KX2-391	Clinical trials in cancer
503.0712795369915	1.28133836977116	510.78885468184507	-0.0318476625029689	0.311	502	56	KIRC	RASAGILINE	Approved in other pathologies
1213.3249947962317	18.7229721759684	1108.6071105997648	-3.25630139028749	0.929	435	184	THCA	DASATINIB	Approved in cancer
153.28920705090033	6.94943081401402	211.1985847642905	-9.15245054102684	0.0004	343	45	HNSC	ML214	Experimental
249.73834867518678	-57.7747397045827	219.13811547345227	-11.7492039034377	0.0006	512	75	UCEC	RU85053	Experimental
309.3452780884587	4.70322069301398	311.6380968382707	5.89190782726382	0.111	502	52	KIRC	FORMIC ACID	Clinical trials
144.01869871523198	34.213893982717	204.21086391282165	-11.4232224385589	0.0004	512	77	UCEC	ELCPK	Experimental
745.7435106567509	-68.9629618061126	732.4945863731954	14.6572364451952	0.522	202	38	LAML	ENCORAFENIB	Clinical trials in cancer
765.0746511475821	-36.7557530877667	798.9533102222188	-1.10106011776725	0.592	543	74	LUAD	CI-1040	Clinical trials in cancer
1167.7618540635785	-20.6086061992276	1183.1821009327882	-0.307557617106795	0.981	423	65	COAD	ERIBULIN	Approved in cancer
593.6470544851196	10.5698990434861	593.2738610576861	3.3177636647431	0.391	512	58	UCEC	ICOSAPENT	Approved in other pathologies
275.1572179116672	25.8545018151574	198.80656895667934	28.2715916967041	0.0006	57	24	PAAD	2-({2-[(3-HYDROXYPHENYL)AMINO]-4-PYRIMIDINYL}AMINO)BENZAMIDE	Experimental
1220.1687268722078	9.73725744547482	1202.955208957302	-0.576016223122224	0.998	423	60	COAD	VANDETANIB	Approved in cancer
1240.7204501255762	43.41757803006	1234.0723111409013	-14.0531794960324	0.997	264	197	SKCM	REGORAFENIB	Approved in cancer
1123.3900900289393	4.27672928137261	1136.703959366783	-0.186818852549095	0.937	502	62	KIRC	REGORAFENIB	Approved in cancer
222.03804823378994	-52.205873789748	192.60313105346393	6.12637141909613	0.0004	343	44	HNSC	COMPOUND 44	Experimental
715.3348147313917	-29.0131900904603	751.0399058791527	13.4281289299597	0.544	934	223	BRCA	PF-04691502	Clinical trials in cancer
725.0969491669837	87.9653863823408	732.0375658196874	-46.0275076214044	0.555	264	113	SKCM	ABEMACICLIB	Clinical trials in cancer
1135.817433686335	-42.665009150305	1133.6312315267585	-22.5429503495327	0.939	435	212	THCA	SORAFENIB	Approved in cancer
703.2130322783337	2.62544327680487	710.768140715205	3.19812720427308	0.523	934	214	BRCA	TASELISIB	Clinical trials in cancer
391.5393193611621	7.87054813349664	381.2504715419747	-0.785476784572438	0.181	169	27	READ	EDARAVONE	Clinical trials
1185.8305194788327	-17.3220089975669	1185.5308177480665	-2.9894971320482	0.984	153	23	BLCA	ARSENIC TRIOXIDE	Approved in cancer
889.1642228236921	-17.3840215699146	731.795055747054	32.1914161925105	0.583	264	125	SKCM	OBLIMERSEN	Clinical trials in cancer
157.12863290307916	-19.189754979758	202.62872215935187	-3.36329436706728	0.0008	153	28	BLCA	PI-103	Experimental
172.75733914598084	18.2870015958351	211.3498003439372	-12.0243696573079	0.0006	202	38	LAML	GUANOSINE-5'-DIPHOSPHATE	Experimental
771.388823660139	30.2898158458501	820.4583796338272	-3.6679708482842	0.594	512	87	UCEC	XL999	Clinical trials in cancer
834.7047233883601	-101.605503569445	816.2740988348922	-56.8584117926206	0.582	264	187	SKCM	BI847325	Clinical trials in cancer
170.00757443085638	23.7721065424014	215.19394128438717	10.576073836369	0.0006	264	34	SKCM	2-CHLOROPHENOL	Experimental
787.6360747651826	9.70296864486596	779.1148857396272	-8.11738247375723	0.583	512	75	UCEC	TAK-733	Clinical trials in cancer
210.05437504900675	4.84253602593046	190.72029120914888	-9.11858728707091	0.0006	512	53	UCEC	CAND 5	Experimental
293.5245298556193	-63.9528037307366	164.47413984104955	-21.7234900294752	0.0006	57	24	PAAD	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
210.580898531612	73.4579190262038	185.85814458409664	-47.7278153585886	0.0006	57	24	PAAD	(1AR,8S,10Z,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8-METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H-OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE	Experimental
223.93674093192462	70.3134097947398	176.89211801718037	-0.368865849668623	0.0004	264	73	SKCM	CYTOCHALASIN B	Experimental
312.8379685732004	6.9459594380744	306.2747489436252	0.980952706849166	0.111	502	52	KIRC	TBC-3711	Clinical trials
109.29749682325001	67.7210299278358	190.7373211206543	36.122517319992	0.0006	264	133	SKCM	TRIFLUOROETHANOL	Experimental
380.9497697198161	-8.21603563367685	383.1520718552591	1.05621515678422	0.181	292	34	STAD	ATP	Clinical trials
1200.8964926644458	19.1585387910689	1208.0220357835726	6.20359940433173	1	512	102	UCEC	CETUXIMAB	Approved in cancer
268.5072558294924	-39.49724183982	174.73103399234952	54.2072741810716	0.0008	435	184	THCA	(1E)-N-HYDROXY-5-[1-(4-PIPERIDINYL)-3-(4-PYRIDINYL)-1H-PYRAZOL-4-YL]-1-INDANIMINE	Experimental
270.9557531637511	-2.13693649111707	202.20255632295846	9.09400215926905	0.0006	512	77	UCEC	7-(2-PYRIDINYL)-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE	Experimental
124.66941550814033	82.1077242485417	209.23076256482855	-43.0123732385149	0.0006	264	133	SKCM	N-METHYL-N-{2-[METHYL(7-NITRO-2,1,3-BENZOXADIAZOL-4-YL)AMINO]ETHYL}ACETAMIDE	Experimental
334.7019679381474	13.7912433766994	170.0618469087396	-12.7070890036493	0.0004	264	57	SKCM	TL-1-85	Experimental
719.1378340025665	-9.36248974274642	727.0159861257708	3.15006225836714	0.532	153	16	BLCA	SAR260301	Clinical trials in cancer
780.8091396065448	-58.5213597664063	725.9760341523747	8.97887252575401	0.522	934	214	BRCA	TCMDC-137004	Clinical trials in cancer
741.7484715075486	-39.205466243286	753.0000501369459	0.000144753476888582	0.553	153	24	BLCA	GOSSYPOL	Clinical trials in cancer
585.3415104666994	0.994345232574886	586.3180760887454	-0.159350734450356	0.383	512	56	UCEC	TREPROSTINIL	Approved in other pathologies
68.08482094144614	29.2706966207665	189.37267314887472	-39.1200094226269	0.0004	222	130	LGG	EVODIAMINE	Experimental
689.1860659234861	25.2413194463952	722.5906031281521	-6.50713117150008	0.511	435	183	THCA	DHA-PACLITAXEL	Clinical trials in cancer
524.3331556738004	-0.334670379508481	522.5663941190066	1.29702546129556	0.321	502	52	KIRC	DROTRECOGIN ALFA (ACTIVATED)	Approved in other pathologies
238.1905519032295	87.8610633796363	161.6314002788301	19.1075280340832	0.0004	264	104	SKCM	NVP-BHG712	Experimental
164.80888769085337	-16.2367855535084	221.39912472308248	7.7486295573699	0.0008	423	89	COAD	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
192.16019411951075	34.9659535989455	208.80876924590976	-15.2752009336871	0.0006	512	75	UCEC	RU78262	Experimental
794.3451987594354	-4.790725635923	747.528127823269	1.27254666544843	0.551	389	44	LUSC	S-8184	Clinical trials in cancer
771.8327505186463	-3.70265218778985	780.4738482838566	1.26365007283357	0.583	292	36	STAD	OBLIMERSEN	Clinical trials in cancer
666.3797334905805	-29.5051559849645	691.8987343396717	-2.14128237898026	0.523	57	24	PAAD	XL281	Clinical trials in cancer
216.46312241390402	18.6037446882444	178.5786505205761	-21.7929867806993	0.0008	512	78	UCEC	PHOSPHOTYROSINE	Experimental
752.5256096278298	13.8811686104555	775.5424800658697	1.22188387389701	0.583	292	36	STAD	OBATOCLAX	Clinical trials in cancer
600.5039544032227	-3.55970610191648	612.0000680205275	-0.00039180900307656	0.412	543	60	LUAD	GI-4000	Clinical trials in cancer
1175.2293074279391	6.52253449867396	1193.90943181977	-0.726088168726164	0.994	543	82	LUAD	REGORAFENIB	Approved in cancer
1114.3554873680114	-12.3888413389268	1107.793978719013	1.99491941669544	0.912	202	28	LAML	BORTEZOMIB	Approved in cancer
267.61439690768225	-18.3099273020873	221.26018204355995	-15.0093255655193	0.0004	264	106	SKCM	COMPOUND 44	Experimental
704.9406506284532	-16.7268697761703	689.0583827950043	2.58484002909199	0.491	512	69	UCEC	INDISULAM	Clinical trials in cancer
520.38122200269	1.36216791572107	519.2667013248488	-1.47141885542806	0.323	502	56	KIRC	PEGAPTANIB	Approved in other pathologies
729.6206788877051	55.878177031403	706.1825491169263	-10.02885528822	0.521	435	183	THCA	AVI4126	Clinical trials in cancer
1148.465994122937	-17.6208125412893	1181.0192091464614	0.138577150423771	0.986	153	19	BLCA	BOSUTINIB	Approved in cancer
226.6881926892299	-43.2091088316998	204.14137276731628	3.32798006451117	0.0004	343	44	HNSC	LY-294,002	Experimental
772.3111514671783	-31.1080994166001	787.0493839285871	-6.77417776506582	0.595	423	79	COAD	COPANLISIB	Clinical trials in cancer
168.9176284767584	65.4320286991714	195.58944769926129	19.4589879770867	0.0006	512	75	UCEC	PAS219	Experimental
690.6535656914198	13.601647950313	726.2623598089274	1.04672952023998	0.539	202	36	LAML	SELUMETINIB	Clinical trials in cancer
1154.4561055687227	-4.32025371521704	1173.9183219132603	-0.00116873350566493	0.972	343	119	HNSC	DOCETAXEL	Approved in cancer
1172.4019152690794	-32.2230132851956	1196.4068949303796	2.39103347916978	1	169	43	READ	TRAMETINIB	Approved in cancer
1159.925920252203	-46.7486974409363	1216.4802010305038	9.08300340619661	1	264	187	SKCM	TRAMETINIB	Approved in same tumor type
222.09729889131154	-28.707135560459	206.3276044491942	-11.6448561843038	0.0004	343	48	HNSC	TIPIFARNIB-P2	Experimental
1067.458936817443	1.74374872848671	1057.9714071127762	0.112055115859334	0.861	169	40	READ	PEMETREXED	Approved in cancer
517.2519124949288	8.30006887783622	513.5195358222201	-2.45879760704406	0.311	57	7	PAAD	IBUPROFEN	Approved in other pathologies
170.04224725945022	4.5697400474547	188.15216480061275	3.57735694014718	0.0004	343	44	HNSC	TW-37	Experimental
599.7984710279601	7.57451355190142	611.8572626579378	5.1675102411823	0.412	934	214	BRCA	BUPARLISIB HYDROCHLORIDE	Clinical trials in cancer
1129.563960008054	4.64833159372603	1122.9513960261659	-5.40867570741011	0.923	202	38	LAML	PONATINIB	Approved in same tumor type
807.2253130994602	-41.2214001902166	784.3561497251743	0.969315107480497	0.592	343	62	HNSC	APITOLISIB	Clinical trials in cancer
867.8966230092583	55.8941821386252	758.1589743063035	8.29078634187388	0.56	57	24	PAAD	SELUMETINIB	Clinical trials in cancer
1125.6186137729474	-5.190571775123	1132.42212986722	0.458122427041644	0.93	543	62	LUAD	ERLOTINIB	Approved in same tumor type
238.7250839164262	-19.796293595219	189.51003463248162	5.37816567871641	0.0006	202	29	LAML	N-METHYL-N-{2-[METHYL(7-NITRO-2,1,3-BENZOXADIAZOL-4-YL)AMINO]ETHYL}ACETAMIDE	Experimental
1125.0031799305648	9.14651989097331	1128.9510112066375	4.01806658149508	0.93	543	73	LUAD	CETUXIMAB	Approved in cancer
800.8535331291911	-41.1772353372441	780.7883616036709	7.32930881661377	0.585	543	76	LUAD	PF-04691502	Clinical trials in cancer
1028.2727465115354	-18.1362252294046	1019.4318545805321	0.00173634614026241	0.822	264	106	SKCM	DABRAFENIB MESYLATE	Approved in same tumor type
148.58847287796019	2.44976157202126	197.23019892769068	-11.0351207707017	0.0006	543	77	LUAD	PHOSPHOTHREONINE	Experimental
185.62809583414995	-35.646899912449	185.73902680990943	16.3533635071303	0.0006	502	55	KIRC	METHYL N'-BUTYLCARBAMIMIDOTHIOATE	Experimental
1212.260048614563	-47.1161047912124	1154.1881266286273	4.24838227728003	0.997	264	187	SKCM	COBIMETINIB	Approved in same tumor type
668.6193063282568	-2.17575963939458	720.4486782022146	7.95893401407693	0.521	502	56	KIRC	ABT-510	Clinical trials in cancer
775.3893244228923	-0.582218148111082	752.0287606962003	1.71054732682978	0.553	389	44	LUSC	OBLIMERSEN	Clinical trials in cancer
764.1229011565267	43.8559429608131	728.664368504374	-15.474496294396	0.525	202	32	LAML	REFAMETINIB	Clinical trials in cancer
611.3157797371144	30.0452648680502	629.0216853233469	11.543610515751	0.431	222	128	LGG	INDISULAM	Clinical trials in cancer
716.0125662432882	-15.0270114635742	742.1667502552831	8.55164233993264	0.542	934	221	BRCA	GSK2636771	Clinical trials in cancer
195.06989400970392	-60.4020385778859	196.9536851465431	3.0949188668792	0.0006	502	52	KIRC	(4'-AMINO-5'-FLUORO-1H,1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-1-YL)[4-(AMINOMETHYL)PHENYL]METHANONE	Experimental
757.9767034625105	69.8479656406262	768.2216239717496	15.9650795402122	0.594	512	144	UCEC	SF1126	Clinical trials in cancer
166.81582799997045	-55.8303757333971	184.68200928522836	-3.29215434289972	0.0008	423	89	COAD	SB 203580	Experimental
170.23984152437913	-12.4251627834553	208.0682712863994	1.5909448987768	0.0008	502	56	KIRC	IMC-1C11	Experimental
1215.123704599517	7.24905383936994	1203.9200707844022	-20.5767760460194	0.997	264	37	SKCM	PAZOPANIB	Approved in cancer
198.31970305463682	-13.0444905926011	189.63750069053074	-3.51713364141756	0.0006	543	63	LUAD	1,9-PYRAZOLOANTHRONE	Experimental
383.7823829676064	-3.92911699682955	381.5503445306565	6.45193516370989	0.182	512	72	UCEC	JSM 6427	Clinical trials
1025.8737730405776	3.17375357004263	1027.5738546942925	-2.36325681967264	0.831	934	214	BRCA	PEMETREXED	Approved in cancer
867.6412484825262	-24.5714218400038	792.673711236209	-4.11586409395193	0.591	512	54	UCEC	TAK-593	Clinical trials in cancer
707.7355330308752	48.9622721425194	760.5661856317113	-20.7411136596767	0.535	57	24	PAAD	PD-0325901	Clinical trials in cancer
1041.5093120942888	-5.2542535923051	1041.3176362472157	2.35448649424075	0.841	543	64	LUAD	PEMETREXED	Approved in cancer
1100.02210391392	3.66270428675986	1090.9998829314072	-0.000144848757599902	0.891	292	31	STAD	PEMETREXED	Approved in cancer
177.37843262877422	-21.0658113386192	195.8750014846213	2.66942605497388	0.0008	153	16	BLCA	WORTMANNIN	Experimental
853.4385694084154	-5.56800590974828	813.6703859503078	15.6523316478113	0.593	169	45	READ	PICTILISIB	Clinical trials in cancer
142.90069304368862	85.4922968880717	209.48463051698377	15.2958287303393	0.0004	57	24	PAAD	NSC632839	Experimental
995.8102997586544	7.8387217278995	991.5013073338422	2.59307546062189	0.792	264	33	SKCM	NINTEDANIB ESYLATE	Approved in other pathologies and in clinical trials in cancer
1181.871601025139	-28.2928350112592	1201.1743540132834	-7.39180945137241	0.997	423	89	COAD	COBIMETINIB	Approved in cancer
759.9640981913835	20.0525374608814	795.2090538326005	9.52882470691611	0.583	543	77	LUAD	ENCORAFENIB	Clinical trials in cancer
238.63224583021696	44.2968644880877	238.02011234154142	-9.26120746527573	0.0004	264	38	SKCM	PIPERLONGUMINE	Experimental
688.3701426575855	8.54938560318226	709.1643573052177	1.34395987901053	0.511	502	52	KIRC	AMG 386	Clinical trials in cancer
631.6037528742718	-19.5853147832288	640.9997575427576	-0.000123484389462192	0.441	264	111	SKCM	ABT-751	Clinical trials in cancer
792.6126658760866	12.4688052972418	787.6545592965502	-3.13869653618241	0.594	512	79	UCEC	MK-2206	Clinical trials in cancer
662.4461687176154	35.9351365343172	735.9885909199756	-22.8937965901123	0.513	435	183	THCA	OBLIMERSEN	Clinical trials in cancer
623.2794833747149	-2.08862534123779	629.4680512080074	-1.59356495357292	0.432	343	44	HNSC	BUPARLISIB HYDROCHLORIDE	Clinical trials in cancer
1011.3820627680784	-23.5147174440074	1033.0029557719256	0.986508532839252	0.822	435	211	THCA	CETUXIMAB	Approved in cancer
169.25638345196393	36.8514370702868	229.6814281526088	-7.54574849826793	0.0006	512	75	UCEC	N-(4-ANILINO-6-QUINAZOLINYL)ACRYLAMIDE	Experimental
244.44354655141345	-88.702946343181	154.72766564683903	-8.95592574386023	0.0006	435	211	THCA	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
164.89247998330353	6.81198227881697	204.49012321363352	13.8808380798691	0.0004	543	62	LUAD	PP-30	Experimental
810.1635913747048	-25.6793324087142	803.588599088681	-4.03745411249315	0.594	292	41	STAD	PF-04691502	Clinical trials in cancer
738.4355199612044	12.29732805314	726.0617533438568	2.3908387272345	0.522	343	52	HNSC	TCMDC-137004	Clinical trials in cancer
700.7378349554097	-14.6782821494139	726.9697073981102	-2.11794496475613	0.533	934	101	BRCA	OBLIMERSEN	Clinical trials in cancer
158.80578832115143	-29.2592876260544	202.7482880643974	-21.8646479433755	0.0006	502	52	KIRC	N5-(N'-PROPYLCARBAMIMIDOYL)-L-ORNITHINE	Experimental
233.08110615731852	-43.0418805236651	199.74202892975623	-0.314310840765074	0.0006	543	75	LUAD	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Experimental
213.33442229846045	5.87345785709314	187.07236175585217	-16.5345165678799	0.0006	512	53	UCEC	BROLUCIZUMAB	Experimental
620.0084072122578	16.4736868059211	624.4707475055878	-4.46973534965855	0.423	934	214	BRCA	CH5132799	Clinical trials in cancer
1034.929845932465	-7.43598114018064	1035.426158562691	2.36288221687346	0.832	934	214	BRCA	CETUXIMAB	Approved in cancer
1136.0850930491076	3.9720626789447	1118.8939216191484	3.20017671063422	0.921	57	8	PAAD	PACLITAXEL	Approved in same tumor type
205.28402888059182	5.90835908920059	229.70803969354697	15.16272300496	0.0006	512	78	UCEC	SB 203580	Experimental
763.2771719238208	10.7810477652668	767.5636604088885	0.428876092051894	0.581	512	53	UCEC	BEVACIZUMAB+TRASTUZUMAB	Clinical trials in cancer
758.0727735112049	-35.8134579929308	794.9650797115145	11.7486736432343	0.596	423	89	COAD	PD-0325901	Clinical trials in cancer
231.74809315857186	4.16230681449355	195.15094821751063	-6.75196789307779	0.0006	512	76	UCEC	OLOMOUCINE	Experimental
1116.3892657814529	-41.7608143033582	1118.4628722499428	12.0523577391091	0.937	435	212	THCA	COBIMETINIB	Approved in cancer
1163.4689759554333	-2.75873209409804	1150.2120208425274	-0.00186127522908919	0.951	389	44	LUSC	ERIBULIN	Approved in cancer
741.2799721864988	7.33767202226733	771.5854368821509	3.73341509737452	0.587	543	76	LUAD	SONOLISIB	Clinical trials in cancer
733.5160196011915	9.11882066478103	711.6929455704791	-6.23058492021391	0.512	202	31	LAML	RO4987655	Clinical trials in cancer
763.750179721921	-49.3184117258868	782.7121783747599	3.84402763774142	0.583	153	28	BLCA	NAVITOCLAX	Clinical trials in cancer
162.1647217240728	-45.6165032816198	201.8518221714937	6.05183188306864	0.0004	153	17	BLCA	PNU-74654	Experimental
786.8789576194073	-17.4139314230652	797.0021250945571	-6.03434649319388	0.594	343	62	HNSC	GEDATOLISIB	Clinical trials in cancer
1252.459356801922	-17.2858795261981	1178.912798859415	44.1457551153018	1	264	188	SKCM	DABRAFENIB	Approved in same tumor type
708.1318671298582	11.74327214295	746.1995421669324	-14.1102076252018	0.545	934	224	BRCA	ALPELISIB	Clinical trials in cancer
772.6539055415064	106.26142662049	770.1607752477008	-34.5900997503294	0.562	57	24	PAAD	SF1126	Clinical trials in cancer
181.92358106854562	39.3745937201387	191.18725021696775	-3.68844259028873	0.0006	512	53	UCEC	PIDOLIC ACID	Experimental
689.3530547134676	53.9683746094171	785.130992796407	-52.6079005140162	0.582	264	143	SKCM	1096708-71-2	Clinical trials in cancer
700.9710873790168	31.8206655671374	718.4532060233394	-17.5076295701049	0.522	202	53	LAML	GSK2636771	Clinical trials in cancer
752.2660725475295	-29.6985051579555	797.3157915033399	-17.220010965947	0.595	423	89	COAD	PIMASERTIB	Clinical trials in cancer
245.3319464981851	10.9533140870614	198.22181444300622	3.00823312895835	0.0006	264	34	SKCM	2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE	Experimental
834.5313817105393	9.37616215267377	796.9807378912066	-1.55886950548506	0.596	512	76	UCEC	REFAMETINIB	Clinical trials in cancer
782.7252619915461	2.47142360012882	765.3353653640934	8.26900926111256	0.581	512	67	UCEC	CC-401	Clinical trials in cancer
1115.8993562632763	53.7910255425981	1097.7947569401954	-17.8245014959427	0.924	435	211	THCA	ARSENIC TRIOXIDE	Approved in cancer
152.27869883741974	-48.7813400810165	200.7056313361607	-7.2509164340031	0.0006	502	52	KIRC	4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE	Experimental
241.35972835166152	1.28610585113969	224.2230261922025	12.8582154837983	0.0006	512	75	UCEC	RU82129	Experimental
261.52483662783004	55.9475411027925	195.78473277702832	13.5596244512239	0.0006	264	42	SKCM	MYRISTIC ACID	Experimental
743.4083381722184	-106.247468007295	856.4463128662929	-24.2057046715251	0.582	264	186	SKCM	RO4987655	Clinical trials in cancer
242.4848188620856	-37.2629386884952	203.01903066462904	-1.20997360076467	0.0008	599	72	GBM	PI-103	Experimental
231.90920423284655	67.533978249424	179.54726978464433	-10.3255330525991	0.0006	512	75	UCEC	1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-PHENYLUREA	Experimental
1191.3777919105466	-17.9522746739507	1185.4668126333654	2.6333007172243	0.983	153	20	BLCA	REGORAFENIB	Approved in cancer
697.2727322059169	-0.11093353450363	702.7431761656543	-2.83413311175059	0.513	202	22	LAML	ENMD-2076	Clinical trials in cancer
204.38464865185733	88.8319348075848	172.52300811147472	-12.0835455658648	0.0004	435	183	THCA	KU 0060648	Experimental
1203.8706558454435	37.5232482539993	1202.0145833558333	0.624667089259844	1	512	108	UCEC	TEMSIROLIMUS	Approved in cancer
192.74192952459876	-66.3402080637396	197.7485645137607	0.512473154207328	0.0008	423	89	COAD	(5S,6Z)-4,5-DIFLUORO-6-[(2-FLUORO-4-IODOPHENYL)IMINO]-N-(2-HYDROXYETHOXY)-1,3-CYCLOHEXADIENE-1-CARBOXAMIDE	Experimental
803.8729164233258	-32.0700339004609	793.5276410202199	-0.0133855035694523	0.584	543	76	LUAD	SF1126	Clinical trials in cancer
923.4112434548631	-8.42767459112625	920.9998247666682	-0.000343225956839888	0.721	435	183	THCA	NADROPARIN	Approved in other pathologies and in clinical trials in cancer
750.9840849786102	9.42912969013895	753.1401119398796	-1.65577359785027	0.553	512	67	UCEC	RIGOSERTIB	Clinical trials in cancer
206.7658323278075	-34.4945552025472	210.85001641664988	-13.4395472573831	0.0006	264	33	SKCM	2-({2-[(3-HYDROXYPHENYL)AMINO]-4-PYRIMIDINYL}AMINO)BENZAMIDE	Experimental
751.7865081410483	-35.9769466299955	761.9104144459702	-0.0697001902858574	0.563	153	16	BLCA	ENCORAFENIB	Clinical trials in cancer
757.9396214007014	1.13595413562535	783.4565311245672	-6.69531278921818	0.596	292	42	STAD	VOXTALISIB	Clinical trials in cancer
537.9432084905421	0.301616521519776	541.000188729317	0.000216847146020882	0.341	934	104	BRCA	IBUPROFEN	Approved in other pathologies
851.3336601125407	58.2335108308566	748.5718136317465	22.1363779560021	0.562	57	24	PAAD	PF-04691502	Clinical trials in cancer
580.8253032195938	3.50344540126665	574.7546142716022	0.826951784050323	0.381	264	40	SKCM	PEGADEMASE BOVINE	Approved in other pathologies
742.9042523401693	-45.8623898656619	811.0179287629254	-11.2996654673116	0.593	423	79	COAD	PICTILISIB	Clinical trials in cancer
203.42644953394452	42.1824276765969	193.50567230261757	-15.1603818469284	0.0008	512	117	UCEC	GUANOSINE-5'-DIPHOSPHATE	Experimental
822.7141019559195	-21.1388540854971	776.1465295976964	-12.1108930305284	0.581	169	27	READ	S-8184	Clinical trials in cancer
812.1042081292763	25.8666373022614	812.4602362708407	-0.903380588953269	0.581	264	33	SKCM	CC-401	Clinical trials in cancer
1179.9160144351306	4.41910720250166	1173.9996997535932	0.00012116980974497	0.974	599	63	GBM	PONATINIB	Approved in cancer
525.2508933244163	3.82759178515374	523.460865441498	-2.87102545853122	0.321	502	55	KIRC	MICONAZOLE	Approved in other pathologies
1219.8467520368617	-7.03475813166943	1197.2878977448497	-3.90248378582731	0.995	264	38	SKCM	LENVATINIB	Approved in cancer
724.2504277472373	0.305002561353348	760.9898143814537	-5.59278451299497	0.543	934	223	BRCA	PWT33597	Clinical trials in cancer
198.74661547952857	-3.32302716684353	186.30911095500187	0.32051900267993	0.0006	543	75	LUAD	[4-({5-CARBAMOYL-4-[(3-METHYLPHENYL)AMINO]-2-PYRIMIDINYL}AMINO)PHENYL]ACETIC ACID	Experimental
229.5775005033757	-39.5359107214751	212.15872376873958	-2.12311600415615	0.0004	543	60	LUAD	FARNESYL	Experimental
831.6317759337095	-76.0326952877226	781.918798324865	34.2761986524931	0.581	264	125	SKCM	S-8184	Clinical trials in cancer
1157.5040887744399	43.457531914308	1196.6427212866154	-37.7661723259986	0.984	264	127	SKCM	PACLITAXEL	Approved in cancer
290.7130676592501	-76.69258997793	180.06021528884023	8.80259454419001	0.0004	934	216	BRCA	FQI-1	Experimental
211.58291727719094	-69.975518696258	227.6845590691198	26.8452472294853	0.0004	512	144	UCEC	LY-2183240	Experimental
830.1316030905572	4.99169730211608	800.2870189844753	19.3066292662338	0.594	512	79	UCEC	IPATASERTIB	Clinical trials in cancer
1115.4321683621342	-1.44598079572327	1134.6623479307013	3.01005767057654	0.934	202	39	LAML	REGORAFENIB	Approved in cancer
183.48282319834894	16.7589409858824	170.88095787009712	-5.82688935558059	0.0006	264	34	SKCM	4-[1-(CYCLOPROPYLMETHYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-2-PYRIMIDINAMINE	Experimental
278.26093958779506	74.9395062017429	190.0701125376564	-16.7286435172653	0.0006	435	211	THCA	PHOSPHOTHREONINE	Experimental
217.1338472606293	-14.1154296980361	211.5496656137604	4.85294160031481	0.0004	512	72	UCEC	BISTRAMIDE A	Experimental
847.2807632477588	9.62754413175617	808.9557120881361	20.1634793134692	0.596	512	144	UCEC	VOXTALISIB	Clinical trials in cancer
781.7357796143687	55.6756311216164	786.3152535665342	22.9615492215971	0.593	512	79	UCEC	TRICIRIBINE	Clinical trials in cancer
202.71642219313756	-36.4415517800778	203.48003955457932	-10.4685636192012	0.0006	502	55	KIRC	L-N(OMEGA)-NITROARGININE-2,4-L-DIAMINOBUTYRIC AMIDE	Experimental
810.145266856004	116.752220167057	850.5297884274839	3.38556916690379	0.583	264	187	SKCM	TAK-733	Clinical trials in cancer
178.12613971295897	-14.0113926412763	190.0099519998753	17.3271423927904	0.0006	502	55	KIRC	5-NITRO-1H-INDAZOLE	Experimental
262.82414110724596	8.20234789866669	240.53841004390372	10.0427933556768	0.0004	264	35	SKCM	PARBENDAZOLE	Experimental
233.36880373102446	103.337477331417	219.0520681380608	-42.2123744992248	0.0006	57	24	PAAD	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXY-2-PYRIDINECARBOXAMIDE	Experimental
385.6618684959355	-15.5890123877781	375.84392559154327	-6.67267519938849	0.183	264	39	SKCM	VX-702	Clinical trials
283.97496210576287	16.3712440623958	229.2271445437023	-3.31035459516067	0.0008	169	38	READ	[2-OXO-2-({[(2E,6E)-3,7,11-TRIMETHYL-2,6,10-DODECATRIEN-1-YL]OXY}AMINO)ETHYL]PHOSPHONIC ACID	Experimental
171.31131619433174	76.7287514642931	191.7578052314207	-31.9769731263133	0.0006	57	24	PAAD	N-(4-AMINO-5-CYANO-6-ETHOXY-2-PYRIDINYL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
146.25185578920377	-21.1390231822389	177.45963978058106	-0.082135472938262	0.0008	423	79	COAD	PI-103	Experimental
164.60697122607317	123.115175385681	212.51911090540034	-39.1970478677711	0.0004	222	127	LGG	PIK-75	Experimental
90.9524304107985	5.36726129842688	214.22693551887812	-13.4624410480081	0.0006	57	24	PAAD	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)-1,2-ETHANEDIAMINE	Experimental
178.84841080783283	42.4700780115324	183.35001363316033	-24.1205162293864	0.0006	512	59	UCEC	LGD-1550	Experimental
204.84643878366285	-29.8579324576921	193.14223002389866	-7.1920321270311	0.0006	543	75	LUAD	(1AR,8S,10Z,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8-METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H-OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE	Experimental
1114.9991618633624	8.24943471538603	1117.7620039585242	-0.949204394145909	0.913	202	31	LAML	SORAFENIB TOSYLATE	Approved in cancer
187.47917686858173	-31.2313471201437	183.06997597403557	-2.87303949324905	0.0006	502	52	KIRC	4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE	Experimental
233.31550279205	75.589729709374	198.1120076625176	-19.3400449025253	0.0004	169	45	READ	LY-2183240	Experimental
250.89631477275037	-6.75888223997782	187.68418509069372	-17.9761063784242	0.0006	169	44	READ	N-[(1S)-1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL]-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
785.2806724316799	95.2676582999613	750.9873967428094	-6.92201389883402	0.541	57	24	PAAD	CC-401	Clinical trials in cancer
508.33297969320665	-16.9635829920938	509.7917221856557	-9.30654004336202	0.311	435	183	THCA	IBUPROFEN	Approved in other pathologies
220.4774847396274	-18.0935169484976	200.6002490248485	-1.80521415089038	0.0008	292	32	STAD	PHOSPHOTHREONINE	Experimental
827.6915867694968	81.5762944530258	774.9364296551709	9.68809704399149	0.562	57	24	PAAD	APITOLISIB	Clinical trials in cancer
935.6425959102183	2.71538541573008	934.9998706657224	-2.10536488793878e-05	0.735	343	48	HNSC	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
684.4644494031332	-19.4258670625079	721.2324295808792	20.4620477540482	0.522	202	53	LAML	PWT33597	Clinical trials in cancer
90.9656224962452	-87.2388272379477	153.82761673934505	39.6350314956076	0.0008	264	186	SKCM	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
788.1530040479436	-60.71497618111	784.629790719733	-17.1328664753969	0.583	423	65	COAD	OBLIMERSEN	Clinical trials in cancer
850.1773217316456	-25.2088804963586	786.3895577392736	-21.993258420977	0.592	169	45	READ	APITOLISIB	Clinical trials in cancer
778.0153327703231	-35.8083298893763	795.5053810535269	-9.74478266523965	0.595	153	26	BLCA	COPANLISIB	Clinical trials in cancer
759.1964285666826	-28.5685110612801	783.6389038653386	-3.15369838465222	0.593	153	26	BLCA	PICTILISIB	Clinical trials in cancer
785.6827885717599	116.792345354654	767.7304265580807	-5.52838080204387	0.563	57	24	PAAD	SONOLISIB	Clinical trials in cancer
188.4295531593521	16.8466711920515	191.0609446355165	1.89354427425496	0.0004	543	61	LUAD	BRD63610	Experimental
700.0776683420902	-4.10779286070766	725.4484002833382	-1.42312779420217	0.531	153	21	BLCA	S-8184	Clinical trials in cancer
836.6563201160874	49.9384913433649	742.0201419186666	49.637482118696	0.586	264	112	SKCM	GEDATOLISIB	Clinical trials in cancer
1169.2448888619683	29.6639456889468	1125.5087061200534	-4.8018639806337	0.919	435	185	THCA	TEMSIROLIMUS	Approved in cancer
237.5527436465075	61.5978819480648	170.5096581112471	-6.09956064320647	0.0008	169	45	READ	PI-103	Experimental
312.8462722035074	52.5541275013435	187.1369830650158	-49.2729391820783	0.0006	435	212	THCA	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)-1,2-ETHANEDIAMINE	Experimental
212.75307786813158	-27.7997423708089	200.303039704927	-18.3891654856093	0.0006	502	55	KIRC	(6R)-6-PHENYL-5,6,7,8-TETRAHYDRO-2,4-PTERIDINEDIAMINE	Experimental
253.74719818047168	-14.4906928688164	209.92956248046536	25.4245716639205	0.0006	512	75	UCEC	ISO24	Experimental
530.1861146733276	13.2279427465216	502.90339248878297	-0.0786054888995409	0.311	57	24	PAAD	CHOLINE	Approved in other pathologies
335.4880690125189	4.18116264224835	322.00038791647916	-4.94529945171962e-05	0.122	202	54	LAML	QUERCETIN	Clinical trials
208.6142297952732	-49.6160891814953	184.46928661334726	3.87385994465376	0.0006	423	63	COAD	N-(4-AMINO-5-CYANO-6-ETHOXY-2-PYRIDINYL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
185.8747647687496	35.7670872810521	194.33193537311323	31.9169133189989	0.0004	512	88	UCEC	NUTLIN-3A	Experimental
875.0606115803263	8.32961614916547	785.8871470424743	14.9964781675842	0.593	169	45	READ	SF1126	Clinical trials in cancer
1192.0813813655718	1.19724934640308	1201.2737100613194	7.73166894821554	0.999	512	75	UCEC	TRAMETINIB	Approved in cancer
790.7999955832607	-0.173737566297234	807.6646228158868	-4.61801739126122	0.596	423	79	COAD	VOXTALISIB	Clinical trials in cancer
857.4969160810757	73.3599932385057	791.7219845220163	11.0715041902313	0.562	57	24	PAAD	PWT33597	Clinical trials in cancer
165.14490869288974	28.9490817736592	207.79205110200775	-21.5754295238294	0.0006	169	39	READ	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXY-2-PYRIDINECARBOXAMIDE	Experimental
378.91159459381333	-4.29791982231043	378.5666424567969	2.58306201721331	0.181	512	53	UCEC	GLICLAZIDE	Clinical trials
255.97085763946177	-0.402183184555582	214.75291573899477	0.0740255445597882	0.0006	512	75	UCEC	3-(4-AMINO-1-ISOPROPYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)PHENOL	Experimental
937.1976600203377	-2.40202380992693	935.7301268359212	0.575893908790022	0.735	502	64	KIRC	NINTEDANIB	Approved in other pathologies and in clinical trials in cancer
795.5190958239282	44.0344954260693	796.4914930665317	-7.6189648951264	0.592	389	47	LUSC	APITOLISIB	Clinical trials in cancer
795.3736645312815	-80.6753220645468	716.573321729105	-17.7832880846336	0.584	264	121	SKCM	RAF265	Clinical trials in cancer
244.82539102798424	-30.7447067100943	208.99282536694983	-5.05952123064827	0.0004	264	32	SKCM	EVODIAMINE	Experimental
675.0876032985652	25.3737568616689	723.9026154386979	-8.53578145553388	0.523	202	53	LAML	ALPELISIB	Clinical trials in cancer
326.3338418781417	-3.14425207553754	321.0630753647446	-2.27566194232986	0.121	502	56	KIRC	GLICLAZIDE	Clinical trials
684.8247164265299	-53.4218078921344	800.6271587669821	5.77273130549338	0.589	222	135	LGG	SELUMETINIB	Clinical trials in cancer
718.0901770006387	40.9179628247484	710.728608521797	10.0145604883995	0.532	264	60	SKCM	REOLYSIN	Clinical trials in cancer
132.86786605516681	20.6907135487583	242.71328287517633	20.7843189208523	0.0004	57	24	PAAD	KINETIN RIBOSIDE	Experimental
233.90512535716823	9.56290710499474	212.54060339827726	-19.6511953031861	0.0006	512	75	UCEC	RU79072	Experimental
139.75161905072926	72.4349047263155	177.9586918268877	-7.2494299798459	0.0004	934	234	BRCA	(−)-NUTLIN-3	Experimental
172.81985927857693	8.27880563769128	209.018094352501	-17.2767879425787	0.0006	502	55	KIRC	N-{(3S,4S)-4-[(6-AMINO-4-METHYL-2-PYRIDINYL)METHYL]-3-PYRROLIDINYL}-N'-(4-CHLOROBENZYL)-1,2-ETHANEDIAMINE	Experimental
591.427265836149	-4.8400846434844	585.0685169482902	-0.00139305722450445	0.384	292	39	STAD	IBUPROFEN	Approved in other pathologies
736.2930286431098	-8.62960626229494	788.3744826239692	14.8367713584175	0.581	423	65	COAD	S-8184	Clinical trials in cancer
795.5687076029587	38.6436596201768	811.0789417145214	8.17560500636586	0.596	512	85	UCEC	MASITINIB	Clinical trials in cancer
94.59066961237338	34.4561503989929	163.32065126558828	2.95821695125545	0.0008	264	111	SKCM	(1E)-N-HYDROXY-5-[1-(4-PIPERIDINYL)-3-(4-PYRIDINYL)-1H-PYRAZOL-4-YL]-1-INDANIMINE	Experimental
192.70226777768755	8.36180450786475	229.98694449044615	-9.04194043763454	0.0006	264	34	SKCM	3-[2-(4-PYRIDYL)ETHYL]-1H-INDOLE	Experimental
314.3552270028695	1.5922545423355	321.00002899530955	0.000186885854532193	0.121	599	105	OV	EDARAVONE	Clinical trials
226.89183910360148	23.2813784544334	200.1056657466645	-14.3693098542955	0.0006	512	53	UCEC	AT001/R84	Experimental
217.4198542527056	-6.05621280472025	200.89032729126947	7.0542600256299	0.0004	292	36	STAD	KINETIN RIBOSIDE	Experimental
767.6186009601778	122.328300793558	777.324668744518	-19.3780206408522	0.562	57	24	PAAD	GSK2636771	Clinical trials in cancer
232.98817017612274	42.1339124006662	211.9144927203854	0.0879198854868264	0.0008	202	32	LAML	ERK INHIBITOR II	Experimental
1176.4819932536004	0.802272183278205	1199.7459678541256	0.0890734064703338	0.999	543	78	LUAD	SORAFENIB	Approved in cancer
264.1454034250416	17.9576342984871	229.51878831972462	6.3958305370752	0.0006	169	44	READ	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
775.9080027243996	-40.6100188190482	796.1451120901474	-6.4873216573481	0.591	512	53	UCEC	ERLOTINIB+BEVACIZUMAB	Clinical trials in cancer
548.9809153637979	8.14024673915617	554.178079330126	-3.7519615354729	0.351	343	84	HNSC	IBUPROFEN	Approved in other pathologies
664.2737386513281	-52.899520504077	765.3684578517519	13.3881620694824	0.533	435	183	THCA	GOSSYPOL	Clinical trials in cancer
288.5899877776574	98.5324017653617	216.12766416174784	40.7586291092482	0.0004	222	127	LGG	NPC-26	Experimental
336.549941760213	50.7754727619583	273.48320007428873	-54.5576284521435	0.0008	264	186	SKCM	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUOROBENZAMIDE	Experimental
561.3958784938642	-5.27979601351757	561.0001025249037	-0.000201553469196369	0.361	153	18	BLCA	CAFFEINE	Approved in other pathologies
772.4626879709876	-56.779611778004	787.919857109059	-10.2206295761623	0.595	292	41	STAD	ALPELISIB	Clinical trials in cancer
197.09918739438064	39.8628423096268	192.43441820399096	23.6547893634861	0.0006	264	34	SKCM	5-(2,6-DICHLOROPHENYL)-2-((2,4-DIFLUOROPHENYL)THIO)-6H-PYRIMIDO(1,6-B)PYRIDAZIN-6-ONE	Experimental
226.91756317476558	-75.6624198310658	168.04460857884118	-45.4956400616445	0.0006	435	212	THCA	(5S,6Z)-4,5-DIFLUORO-6-[(2-FLUORO-4-IODOPHENYL)IMINO]-N-(2-HYDROXYETHOXY)-1,3-CYCLOHEXADIENE-1-CARBOXAMIDE	Experimental
231.28704117369605	-58.1177338219094	239.64856762286857	37.3096087416543	0.0006	435	183	THCA	TRIFLUOROETHANOL	Experimental
254.92138308888525	-25.058712818881	236.04233641981375	2.41484414771861	0.021	512	91	UCEC	TRIPTOLIDE	Clinical trials
561.3632030043768	-0.407684201496664	560.9999454887084	0.000310297667397208	0.361	389	49	LUSC	IBUPROFEN	Approved in other pathologies
178.46719024516318	14.9910775906844	216.48135658554716	-5.58135448989788	0.0004	423	58	COAD	NSC632839	Experimental
135.68158377771607	9.72436253450019	198.3747299290918	-5.62983100760539	0.0008	543	74	LUAD	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
783.8011624830692	50.1257405732777	781.703269635273	-2.90429256407629	0.581	512	74	UCEC	ANTI-THYMOCYTE GLOBULIN (RABBIT)	Clinical trials in cancer
521.2490698424091	5.77661924533351	518.5605860620374	2.9748179206149	0.321	502	57	KIRC	MINOCYCLINE	Approved in other pathologies
193.9537207464022	-0.270981080197004	185.7588755312981	16.943196768703	0.0006	264	34	SKCM	2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE	Experimental
201.013323360677	28.6377240615862	201.67958297604346	-29.1167362979152	0.0006	169	43	READ	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)-1,2-ETHANEDIAMINE	Experimental
930.5784135333823	2.03569805434378	930.364184354517	1.91138838376537	0.731	502	58	KIRC	AFLIBERCEPT	Approved in other pathologies and in clinical trials in cancer
765.562403841299	6.81653151440719	770.955376771819	-6.20613227113677	0.584	543	74	LUAD	PIMASERTIB	Clinical trials in cancer
333.8817182030396	-3.25951590105737	332.2835426897435	-1.77580685912835	0.131	502	56	KIRC	TG100801	Clinical trials
1151.4618914042749	24.8113180730908	1213.8656390859944	-28.5147701322943	0.998	264	131	SKCM	DASATINIB	Approved in cancer
851.1633088745236	2.06414859951013	799.942608490488	5.06880384875353	0.594	292	42	STAD	GEDATOLISIB	Clinical trials in cancer
217.70567693084323	65.2272297905724	188.3198071956349	6.01113132487615	0.0006	264	34	SKCM	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]{3-[(2R)-2,3-DIHYDROXYPROPOXY]PHENYL}METHANONE	Experimental
239.30434314351703	-13.7613698419966	230.74824225837514	-13.3947143787872	0.0006	512	77	UCEC	2-[(5-CHLORO-2-{[2-METHOXY-4-(4-MORPHOLINYL)PHENYL]AMINO}-4-PYRIMIDINYL)AMINO]-N-METHYLBENZAMIDE	Experimental
1183.1777331683095	63.4153988231818	1187.1618523855532	22.8684680036366	0.977	264	113	SKCM	PALBOCICLIB	Approved in cancer
175.8089390283964	-38.5804750631262	194.4895306571186	17.6663923263759	0.0008	423	92	COAD	PURVALANOL B	Experimental
590.5711376760758	6.24886963465138	583.9943441175668	-4.84965470826137	0.381	512	78	UCEC	PEGADEMASE BOVINE	Approved in other pathologies
203.0270722675152	-111.364560518178	254.49201205770387	-6.87729245930939	0.0008	264	181	SKCM	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
991.4272584914986	-3.29346144159024	993.9676146997483	-2.5813257941947	0.792	512	53	UCEC	DALTEPARIN	Approved in other pathologies and in clinical trials in cancer
1139.9883299735618	39.1364268293605	1161.8438266338064	-6.83467056804329	0.932	435	183	THCA	DOCETAXEL	Approved in cancer
218.94299776718182	-31.5249696740495	206.50234665721342	-32.2936258894148	0.0006	512	53	UCEC	VEGF-AS	Experimental
182.27130356559258	-6.80506849855792	191.46750786148405	9.74164100313874	0.0006	502	55	KIRC	ETHYL CARBAMIMIDOSELENOATE	Experimental
1196.3202904302912	24.6510727559818	1197.5463857665593	-5.30226289533465	0.998	512	82	UCEC	DASATINIB	Approved in cancer
580.2015495183011	-21.5190482647869	577.7009134077805	-0.444243853516582	0.381	222	53	LGG	RASAGILINE	Approved in other pathologies
1116.0422956069815	-7.60346221889094	1122.229290876008	2.47608005550046	0.922	502	59	KIRC	DOCETAXEL	Approved in cancer
982.470838369976	-3.69633183823754	986.0896375880507	-3.54485073513331	0.785	512	53	UCEC	RANIBIZUMAB	Approved in other pathologies and in clinical trials in cancer
258.89905052553013	-11.6522906063085	221.2824535437012	-25.8164507717823	0.0006	512	76	UCEC	5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE	Experimental
210.67353263949101	41.8574930918698	213.10593701990337	17.0374547944616	0.0006	264	34	SKCM	6,7-DIMETHOXY-N-[3-(METHYLSULFANYL)PHENYL]-4-QUINAZOLINAMINE	Experimental
205.3822932912891	10.6794632043876	183.72144111790723	23.5142571364108	0.0006	512	53	UCEC	(3R)-5-METHYL-3-{[(10S)-9-OXO-1,8-DIAZATRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL]CARBAMOYL}HEXANOIC ACID	Experimental
1176.6115637603034	46.3642299457215	1145.365110208849	26.7227862762154	0.934	435	212	THCA	REGORAFENIB	Approved in cancer
1139.4389438543867	8.83507113408291	1144.0000313516389	-0.000220531283957826	0.944	153	22	BLCA	PACLITAXEL	Approved in cancer
742.0449019131046	36.2343346999655	752.9997768490232	0.000151869108321989	0.553	599	107	OV	NAVITOCLAX	Clinical trials in cancer
262.1938959296075	-99.6246238437593	202.70258563427646	-18.5197354243583	0.0008	222	127	LGG	ISOCITRIC ACID	Experimental
794.5350236014641	-42.1004994725091	800.4821388041529	17.4752920140668	0.595	423	79	COAD	SONOLISIB	Clinical trials in cancer
180.57117238742694	-10.4847976767212	192.92048738859148	2.46501907330367	0.0006	502	52	KIRC	GLUCOSE-6-PHOSPHATE	Experimental
1181.889247627613	32.034986276374	1181.251166625203	-5.76771357623193	0.988	512	112	UCEC	BOSUTINIB	Approved in cancer
736.0222065304545	-50.6492411797745	720.0463804519646	1.0611863269437	0.523	934	231	BRCA	OMIPALISIB	Clinical trials in cancer
